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Abstract
Perimetry is essential to identify visual field defects in disorders of the visual pathways. In
compliant adults, automated static perimetry (ASP) is the preferred method of visual field
assessment. However, children under 10 years have difficulty with the visuo-motor task and
constant fixation required. Manual kinetic perimetry is often used for children as it can be
adapted to a child’s age. However, it suffers from many of the problems inherent to ASP. In
infants perimetry is limited to the “confrontation” technique which can be imprecise and does
not generate quantitative data. The lack of reliable ASP in children and quantitative perimetry
in infants is a longstanding clinical problem. The aims of this research were to (i) develop, and
(ii) clinically evaluate, a technique for ASP in children which utilises “eye tracking”.
The first part of this research was concerned with the development of the technique, termed
“Saccadic Vector Optokinetic Perimetry” (SVOP). The system comprises a personal computer,
display screen, and an X50 eye tracker (Tobii Technology, Sweden). The eye tracker is non-
contact and provides data on (i) eye position in 3D space, and (ii) the point of gaze. This
allows the screen position of “test stimuli” to be calculated, and eye gaze responses to the “test
stimuli” to be assessed in “real time”. A software algorithm was developed to determine if “test
stimuli” have been perceived based on the direction, amplitude and latency of a subject’s gaze
response.
A feasibility study was conducted with 29 subjects comprising 4 groups: (i) healthy adults, (ii)
healthy children, (iii) adult patients with visual field defects, and (iv) child patients with visual
field defects. Subjects performed SVOP tests which replicated the Humphrey Field Analyser
(HFA) C-40 screening test with a stimulus size of Goldmann III and intensity of 14dB. Subjects
able to do so also performed equivalent HFA C-40 tests for comparison. In healthy subjects
99.1% of SVOP test points were in agreement with a healthy visual field. In patients with visual
field defects, 89.8% of test points were in agreement with HFA equivalent tests. The visual field
defects identified using SVOP in the child patients were consistent with their clinical findings.
A clinical evaluation of SVOP was undertaken in the second stage of this research with 122
subjects comprising the same four subject groups as in the feasibility trial. An “ideal” test
protocol resulted in 8 uniocular visual field tests for each subject comprising 4 SVOP tests
iii
and 4 HFA tests. In children where uniocular testing was not tolerable, two binocular SVOP
tests were performed. The sensitivity and specificity of the SVOP tests were computed using
a direct comparison with reliable HFA tests, and repeatability of SVOP and HFA tests were
assessed using Cohen’s kappa coefficient. In child patients unable to provide a reliable HFA
test, their clinical history, other clinical findings and the repeatability of their SVOP tests were
used to assess the SVOP results. The overall sensitivity and specificity of the SVOP testing
was 72.7% and 96.8% respectively. The sensitivity had a greater variation than the specificity
amongst the different subject groups. The repeatability of SVOP tests was slightly reduced as
compared to the HFA tests across all groups with kappa coefficient’s of 0.65 and 0.74 for SVOP
and HFA respectively. In child patients without reliable HFA equivalent tests the SVOP results
could commonly be associated with other clinical findings and repeatable testing added to the
confidence in the reliability of these cases.
The developed SVOP technique performs well with accurate eye tracking data and an attentive
child. It has proved extremely useful in identifying and monitoring visual field defects in several
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1.1 The clinical problem
Visual field measurement (known as perimetry) is crucial in the diagnosis and management of
children with certain brain tumours, raised intracranial pressure and cerebral visual impairment
(CVI) which can be caused, for example, by the following:1–6
• developmental brain defects,
• asphyxia,
• infections of the central nervous system, and
• head trauma.
In many regions of the world the prevalence of childhood visual impairment is not known.
However, it is thought that complete blindness accounts for approximately one-third of all
visual impairment. In industrialised countries the prevalence of childhood visual impairment,
severe visual impairment and blindness combined has been approximated to be between 10 and
22 per 10,000, while in developing countries it may be as high as 30 to 40 per 10,000.7 Excluding
children who have complete blindness, this means that visual impairment affects approximately
7 to 16 per 10,000 in industrialised countries and 20 to 27 per 10,000 in developing countries.
There is also call for a reliable and sensitive method to monitor visual field changes in chil-
dren who are on the drug Vigabatrin for epilepsy due to a potential visual field constriction
side effect,8–10 and in paediatric glaucoma.11,12 However, the preferred visual field assessment
method, known as automated static perimetry (ASP), is only used in adults as it is not suitable
for use in children.
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ASP requires the patient to fixate on a central target and indicate, by pressing a button, when
they observe light stimuli at various locations in their visual field, so building up a plot of the
patient’s visual field as further stimuli are shown. The test requires a conscious effort by the
patient to inhibit their natural reaction to fixate on the light stimuli. It is very difficult for
children, particularly children below the age of 5 years, to inhibit this natural response13,14 and
maintain stable fixation on a central target.15,16 Also, children have a reduced ability to learn
the task required of them and hence to provide appropriate responses.17 Children are less likely
to cooperate due to their lack of understanding of the test methods and their short attention
span.18–20 Additionally, many children may not tolerate the restrictions of head movement
imposed on them during the test which requires the use of a chin rest. All these factors vastly
reduce the reliability of performing ASP in children and as a result it is not routinely performed
in those younger than approximately 10 years of age.
Alternative methods of perimetry are used to assess the visual fields of children aged between
5 and 10 years. A popular method for this age group, known as Goldmann Kinetic Perimetry
(GKP),21,22 uses light stimuli which are moved manually by the examiner from a blind area
(for example the periphery of the visual field or known blind spot) towards an area where they
can be seen. The patient indicates when they first see the stimuli by pressing a buzzer and this
position is marked by the examiner. This process is repeated at different locations and with
different intensities or sizes of light stimuli to build up a contour map of the patient’s visual
field. GKP gives more control and freedom to the examiner, allowing adaptability to the child’s
age and maturity. However, the child’s cooperation in maintaining a continuous fixation on a
central target during the test is still required. Results are dependent upon the examiner’s skills
and knowledge, and examiner bias is easily introduced.23 In addition, GKP does not provide
the level of detail possible with ASP.
Visual field assessment in children younger than 5 years is currently limited to the technique
of confrontation. The attention of the child is gained using an object such as a small toy while
another object is moved in from the periphery of the child’s vision. The examiner waits to see if
the child orients themselves to view the object and if this does not happen a visual field defect
is suspected. This method of assessment is a very gross technique as it does not generate any
real quantitative data.
The inability of children to accurately perform the more comprehensive adult perimetry tech-
nique of ASP and the lack of any well defined quantitative perimetry in infants is a major
problem in clinical practice. Children born prematurely are known to be at risk of brain ab-
normalities within the visual processing regions.24 As a result it is thought that the number of
children with cerebral visual impairment is rising due the increase in survivors of prematurity.
The early detection of these defects is of great importance in understanding the visual function
of the affected child, and thereby allowing practical advice, to be given if the defect cannot be
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reversed. For example, a child with defective inferior visual field may have impaired mobility
and difficulties with school work which may be helped by the use of mobility strategies and
tilted work desks. Children with brain tumours can also have visual field defects. The ability to
measure these defects would allow early detection and more reliable monitoring of treatment re-
sponses in these patients. Visual field defects occur in children with raised intracranial pressure,
where detection of visual field defect would aid decisions on medical and surgical treatment.
Also, visual field defects can occur as a side effect of taking Vigabatrin, an anti-epilepsy drug.
The drug is used in adults alongside visual field monitoring. However such monitoring cannot
be performed in children and the drug is therefore either used in a way which risks visual dam-
age, or is not used in children who would have otherwise benefited from the improved epilepsy
control it would have provided.
1.2 Purpose of this research
Recognising that ASP is the preferred method of perimetry, in an effort to overcome the dif-
ficulties associated with performing ASP in children under 10 years, researchers have concen-
trated on finding ways of improving children’s test reliability. The development of algorithms
designed to provide faster testing time for ASP such as Swedish Interactive Thresholding Al-
gorithm (SITA) Fast25,26 and Tendency-Oriented Perimetry27 (TOP) have been investigated
with child subjects. However the youngest aged child capable of producing reliable results
remains approximately 7-8 years.20,28,29 Training and familiarisation strategies for particular
techniques have also been investigated as a way of improving reliability.18,30 These research
efforts do not address the fundamental problems inherent in performing ASP on children and
it is a new, child friendly technique which is required. The development and assessment of a
novel technique and system for assessment of visual fields in children is therefore the focus of
this research. The system makes use of relatively new advances in eye tracking technology and
should be more suitable for use with children. The Technique and system, named Saccadic
Vector Optokinetic Perimetry (SVOP)31, uses a personal computer, display screen and an eye
tracker to detect a child’s eye movement when a stimulus is presented in their visual field. The
only task required of the child is to follow their natural reaction to fixate on the stimulus of
interest when they see it, rather than having to maintain continuous fixation on a central target
while stimuli are presented in their peripheral vision. The proposed visual field assessment test
should not require any understanding from the child subject as they are not required to learn
any task or to give subjective responses. The purpose of this research is to:
• develop the technique and system of SVOP, and
• assess the validity of SVOP in children.
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1.3 Summary of thesis structure
This research uses relatively recent advances in eye tracking technology in an effort to solve a
clinical problem within ophthalmology, and so involves two different (although related) topics:
(i) eye movement and eye tracking technology, and (ii) the clinical problem of paediatric peri-
metry. These two topics will be discussed independently in two initial background chapters to
provide readers with sufficient knowledge in both subject areas.
Following the background material, a detailed literature review on methods of perimetry in
children and research efforts, to date, to achieve reliable perimetry in children is presented, and
the specific aims of this research project are also outlined.
There are two main stages to this research: (i) the development of the technique and system
of SVOP for assessment of visual fields in children, and (ii) an assessment of the validity
of the developed system as a diagnostic tool for visual field assessment. These two aspects
of the research make up the contents of the two main chapters (Chapters 5 and 6, “System
Development” and “Clinical Validation Trial”) respectively. Chapter 5 details the aspects of
the system development including theory of operation, the assessment of equipment used, the
physiological data collected and how it is used, and limitations of the system. In addition, a
feasibility study of the technique is undertaken. Within this chapter are several methods and
results sections for each of the individual aspects of the development. Chapter 6 presents the
methods and results for a full clinical validation trial in which the developed system is assessed
as a diagnostic tool by comparison with an established form of adult ASP and as a suitable
form of perimetry for children. Ethical and NHS management approval was gained for both




Background - The human visual
field and its measurement
2.1 The normal human visual field
The visual field is the total area which a person can see when fixating on one location. The
visual field is described in relation to the individual in free space, a normal human visual field
extends approximately 100◦ temporally, 60◦ nasally and superiorly, and 70◦ inferiorly from the
point of fixation for each eye individually. Visual sensitivity is greatest at the point of fixation,
corresponding to the fovea, and decreases towards the periphery in all directions. The visual
field of each eye has previously been described as a hill or island of vision, the peak of which
corresponds to the point of fixation (Figure 2.1).
The shape and height of the hill of vision varies and is dependent upon factors such as patient
age, facial features (for example the nose and eyebrows) and methods of visual field testing (for
example ambient light and the size and duration of visual stimuli used). A visual field defect
is defined as any statistically or clinically significant departure from the expected normal hill
of vision for a particular patient. Specific visual field defects will be discussed in more detail in
section 2.3.1 “Clinical Importance”. However, at this point it is useful to state that visual field
defects (also termed scotomas), are described in terms of size and depth and how much they
depart from the expected normal visual sensitivity. A reduction in, but not total loss of, visual
sensitivity in an area is termed a relative scotoma, whereas total loss of vision in an area is
termed an absolute scotoma. The normal blind spot is an example of a physiological absolute
scotoma due to an absence of photo-receptors at the optic disc.
Considering both the left and right eyes together, there is extensive overlapping of the visual
fields from each eye creating a combined binocular visual field extending approximately 190◦
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laterally, and consisting of a single central binocular region and two peripheral monocular
regions. The visual field of each eye is described in terms of four quadrants laterally and
vertically with the point at which they all meet being the point of fixation.
(a)
(b)
Figure 2.1: The normal right eye hill of vision. (a) The peak corresponds to the point of fixation
where sensitivity is greatest. Sections are cut out to show the sensitivity drop at the natural blind
spot. (b) View from above demonstrating field of view and blind spot location.
2.2 The human visual system
The human visual system, in particular the anatomy of the visual pathways, is important when
understanding the causes of many visual field defects. Problems with the visual system can
lead to very specific changes to the normal visual field, hence by association, assessment of a
patient’s visual field provides a form of diagnosis. This will be discussed in further detail with
particular reference to specific visual field defects in section 2.3.1 “Clinical Importance”. Here,
the anatomy of the human visual system will be discussed so as to provide sufficient information
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to understand the reasons behind specific visual field defects.
The retina comprises three sets of neurones: (i) photoreceptor neurones which exist in the well-
known forms of rod and cone neurons, their function being to commence the visual cycle by
converting light into an electrical signal through photo-transduction. These synapse onto; (ii)
intermediate or bipolar neurones which in turn synapse onto; (iii) retinal ganglion cells. The
retinal ganglion cells conduct action potentials along the visual pathways. A small quantity
of ganglion cells (approximately 10%) are additionally photo-receptive and are involved in
relaying information to the superior colliculus, responsible for controlling eye movements, the
pretectum, which manages the pupillary light reflex and the hypothalamus which regulates
the circadian rhythms. The vast majority (approximately 90%) of ganglion cells project to the
lateral geniculate nucleus (via the optic nerve, optic chiasm and optic tracts) which relays visual
information to the primary visual cortex. There are no synapses between the ganglion cells and
the lateral geniculate body so visual field defects and optic atrophy are caused by damage along
this section of the visual pathways. The visual pathways traverse the optic nerve, the optic
chiasm and an optic tract to end at the appropriate lateral geniculate body in the thalamus.
The thalamus is the major subcortical centre which relays visual information to the primary
visual cortex via the optic radiation.
These visual pathways are shown in figure 2.2. The four quadrants of the visual field for each
eye are colour coded in the figure, along with the individual pathways for each quadrant and
each eye to show the way in which the visual pathways are rigidly structured according to these
sections of the visual field. The pathways are additionally described in the following paragraphs,
each paragraph corresponding to the various sections of the visual pathways after exiting the
eyeballs.
The optic nerves
The physiological blind spot is attributed to the area where the optic nerve leaves the eye at the
optic disc where there are no photo-receptors. The optic nerve is rounded and carries approxim-
ately 1.2 million axons towards the optic chiasm. Initially nerve fibres with visual information
from the macula region are situated temporally within the optic nerve. At approximately 1cm
behind the eyeball, the retinal artery (heading towards the eyeball) enters the optic nerve, and
at this same point, the nerve fibre bundles carrying visual information from the various parts
of the visual field move so that the macular bundle now occupies the centre of the optic nerve
and peripheral retinal fibres are situated peripherally, heading towards the optic chiasm.
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Figure 2.2: The human visual field and corresponding visual pathways. The four visual field
quadrants of each eye are colour coded to enable depiction of the various pathways carrying visual
information from each quadrant. Additionally, the pathways of the left nerve fibre bundles are
shown with dashed lines while those from the right eye are displayed with full lines.
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The optic chiasm and optic tracts
At the optic chiasm the optic nerves from the left and right eyes meet and approximately 50%
of the axons cross over to the opposite pathway and 50% continue on the same side. Vision
in the nasal visual field stimulates the retina on the temporal side of the fovea and the fibres
carrying these impulses pass through the chiasm without decussating. Vision in the temporal
field causes stimulation in the retina on the nasal side of the fovea and these fibres cross to
the opposite optic tract. Information about the right side of the visual field now passes along
the left optic tract, and conversely, information about the left side of the visual field is located
on the right side of the brain along the right optic tract. All the nerve fibres concerned with
vision pass along the optic tracts from two posterior corners of the optic chiasm to the lateral
geniculate bodies.
The lateral geniculate bodies
The nerve fibres from each of the optic tracts end at the Lateral Geniculate Nucleus (LGN)
in the thalamus where they synapse with nerve cells. Fibres arising from upper quadrants of
the retina (relating to the inferior quadrants of the visual field) end in the medial portion of
the body. Those arising from the lower quadrants of each retina are represented laterally. The
LGN is composed of six layers of cells (figure 2.2). The layers are numbered 1 to 6. Layers
1, 4 and 6 correspond to information from the contralateral (crossed) fibres of the nasal visual
field. Layers 2, 3 and 5 correspond to information from the ipsilateral (uncrossed) fibres of the
temporal visual field. Additionally, specific LGN layers are concerned with visual functions such
as the processing of colour and fine detail (the parvocellular layers 3 to 6), and the detection
of depth and motion (the magnocellular layers 1 and 2).
The optic radiation
From the lateral geniculate body, fibres of the optic radiation fan out as they pass to the
primary visual cortex. Specifically, fibres representing the superior visual field pass through the
temporal lobe of the brain (known as Meyer’s loop) and fibres representing the lower visual field
pass through the parietal lobe of the brain in the retrolenticular limb of the internal capsule.
The primary visual cortex
The primary visual cortex has a representation of the contralateral visual hemifield. The foveal
region is mapped in the most posterior part of the visual cortex, whereas more peripheral parts
of the visual field are mapped in progressively more anterior parts. The upper visual field is
mapped on the lower bank of the calcarine sulcus, the lower visual field on the upper bank.
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2.3 Visual field measurement - perimetry
2.3.1 Clinical importance
Due to the well defined nature of the visual pathways, lesions involving the pathways can have
a very well defined effect on the visual field. Characteristic visual field defects can be observed
when lesions are present at different locations along the visual pathways meaning visual field
assessment can be a highly useful form of diagnosis. Most visual field defects resulting from
CVI respect (do not cross over) the horizontal and/or vertical midlines of the visual field (which
intersect at the point of fixation).
Figure 2.3 shows the types of visual field defects that would develop due to lesions at various
sites along the visual pathways. It is possible to determine which defect corresponds to each
site due to the structured anatomy of the visual pathways bearing in mind the following points
relating to the anatomy of the visual pathways:
• The retinal image is reversed and inverted with respect to the visual field such that the
temporal visual field is projected to the nasal part of the retinas and the nasal visual field
is projected to the temporal side of the retinas. Similarly, the superior and inferior visual
fields are projected to the inferior and superior parts of the retinas respectively.
• Nerve fibres resulting from the temporal half of the visual field from each eye cross over in
the optic chiasm resulting in fibres carrying information about the left visual field passing
along the right optic tract and those carrying information about the right side of the
visual field passing along the left optic tract.
• Posterior to the optic tract, nerve fibres carrying information about the lower and upper
visual field separate. Those carrying information about the inferior visual field are found
in the superior optic radiation, those with information relating to the superior visual field
are located in the inferior radiation (Meyer’s loop) passing through the temporal lobe.
Loss of half of the visual field is called a hemianopia. Loss of half of the visual field on the
same side of each eye is termed a homonymous hemianopia, for example a lesion in the left
optic tract causes a right homonymous hemianopia. If visual field loss is in the temporal fields
of each eye it is termed a bitemporal hemianopia, and if it is in the nasal fields it is termed a
binasal hemianopia. A quadrantanopia is the term for loss of vision in a quadrant of the visual
field and additionally may be termed superior or inferior depending on whether the upper or
lower visual field is affected. Similarly these types of defect can also be homonymous and
bitemporal/binasal.
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Figure 2.3: The human visual pathways, potential lesion sites and resultant visual field defects.
The resultant visual field defects (coloured black) are shown on the right and correspond to the
9 lesion sites shown along the visual pathways.
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Types of field defects are discussed in further detail, with reference to the various areas within
the visual pathways, in the following paragraphs.
The optic nerves
Lesions in the area behind the eye and anterior to the chiasma (termed retrobulbar lesions),
whether due to inflammation or compression, usually give rise to central scotoma (figure 2.3,
lesion site 1). The scotoma in these cases typically occupies both sides of the central midline.
If a field defect is limited to one eye then the site of the lesion must be anterior to the chiasma.
If there is a complete lesion of an optic nerve then this results in total blindness in one eye
(figure 2.3, lesion site 2).
The optic chiasm
Assessment of visual field defects is extremely important in the diagnosis of chiasmal lesions.
A pituitary tumour will cause bitemporal field defects if the tumour is in the midline as it
will compress the crossed nasal fibres first (figure 2.3, lesion site 4). The uncrossed temporal
fibres may still remain undamaged due to their wider position. Pressure on an optic nerve
at its junction with the chiasma interferes with the anterior knee of Wilbrand and the inferior
peripheral retinal nasal fibres from the other eye may be impaired resulting in an upper temporal
quadrantic defect in that eye’s visual field. An inferior temporal quadrantic defect would result
from interference with the posterior knee of Wilbrand. However, this is less commonly seen.
Pressure on the chiasma in the midline posteriorly by an expanding pituitary tumour hinders
conduction in the macular crossing fibres and tends to cause bitemporal central defects.
The optic tracts
A complete lesion of an optic tract will cause a total contralateral homonymous hemianopic
defect, for example a right homonymous hemianopia is caused by a complete lesion of the
left optic tract (figure 2.3, lesion site 5). However, partial lesions of the optic tract are more
common. These will also cause contralateral homonymous defects, but due to the position of
the retinal nerve fibres which relate to the various areas of the visual field, incongruity often
results, with different patterns of visual field loss in the two eyes. As such, marked incongruity
in partial hemianopia indicates a tract lesion, since lesions of the optic radiations cause only
mild incongruity, and striate lesions are highly congruous. A lesion of any part of the visual
pathway anterior to the lateral geniculate bodies causes optic atrophy in addition to visual field
defect. The nearer the lesion to the eyeball, the earlier the atrophy occurs. Atrophy can be
seen in a retinal image as pallor of the optic disc and may take months to appear due to an
optic tract lesion. This is one reason why visual field assessment is essential in tract lesions.
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The lateral geniculate bodies
Lesions of the LGN are relatively uncommon due to their small size and secluded location.
Tumours of the temporal lobe are those which most frequently affect this area. By the time
they are large enough to damage the visual pathway they distort the adjacent structures so
much that it is often difficult to be sure whether the interference is in the posterior end of the
optic tract, the LGN, or beginning of the optic radiation. All three structures may be involved.
The main defect seen with LGN lesions is an incongruous hemianopia, much like that seen with
optic tract lesions, reflecting the continued segregation of ocular inputs in the LGN.
The optic radiation
The optic radiations can potentially be affected anywhere along their paths and the type of field
defect is still related to the site of the damage. Damage close to the visual cortex usually causes
a complete homonymous hemianopia (figure 2.3, lesion site 8). A quadrantanopia results from
interruption of either the superior or inferior optic radiation (clinically this usually involves a
lesion in either the parietal or temporal cortex) or alternatively from a partial lesion of the
visual cortex. Lesions of the ventral fibres in the anterior temporal lobe cause a contralateral
superior quadrantanopic visual defect (figure 2.3, lesion site 6). Lesions of the dorsal fibres in
the parietal lobe cause an inferior quadrantanopic defect (figure 2.3, lesion site 7). Because
there is no sharp demarcation of the dorsal fibres from the ventral fibres in these portions of
the posterior pathway, the defects do not always conform to the horizontal midline.
The primary visual cortex
Lesions of the visual cortex produce homonymous contralateral hemianopic field defects. How-
ever, unlike the defects from lesions of the optic radiations and the optic tracts, the hemianopic
defects from visual cortex lesions are highly congruent, with virtually identical defects in the two
eyes. Complete destruction of visual cortex causes a complete homonymous hemianopic visual
field defect, but because this involves not only peripheral vision but also the contralateral half
of the foveal region, it is called a macular-sparing homonymous hemianopia (figure 2.3, lesion
site 9). Most cortical lesions are not large enough to affect the whole extensive cortical area
representing the macular, thus leaving some of the area unaffected. Macular splitting hemian-
opias can occur with complete lesions anywhere along the post-chiasmal visual pathways, and
can thus lack localising value. In these cases other signs may help in localisation, such as optic
atrophy and the relative afferent pupillary defect with optic tract lesions.
Of course, neuroimaging can provide highly detailed images which are used to confirm diagnosis
and monitor disease, but due to the characteristic visual field defects which can arise as a result
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of many neurological disorders, quantitative visual field testing is also of immense value in
diagnosing and managing the causes of CVI. In addition to simple and quick diagnosis visual
field testing also provides an effective way of monitoring response to treatment over time.
Retina
Whilst the main cause of visual impairment in children is attributed to CVI, in addition to these
it is also useful to mention retinal diseases which cause visual field defects and in particular
glaucoma. Visual field testing has a role in diagnosing and treating many retinal diseases.
However, direct observation of the retina through ophthalmoscopy is also of great value in
retinal disease diagnosis as defects will often correspond to inflammatory or degenerative disease
which can be seen with the ophthalmoscope. Perimetry becomes one of many supplementary
examinations. Retinal lesions cause field defects that correspond to the path of the retinal
nerve fibres or to the area of supply of the retinal blood vessels and they can cross the vertical
midline through the fovea. For example, arcuate defects which commonly occur with glaucoma
conform to the course of the retinal nerve fibres and also cross the midline. Although glaucoma
is the most well-known and most commonly occurring retinal disease, arcuate scotoma can also
occur in other retinal conditions.
Glaucoma refers to a group of diseases that affect the retina and which cause damage to ret-
inal ganglion cells resulting in visual field loss presenting in a characteristic pattern. Raised
intraocular pressure (IOP) is the main significant risk factor for developing glaucoma. IOP is
related to the production of liquid aqueous humour by the ciliary processes of the eye and its
drainage through the trabecular meshwork. Aqueous fluid flows from the ciliary processes into
the posterior chamber. It then flows through the pupil of the iris into the anterior chamber,
bounded posteriorly by the iris and anteriorly by the cornea. From here the fluid is released into
general blood circulation through drainage channels in the trabecular meshwork. In the normal
eye, the fluid produced is equalled by the fluid draining out. However, a pressure increase will
result if it cannot drain away properly or too much is produced. If the eye is under increased
pressure damage can occur which is dependent on the increased level of pressure and how long
it has existed and additionally whether there is a good blood supply or any other weakness to
the optic nerve.
Glaucomatous visual field loss usually occurs first in the so-called Bjerrum areas of the upper and
lower hemifields. These two areas curve around the macula, extending upward and downward
from the blind spot toward the nasal field in two arcs. Early glaucomatous field defects often
take the form of relative scotomas, or small regions of decreased sensitivity. Defects in the nasal
field are particularly common, and sensitivity differences across the horizontal meridian are often
used diagnostically, particularly in the nasal hemifield. Perimetric testing of glaucoma patients
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is rarely done outside the central 30◦ field because only a small percentage of glaucomatous
defects occurs in the peripheral field alone. Types of glaucoma are listed in the following
paragraphs.
Primary open angle glaucoma is the most common form of glaucoma, occurring over time it
is often referred to as chronic glaucoma. There is reduced flow through the trabecular meshwork
with IOP rising very slowly. Initially there are no symptoms and if it is not diagnosed and
treated, it will cause a gradual loss of vision without noticeable sight loss for many years. It
will usually respond well to medication particularly if diagnosed and treated early. However,
sight loss sustained is irreversible.
Angle closure glaucoma (also known as acute or narrow angle glaucoma) differs from open
angle glaucoma in that there is a sudden and more rapid increase in IOP due to the iris being
pushed forward against the trabecular meshwork, blocking fluid from escaping. Treatment of
angle closure glaucoma usually involves surgery to create a small hole in the peripheral iris (a
procedure known as “laser iridotomy”). This allows aqueous fluid to flow through the hole in
the iris and bypass the resistance flow at the pupil. With equalisation of pressure between the
anterior and posterior chambers, the iris is no longer pushed forward and settles into its normal
position allowing IOP to return to normal. Symptoms of angle closure glaucoma may include
headaches, eye pain, nausea, rainbows around lights at night, and very blurred vision.
Normal tension glaucoma (also known as low-tension or normal pressure glaucoma) causes
damage to the optic nerve and resultant visual field loss despite a normal IOP level. The reason
for this is not well-known. However those at higher risk for this form of glaucoma are those
with a family history of normal tension glaucoma and people with a history of systemic heart
disease. It is treated with medication or surgery which will maintain a low IOP.
Secondary glaucoma is caused when a rise in eye pressure is caused by an additional eye
condition for example as the result of an eye injury, inflammation, tumour or by certain drugs
such as steroids. This form of glaucoma may be mild or severe. The type of treatment will
depend on whether it is open angle or angle closure glaucoma.
Paediatric glaucomas consist of congenital glaucoma (present at birth), infantile glaucoma
(appears during the first year) which by convention is also often referred to as congenital, and
juvenile glaucoma (above infancy through the teenage years), and all the secondary glaucomas
occurring in the paediatric age group. Congenital glaucoma is present at birth. However
sometimes symptoms are not recognised until later in infancy or early childhood. It is very
important to catch paediatric glaucoma early in order to prevent blindness.
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2.3.2 Methods of perimetry
Visual field testing (known as perimetry) is the method by which the extent and the sensitivity
of the visual field is measured. Perimetry may be kinetic or static and manual or automated.
Methods of perimetry are described in this section with reference to some common instruments
and strategies used for visual field measurement.
2.3.2.1 Visual threshold
An important concept in perimetry is visual threshold. Each point within the visual field has a
visual threshold level. The threshold level at a location within the visual field is defined as the
weakest stimulus that is visible in that visual field location, such that at that location all visual
stimuli that are larger or brighter than the threshold stimulus can be seen and those smaller or
less bright cannot be seen. A stimulus that is stronger than the threshold stimulus is described
as a suprathreshold stimulus.
A threshold visual field test seeks to identify the visual threshold levels within the visual field
area that is tested, while a suprathreshold test is used to identify defects but not identify the
depth of these defects.
2.3.2.2 Static & kinetic perimetry
There are two main techniques used for presenting visual stimuli – static and kinetic perimetry.
Static perimetry involves presenting stimuli at specific locations and recording whether or not
the stimuli are seen at each location, while kinetic perimetry involves the presentation of a
stimulus which is moved from an area where it is unseen towards an area where it is expected
to be seen (this is usually in a direction towards the fixation point), and this point is recorded.
Static perimetry asks, “What is the visual sensitivity for a specific location?”, while kinetic
perimetry asks, “Where is the threshold for a specific stimulus?” In general, kinetic methods
are used in manual perimetry and static methods are used in automated perimetry. However,
kinetic perimetry can make use of static methods, and kinetic perimetry can be performed by
some automated perimeters.
Static perimetry
In static threshold perimetry, the patient is instructed to look at a fixation target which is
located in a central position. Once fixation has been achieved, a visual stimulus (usually in
the form of a spot of light) is presented at a location within the visual field and the patient
indicates whether they have seen it. The visual stimulus presented is of a specific size and
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brightness intensity and is presented on a screen with known background intensity. The size
of the stimulus and the background illumination are kept the same throughout the test and
the dimmest stimulus that can be seen (the threshold level stimulus) at specific predetermined
locations of interest in the visual field is determined by trial and error using stimuli of varying
brightness. The method is termed static perimetry as specific locations are chosen and the
stimuli are presented at these locations without being moved.
Static threshold perimetry is useful in that it determines the sensitivity of locations in the
visual field. However, it can be time consuming and is not a good method for determining the
boundaries of a visual field as this requires a large number of visual field locations to be tested.
Automated perimeters now include strategies which shorten the testing time and this technique
is the most widely used method of perimetry.
Similarly static perimetry can be suprathreshold, where the threshold is not specifically de-
termined at locations within the visual field, but it is determined whether or not the patient
can see stimuli presented at a specific brightness level in a static fashion. A suprathreshold test
is useful as a fast screening test to quickly identify visual field defects of a certain level but not
quantify the specific threshold level.
Kinetic perimetry
A continuous line connecting common threshold levels within the visual field is termed an
isopter. Visual stimuli greater than the threshold cannot be seen outside the region surrounded
by an isopter line but can generally be seen everywhere inside the isopter region. The isopter
line is in effect a boundary between “not seeing” and “seeing” a stimulus of a certain intensity.
Because of this fact the location of the isopter for a given stimulus can be determined by moving
the stimulus from an area where it is not seen towards an area where it is expected to be seen.
This is usually from the periphery toward the point of fixation.
In kinetic perimetry the patient is instructed to look at a fixation target which is located in a
central position and a stimulus of a specific brightness and size is moved from an area where
it is not seen toward an area where it is expected to be seen. When the patient first sees the
stimulus they communicate this to the examiner and the location is recorded. This process
is repeated from several directions toward the central fixation point until the isopter can be
drawn by connecting the points recorded. Several different isopters can be drawn by repeating
the process with visual stimuli of differing intensity or size. When several isopters are plotted
together on a chart, they give a picture of the overall extent of the visual field and a measure
of the sensitivity of the visual field, depending on how far the isopters extend for a particular
size and intensity of stimulus.
It should not always be assumed that all areas inside an isopter boundary line will respond
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to the isopter level or brighter stimulus. An area of visual field defect (scotoma) could be
contained within the boundaries of an isopter. These can be found kinetically by moving the
stimulus around inside the isopter boundary and having the patient indicate if the stimulus
dims or disappears at any point. A scotoma found could then be mapped by presenting the
stimulus in a non-seeing area and moving outward until seen. The determined location of the
isopters depends on the rate of movement of the stimulus and the reactions of the patient.
2.3.2.3 Non-quantitative perimetry: the confrontation technique
Not all methods of visual field testing quantify the visual threshold at representative locations
in the field. For certain diagnostic purposes, quantified threshold determination may not be
necessary or possible (e.g. in young children).
The confrontation visual field test is a quick screening test that can determine the limits of
the visual field and can also detect large visual field defects.32,33In adults the test involves
a comparison of the patient’s visual field with the examiner’s visual field. The patient sits
facing the examiner and is instructed to look at the examiners face (a specific feature such as
the nose or one eye is often used) with one eye covered. The examiner also covers their eye
(corresponding to the same eye as the patient) so that the visual fields of the examiner and
patient will correspond. The examiner holds up some fingers in each of the visual field quadrants
in turn and the patient must identify how many fingers are presented at each location. If the
patient is unable to confirm the presence of the examiners fingers or is unable to identify the
number of fingers a visual field defect can be suspected. A problem with the procedure described
above is that the limits of the visual field are not tested, and an alternative method whereby
the examiner moves their fingers slowly in from the periphery of vision until the patient sees
them can be used.
Monocular confrontation testing in adults and older children (which depends on congruence
between the visual field of the examiner and patient) is routine. However, in infants, younger
children and older patients unable to participate in monocular testing, binocular testing will
often be performed. The child’s gaze is attracted to an interesting (but not too captivating)
central stimulus. For example, a toy or face is an appropriate central stimulus if the child is
less than 6 months old. Then a dynamic stimulus is presented peripherally while observing
the orienting eye and head movement of the child towards the peripheral stimulus if it is seen.
This dynamic peripheral stimulus will often take the form of another toy or graded white balls
(known as Stycar balls) which are also commonly used for assessing visual acuity in young
children.34
The confrontation method is simple to perform and does not require a great deal of equipment.
However, it is only useful for detecting large field defects such as hemianopia and quadrantanopia
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and results are imprecise and not quantifiable. In children, its usefulness is limited by the
attention and concentration of the child and the technique is dependent on examiner experience.
The confrontation method is widely used and is currently very important in visual field as-
sessment in children because, despite its lack of quantitative data, it is often the only form of
perimetry possible in these patients.
2.3.2.4 Perimetry devices & strategies
There are two main types of equipment in regular use for testing the visual field. These
are manual projection devices and automated perimeters. This section provides an overview
on each type of device with specific reference to two of the main perimeters used for the
manual projection and automated techniques (The Goldmann Perimeter and the Humphrey
Field Analyser).
Manual projection perimetry: the Goldmann perimeter
Manual projection perimeters require the examiner to control the stimulus selection and present-
ation. A commonly used example of the manual perimeter is the Goldmann perimeter which is
a device employing the kinetic perimetry method.
The Goldmann perimeter standardised many of the variables in perimetry testing. The back-
ground light level was standardised by using an evenly illuminated bowl into which the patient
looks and the “test stimuli” were standardised by enabling them to be varied by known specific
increments of brightness and size.
Testing is performed with one eye covered so as to perform uniocular testing. The patient is
instructed to maintain fixation on a central target at all times and light stimuli are moved
manually by an examiner through the use of a mechanical projection system. The patient
indicates when they first see the stimuli by pressing a buzzer. This process is repeated to build
up a contour map of the patient’s visual field (as described in the section 2.3.2.2). Figure 2.4
shows the Goldmann manual projection perimeter.
19
Figure 2.4: The Goldmann manual projection perimeter.
The Goldmann standard - stimulus intensity
Brightness intensity, also termed luminance, is measured in the SI units of Candelas per meter
squared (cd/m2). However, another unit also used for luminance is the apostilb (asb) where:
1 cd/m2 = 1 asb/π
The Goldmann perimeter can project a spot light stimulus with a maximum luminance of 1000
asb onto a bowl illuminated with a background luminance of 31.6 asb. Light stimuli at different
intensity (luminance) levels are created by the use of filters which attenuate the light intensity
by specified amounts.
The attenuation of light is expressed in decibels (dB) on a logarithmic scale related to the
maximum stimulus luminance such that a ratio between the maximum luminance and a level
of stimulus luminance can be expressed in dB by:





Where LdB is the stimulus luminance measured in dB, LMax is the maximum luminance for
that device and LStim is a luminance value corresponding to a specific stimulus luminance (so




As these logarithmic values relate to the maximum stimulus luminance available for a given
perimeter, 1 dB on one device may not be equivalent to 1 dB on another unless they have the
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same dynamic range (and other test conditions such as background luminance). For example,
the maximum stimulus on Goldmann perimeter is 1000 asb while on the Humphrey Field
Analyser (a device discussed in the next section) it is 10,000 asb, so 1dB represents a luminance
of 794.3 asb on the Goldmann perimeter, but 7943 asb on the Humphrey Field Analyser.
The units of dB rather than absolute luminance values are often used because visual percep-
tion relates well to ratios between light intensities rather than differences between them. For
example, the sensation related to doubling the intensity from 50 to 100 asb is equivalent to the
sensation of doubling the intensity from 500 to 1000 asb, even though the latter involves an
increase of 500 asb. An additional advantage of using logarithmic units is that visual threshold
can be examined over a wide range.
The Goldmann perimeter standardised this method of presenting varying levels of stimulus
luminance. In order to provide this wide luminance range the Goldmann perimeter is equipped
with three sets of filters designed to attenuate light from the maximum luminance level. The
first set of filters (with notation 1 to 4) attenuate light in steps of 5 dB such that filter 4 produces
no attenuation, filter 3 produces a 5dB attenuation, filter 2 produces a 10dB attenuation and so
on. A second set of filters (with notation a to e) attenuates the light in steps of 1dB such that
filter e provides no attenuation, filter d provides attenuation of 1dB, filter c provides attenuation
of 2dB and so on. One filter from each set is used in combination to provide varying levels
of light attenuation from the maximum, and the notation used to describe the attenuation is
simply the number-letter combination. Additionally, a third set of filters can be used which
allow a 20 dB or 40 dB attenuation. The notation for when either of these two filters are used
is to place a single or a double bar above the previously described number letter combination
(for the 20 dB and 40 dB filter respectively). For the Goldmann Perimeter (with maximum
luminance of 1000 asb) several decibel, luminance and Goldmann notation values are shown in
table 2.1












Table 2.1: Stimuli dB, luminance and Goldmann notation for the Goldmann Perimeter.
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The Goldmann standard - stimulus size
The projected stimulus light spot is described in terms of area (with a known distance between
the eye and the screen) or in terms of the angular diameter of the stimulus (i.e. the angle
subtended by the stimulus to the eye). The Goldmann perimeter has the patient’s eye located
at a distance of 30cm from the screen and uses notation in Roman numerals to define five
standard sizes (Table 2.2).






Table 2.2: The Goldmann standard stimulus sizes.
The Goldmann perimeter - advantages and disadvantages
The Goldmann perimeter is best suited for kinetic perimetry. It enables the examiner to test
both central and peripheral fields with one instrument, it is relatively inexpensive and can
provide basic visual field information in a relatively fast and efficient manner. When it was
introduced it standardised many of the variables associated with perimetry. However, the main
disadvantage of the instrument is that the movements of the stimuli are controlled by the
operator, limiting the reliability of serial visual field results. It cannot perform static perimetry
efficiently and so is rarely used for this purpose meaning that it can be difficult to detect and
investigate smaller scotomas.
There are significant disadvantages with using this system in children, in addition to examiner
dependence and skill, a child has to maintain a fixed head position in front of a hemispheric bowl.
This requires prolonged cooperation by the child who will need teaching and encouragement to
reinforce good central fixation, because it is harder for children to suppress the natural orienting
eye movements. Furthermore, “reaction time” may be delayed in very young children, and in
older children with developmental difficulties, and the speed of the kinetic scan must be set
slower than with adults, at 2-3 degrees per second for example.
Automated perimetry - the Humphrey Field Analyser
Due to the fact that it is difficult to standardise and reproduce results with manual kinetic
perimetry methods, the automated perimeter has now become the standard (in adults). Auto-
mated perimetry predominantly uses static perimetry as its technique, although some auto-
mated devices also offer the capability of kinetic perimetry (despite it not being routinely
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used). Most automated devices are also capable of both static threshold and suprathreshold
(screening) tests. There are many devices from various manufacturers capable of automated
static perimetry. However, the Humphrey Field Analyser (HFA), from Carl Zeiss Meditec, is
the most commonly used computer assisted static perimeter and as such has virtually become
a standard in its own right. The HFA is shown in figure 2.5.
Figure 2.5: The Humphrey field analyser.
To accomplish full threshold testing, the HFA presents stimuli of variable intensity randomly
at different retinal coordinates within a bowl with constant photopic background illumination.
Fixation is maintained on a central “fixation” point and the patient indicates that the stimuli
are seen by pressing a button for the computer to record which stimuli are seen and which are
not. The intensity of a stimulus presented at a given location is decreased from a previous
presentation if the patient saw the previous stimulus at that location, and vice versa. This
requires a computer decision based on the accumulated responses of the patient. The process
is repeated until threshold levels for each location have been reached.
For static suprathreshold testing, stimuli of a selected intensity are presented in predetermined
locations, and the perimeter simply records for each location whether the stimulus was seen or
not. Some important aspects of automated static perimetry devices, and of particular relevance
to the HFA, are discussed below.
Stimulus size
While in kinetic perimetry both the size and the intensity of a stimulus may be adjusted to
achieve a range of isopters, in static threshold perimetry the size of the stimulus is kept fixed
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during a test and only the intensity is changed. A common stimulus size used by automated
perimeters is a size equivalent to Goldmann size III (table 2.2), because the smaller size I at
maximum intensity is not a strong enough stimulus to quantify the full depth of some defects.
Stimulus intensity
In static perimeters that use uncovered LEDs the stimulus intensity is simply the intensity of
light produced by the LED. In projection perimeters the total luminous intensity in the spot
of light is the intensity of the background plus the additional light projected as a stimulus.
However, the stimulus intensity is still usually expressed simply as the amount of light (in
apostilbs) projected onto the existing background or the corresponding dB level despite the fact
that it is not the absolute intensity but the difference between the spot and the surrounding
“background” that is relevant to the visual perception tested in perimetry.
Static threshold strategies
In automated perimetry a bracketing or “staircase” strategy is used to determine threshold
levels. At each visual field location, stimulus brightness is first changed in large steps until
the boundary from invisibility to visibility (or vice versa) is crossed. This brackets the general
range of luminance that contains the threshold value. Then going back and forth with smaller
increments of luminance, the threshold is more accurately determined. The various automated
strategies differ with regard to how it is determined when the end point has been reached and
with regard to the interval of luminance used in the final steps. The threshold is not necessarily
determined at one location before moving on to another. These details affect how long the
test takes as well as the precision of the threshold value obtained and its reproducibility on
retesting. The strategy used is beyond the control of the examiner and they must depend
on the manufacturer for a reasonable compromise between accuracy and the time required to
perform the test.
Several methods are used to reduce the time required for the visual field test by anticipating
the threshold at each location. One estimate is the normal expected threshold value for the
age of that person. This method provides a good estimate for nearly normal fields, but not
so good for those with more severe defects. Another estimate is the threshold determined on
the previous visual field examination in that individual. This method is particularly useful for
abnormal fields but depends on the instruments having the capability of storing and retrieving
the previous test results. Another method (called prethresholding), effective for both normal
and abnormal fields, is to determine threshold completely at one point in each quadrant and
then use the value obtained at each spot as a starting point for determining threshold at the
several immediately adjacent points, the values at those locations are then used as starting
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points for the next series of surrounding points, and so on. This method uses the fact that an
abnormal visual field point is likely to be surrounded by other abnormal points while normal
points are likely to have other normal points adjacent to them.
Printouts
When static perimetry is performed at numerous locations, as is typically done in full threshold-
ing programs of automated perimeters, the results may be reported as threshold values printed
on a map of the visual field. To aid in perceiving a diagnostic pattern at a glance, a greyscale
is often also provided. Each grey level represents a certain small range of threshold values.
The boundary between the grey levels is equivalent to an isopter. In some printouts not all the
locations with a greyscale symbol are tested. Untested locations may be assigned a presumed
threshold value (calculated by interpolation from neighbouring points that were tested) to shade
in the greyscale plot and make the contour of the isopters easier to appreciate. As with kinetic
perimetry, the threshold is known only at the points tested and the threshold at other locations
is either estimated or assumed.
Additional features
Automated programs may also (routinely or as an option) perform “catch trials”. To catch
false-positive responses (in which the patient responds to a light they did not see), the device
may make all the mechanical sounds of presenting a stimulus but not actually do so. Doing this
several times during a test allows calculation of the proportion of times the patient responds to
a non presentation. To catch false-negative responses, a bright stimulus is presented in a known
seeing region of the field and the number of times the patient fails to respond to it is recorded.
Various methods are used to monitor the steadiness with which the patient maintains visual
fixation on the central target. The Heijl-Krakau methods consist of presenting a “test stimulus”
in the known position of the physiologic blind spot.35,36 The patient can see it only if the eye
has wandered from the central position of gaze. In other instruments fixation is monitored by
the image of the pupil or a corneal reflection. This method is continuous whereas the Heijl-
Krakau method is an intermittent sampling of fixation steadiness. Neither of these automatic
methods is totally satisfactory for fixation monitoring. The best method is direct observation
by the perimetrist, either through a telescope or on a video monitor.
One advantage of static fields is that it produces numerical data at pre-determined points which
can be handled statistically. Despite these there are limitations for its use in children and only
children above 8 to 10 years are capable of the vigilant rapid response and good fixation required
so it is rarely used in this patient group.
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Chapter 3
Background - Eye movements and
eye tracking technology
3.1 Human Eye Movements
For any application of eye movement instrumentation the type of eye movements to be observed
must be understood. There are three main categories of eye movements which are related to
the situations in which they occur:
• fixational eye movements,
• gaze shifting movements, and
• image stabilising movements.
The following three sections (3.1.1, 3.1.2 and 3.1.3) describe the specific eye movements within
each of the three categories listed above which are relevant to this research. By way of example,
prior to the detailed descriptions in the following three sections, several types of eye gaze
movements are shown in figure 3.1. The figure shows horizontal and vertical eye gaze position
on a computer screen and demonstrates fixation, saccadic eye movement and smooth pursuit.
Screen position is measured in pixels and the location (0,0) refers to the top left corner of
the screen. Initially fixation is maintained at a screen location of (800,800) before a saccadic
fixation change to an area in the top right of the screen where fixation is again maintained prior
to a smooth pursuit eye movement back to the original screen location. The data within this
figure was collected using a Tobii x50 eye tracker (Tobii Technology, Danderyd, Sweden) at a















Figure 3.1: Horizontal and vertical gaze position on a computer screen demonstrating fixation,
saccadic eye movement and smooth pursuit. Screen position is measured in pixels and the
location (0,0) refers to the top left corner of the screen. Initially fixation is maintained at a
screen location of (800,800) before a saccadic fixation change to an area in the top right of the
screen where fixation is again maintained before a smooth pursuit movement back to the original
screen location.
3.1.1 Fixation movements
Fixation movements include a variety of motions which are generally less that 1◦ in amplitude
and occur during fixation on a target. Drift is the slow random motion of the eye away from
a fixation point at velocities of only a few minutes of arc per second. Flicks, or microsaccades,
are small rapid eye movements which have been shown to be dynamically of the same nature
as large voluntary saccades, of magnitudes as large as 1◦, occurring at intervals separated by as
little as 30ms and which generally redirect the eye towards the position necessary for fixation on
the target. Both flicks and drifts tend to occur along a single preferred axis in any individual.
There is currently no general agreement on the error-correcting nature of the flicks or drifts.
In addition normal individuals fixating on targets exhibit a high frequency tremor in the range
30 to 150Hz with peak amplitudes of approximately 30 arc seconds in the region of 70Hz.
Because of the presence of these fixation movements, accuracy of 0.5 to 1◦ is often sufficient in
eye-monitoring tasks designed to show what part of the visual field is being fixated.
The role of microsaccades in visual perception has been a debated topic which is still largely
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unresolved. It has been proposed that microsaccades correct displacements in eye position
produced by drifts, although non-corrective microsaccades also occur. Microsaccades were also
believed to prevent the retinal image from fading, but they do not occur often enough for that
purpose, considering that perfectly stabilised images can disappear from perception in a few
seconds or less. The current consensus is that all fixational eye movements are important for
the maintenance of visibility.
Some of the errors in eye gaze data produced by eye trackers can be eliminated because mi-
crosaccades of equal magnitude and direction will typically occur in both eyes at the same
time, whereas errors due to the eye tracking technique will seemingly occur randomly without
correlation between the left and right eye (as can be seen in figure 3.1).
3.1.2 Gaze shifting movements
Of the three gaze shifting mechanisms detailed below, the saccadic eye movement is of most
importance in this research as it is saccadic movement which is to be detected and measured
as part of the automated perimetry test developed. Smooth pursuit and vergence movements
are described briefly for completeness.
3.1.2.1 Saccades
Saccadic eye movements are the fast, conjugate movements by which fixation is changed from
one point to another voluntarily with the purpose of fixating an image of a target of interest on
the fovea. They are characterised by very high initial acceleration and a peak velocity during
the motion which varies with the amplitude of the saccade and may be as high as approximately
600◦/s.37 The duration of a saccadic eye movement also varies depending on its magnitude,
with saccades larger than 5◦ lasting approximately 20-30ms plus 2ms for each additional degree
of amplitude.38,39 Head movement is often involved when the target motion exceeds 30◦. In
response to a visual stimulus saccadic eye movements exhibit a variable latency from 120-
350ms or more which is dependent on several factors such as the task being undertaken or the
brightness of the stimulus which triggered the saccadic eye movement.37,40
3.1.2.2 Smooth pursuit
Pursuit movement is the ability of the eyes to smoothly follow a moving object. These slow
tracking conjugate eye movements are used to track slowly moving visual targets (less than
approximately 30◦/s) and the pursuit of targets moving with velocities larger than this usually
require catch-up saccades.41 The purpose of smooth pursuit movements are again to stabilise
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the image of a moving target or background on the fovea, independent of the saccadic eye-
movement system. Smooth pursuit movements are not generally under voluntary control and
usually require the existence of a moving visual target for their execution.
3.1.2.3 Vergence
Vergence eye movements are movements of the two eyes in opposite directions in order to com-
bine the image of near or far objects. These movements are considerably slower and smoother
than the fast conjugate saccadic eye movements and are normally performed unconsciously in
response to visual objects which are closer or further away from the eyes, being stimulated by
focusing error as well as binocular disparity.37
3.1.3 Image stabilising movements
The understanding of these types of eye movements is useful so as to enable comprehension of
some limitations of the developed perimetry device and additionally for understanding some
patient eye movement disorders. So for these reasons, and for completeness, several types of
image stabilising eye movements are briefly described below.
3.1.3.1 Optokinetic reflex
The optokinetic reflex allows the eye to follow repeating pattern targets while the head remains
static. It demonstrates a characteristic sawtooth pattern of eye motion occurring as a result
of a moving visual field containing repeated patterns. Optokinetic reflex consists of a slow
phase, where the eye fixates on and follows a particular moving target with pursuit motion, and
then a fast phase or return saccadic “jump” where the eye fixates on a new location, reversing
the previous pursuit motion. The minimum time between fast phases is approximately 0.2s,
resulting in a maximum frequency of 5Hz, although the reflex frequency may be less for slow
field motions. The amplitude of the optokinetic reflex is variable, generally from 1 to 10◦.42
3.1.3.2 Vestibulo-ocular reflex
The vestibulo-ocular reflex (VOR) is an eye movement which stabilises images on the fovea
during head movements. It is primarily attributable to stimulation of the semi-circular canals
and the otoliths in the inner ear. The vestibulo-ocular reflex has both rotational and transla-
tional aspects. When the head rotates about any axis, be that horizontal (head rotation up and
down), vertical (head rotation left and right) and torsional (head rotation along line of sight,
often called “counter-rolling”), images are stabilised on the retina by rotating the eyes about the
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same axis but in the opposite direction. When the head translates, during walking for example,
visual fixation is maintained on a target by rotation of the eye by an amount that is dependent
on the distance to the target.
The “gain” of the VOR is defined as the change in the eye rotation angle divided by the change
in the head rotation angle such that equivalence between the two angles would result in a gain
of 1.0. The gain of horizontal and vertical VOR is usually close to 1.0, but the gain of the
torsional VOR (rotation around the line of sight) is generally lower and varies depending on
several factors including the amount of head tilt.43,44
3.2 Eye tracking
Eye tracking is the method of measuring the point of fixation usually by measuring the motion
of an eye relative to the head. An eye tracker is a device for measuring eye movement and
computing point of gaze.
3.2.1 Eye tracking uses
Measurement of the direction of gaze has long been of interest. It can provide information
of clinical importance for example in oculomotor disorders such as nystagmus and neurological
disorders where eye movement characteristics are important in diagnosis. In psychology, reading
specialists have understood the importance of measuring gaze for assessing good reading practice
and its importance for child development. Additionally much research has been conducted
looking into visual searching behaviour and the patterns of perceiving and processing visual
information. Human factors engineers, concerned with the design of systems and the placement
of controls and displays (for example in the design of helicopter cockpits) are interested in
gaze patterns while looking at instruments, controls, and the world scene. Research engineers
interested in biological control systems and bionics have found eye movement control systems
particularly challenging. However there are now assistive technology systems which are able
to aid with communication by using eye movements in people with certain disabilities such as
cerebral palsy. In more commercially orientated research, such as advertising and marketing,
the evaluation of the effectiveness of visual stimuli are of interest and can be made using
measurements of gaze and also pupil size as indicators of levels of interest. More recently web
site usability has become a subject of great interest and ability to monitor gaze is highly useful
in these studies.
The wide range of possible interest and applications involving assessment of eye movement and
gaze position has resulted in a wide variety of measurement techniques.42
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3.2.2 Eye tracking methods and technologies
3.2.2.1 Historical techniques
Direct observation would have been the first technique for determining the nature of human eye
movement and is still the basis for fast clinical tests employed today to diagnose nystagmus or
gross disorders of the saccadic or pursuit tracking systems. Direct observation obviously suffers
from the shortcomings of no quantitative data and the lack of any record.
Early researchers were particularly imaginative in developing mechanical methods to detect and
record eye movements. For example, a light rod fixed directly to the cornea of an anaesthetised
eye by means of a plaster-of-paris ring. The mechanical motion of the rod, passing through a
number of levers to amplify its motion, was recorded directly on a rotation drum kymograph.45
A later development took advantage of the shape of the cornea to detect the movement of
the corneal bulge through a closed eyelid. All these direct mechanical techniques, of course,
interfered with the normal eye movements, but set the standard later surpassed by photographic
and photoelectric techniques.
In the early 1900’s photographic records of eye movements were made. Horizontal eye position
could be tracked by the displacement of the light-dark boundary between the sclera and the
iris. Use of continuous constant speed film later extended the method. A number of researchers
improved the photographic technique by attaching some bright foreign object to the eye.46–48
The use of direct high-speed motion-picture photography for recording torsional eye movements
later became one of the most reliable and simple techniques for measurement about that axis. In
all direct photographic techniques, each frame is compared with master calibration photographs
to determine the angle of eye movement. These methods were expensive and required excessive
time during post-processing of individual frames to determine the history of eye movements.
The contact lens has also been used as a method of direct contact eye tracking. Eye movement
could be measured using a magnetic sensor or mirror embedded in the lens providing accurate
measurements with tight fitting lenses.49–51 The main issue with these techniques is the comfort
of the subject. For example many earlier systems were painful, had to be performed under
anaesthetic, did not allow the subject to blink and could not be used over very long periods.
3.2.2.2 Current techniques
The techniques currently in use for measuring eye movements can be grouped into two main
categories:
• methods using the electrical characteristics of the eye (electrooculography), and
• methods using the optical properties of the eye (video-oculography).
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Electrooculography (EOG)
The position of the eye can be measured by placing skin electrodes around the eye and recording
potential differences. The source of the electrical energy is the corneoretinal potential which
changes with respect to the rotation of the eye. The cornea remains approximately 1mV positive
with respect to the retina, attributable to the higher metabolic rate at the retina. Usually, pairs
of electrodes are placed either above and below the eye or to the left and right of the eye. As
the eye rotates, the electrostatic dipole rotates with it. Consequently, a potential difference
occurs between the electrodes and assuming that the resting potential is constant, the recorded
potential difference is a measure for the eye position. This is not constant though which causes
the method to be unsuitable for measuring slower eye movements and fixations, and is better
for measuring the fast saccadic eye movements. It is most commonly used to measure rapid eye
movements during sleep.
The recorded potentials are small, in the range of 15 to 200μV, with nominal sensitivities of
the order of 4μV per degree of eye movement. These signals are at times difficult to detect in
the presence of large muscle-action-potential artifacts, which can also be picked up as potential
differences by the skin electrodes. EOG accuracy is 0.5 to 1.5° with sufficient care in preparation,
and has an advantage in that is works well with large eye movements (up to ±90°).
Video-oculography (VOG)
VOG uses optical techniques which generally do not have any contact with the head by analysing
light reflections (often infrared) from the eye. One or more characteristic reflections are detected
and measured for changes in position. The reflection from the cornea and the location of the
pupil are features often used. Optical methods, particularly those based on video recording, are
widely used for gaze tracking and are favoured for being non-invasive and unobtrusive. There
are different types of VOG setups, they may be head mounted, non-contact but requiring fixed
head position (e.g. using a chin and forehead rest), and more recently non-contact devices
allowing head movement. Those which are non-contact and also allow head movement must
also track the location of the eyes by computing eye position optically or magnetically (which
requires a head mounted transmitter and an additional receiver somewhere nearby).
Methods of VOG
Limbus tracking. The limbus is the boundary between the white sclera and the dark iris of
the eye. Due to the fact that the sclera is (normally) white and the iris is darker, this boundary
can easily be optically detected and tracked. This technique is based on the position and shape
of the limbus relative to the head, so either the head must be held quite still or the apparatus
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must be fixed to the user’s head. Due to the more or less occasional covering of the top and
bottom of the limbus by the eyelids, limbus tracking is more suitable for precise horizontal
tracking only.
Pupil tracking. Tracking the direction of gaze by the pupil tracking technique is similar to
limbus tracking, only here the smaller boundary between the pupil and the iris is used instead.
Once again, the apparatus must be held completely still in relation to the head. An advantage
of this technique over limbus tracking is that the pupil is far less covered by the eyelids than
the limbus, and thus enables additional vertical gaze tracking. The disadvantage is that the
difference in contrast is lower between the pupil and iris than between the iris and sclera-thus
making the border detection more difficult.
Corneal and pupil reflection relationship. The most widely used current designs are
video-based eye trackers. A camera focuses on one or both eyes and records their movement
as the viewer looks at some kind of stimulus. Most modern eye-trackers use infrared and near-
infrared non-collimated light to create a corneal reflection and also to locate the centre of the
pupil. The vector between these two features can be used to compute gaze intersection with a
surface after a simple calibration for an individual.
When (infrared) light is shone into the user’s eye, reflections occur from the boundaries of the
lens and cornea (known as the four Purkinje images). The first Purkinje image from the front
of the cornea, called the glint, is the brightest and this, together with the reflection of light
off the retina (the so-called bright-eye corresponding to the pupil) can be video-recorded using
an infrared sensitive camera as a very bright spot and a less bright disc, respectively. When
the eye gaze changes, the relative positioning of the glint and the centre of the bright pupil
change accordingly, and the direction of gaze can be calculated from these relative positions.
Additionally head movements can be compensated for, so long as eye position is known so
as to allow computation of gaze angle and target intersection, as head movement does not
significantly change the position of the bright “glint” on the eye. Figure 3.2 shows images of
a subject’s eye taken using a simple computer camera with a white LED mounted above it.
Images were then taken with the subject’s eye staring straight ahead but in different locations
(a and b), and also gazing in different directions (c - f) to demonstrate the principle of the
corneal-pupil reflection technique.
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Figure 3.2: The pupil-corneal reflection eye tracking technique. The figure shows a left eye and
how the relative positions of the bright “glint” and pupil change under different gaze and head
positions. a) gaze straight forward. b) gaze straight forward after head translation left. c) gaze
left. d) gaze right. e) gaze down. f) gaze up.
Two general types of eye tracking techniques are used: bright pupil and dark pupil. Their
difference is based on the location of the illumination source with respect to the optics. If the
illumination is coaxial with the optical path, then the eye acts as a retroreflector as the light
reflects off the retina creating a bright pupil effect similar to “red eye”. If the illumination source
is offset from the optical path, then the pupil appears dark because the retroreflection from the
retina is directed away from the camera.
Bright Pupil tracking creates greater iris/pupil contrast allowing for more robust eye tracking
and greatly reduces interference caused by eyelashes and other obscuring features. It also
allows for tracking in lighting conditions ranging from total darkness to very bright. But bright
pupil techniques are not effective for tracking outdoors as extraneous IR sources interfere with
monitoring.
Eye tracking setups vary greatly; some are head-mounted, some require the head to be stable
(for example, with a chin rest), and some function remotely and automatically track the head
during motion. A sampling rate of approximately 50/60 Hz is most common as this is sufficient
to monitor eye movements for most applications. Larger sample rates (>200Hz) are available
for applications which are interested in studying the detail of fixational eye movements for
example.
The problems associated with this technique are primarily those of getting a good view of the
eye. Lateral head movement can put the video image of the eye out of focus, or even make the
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image of the eye fall out of view of the camera. The range over which the direction of gaze can be
tracked by simple software algorithms is ±12◦ to 15◦ due to the fact that further eye movement
may render the glint outside the spherical part of the cornea. More complex algorithms are




Literature review and research aims
4.1 Literature review - perimetry in children
Existing “gold standard” techniques for visual field assessment, namely devices utilising ASP, are
not routinely used in children and remain a “gold standard” only in the adult population. Many
researchers have documented the problems which prevent accurate ASP testing in children.
Difficulties in learning the task required to perform the test17, maintaining a stable fixation
on a central target15,16 and sustaining attention and concentration18–20 are some of the major
contributing factors which lead to poor test reliability with young children. Additionally, for
children below the age of approximately 5 years it is difficult to inhibit the natural saccadic
response that is normally triggered by the sudden appearance of light stimuli in the visual
field13,14,52 also leading to poor test performance. Some children may also not tolerate the
restrictions of head movement imposed on them during the test as they are required to place
their head on a chin and forehead rest facing an immersive bowl shaped screen.
As discussed in previous chapters, the methods of visual field assessment in children are highly
dependent upon their age. For example ASP is not routinely performed in those younger
than approximately 10 years of age,53 and visual field assessment in children younger than 5
years is limited to the technique of confrontation which provides only very limited detail.54
However, visual field assessment is still crucial in the diagnosis and management of children
with certain brain tumours, raised intracranial pressure and cerebral visual impairment, caused
by developmental brain defects, asphyxia, infections of the central nervous system and head
trauma2–6. There is also call for a reliable and sensitive method to monitor visual field changes
in children who are on the drug Vigabatrin for epilepsy due to a potential visual field constriction
side effect,8–10 and in paediatric glaucoma.11
Recognising the difficulties associated with performing perimetry in children, previous research
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has largely concentrated on using various current perimetry techniques (used normally in the
adult population) on children, and investigating the lower limits of age that can be tested. This
review reports on these studies. The two main traditionally used methods of perimetry can be
divided into kinetic and static perimetry. Studies involving these main types of perimetry will
be discussed first. In addition, there are also a number of more recently developed “computer
graphics” perimetry techniques and the use of these techniques in children is also reviewed.
4.1.1 Automated static perimetry and kinetic perimetry
4.1.1.1 Automated static perimetry
As stated, the majority of studies have focused on how to use current adult ASP techniques with
children. These studies have all involved using testing strategies which have become available
as standard on ASP devices (designed mostly to reduce test time), and also by introducing new
strategies not routinely used, for example training and familiarisation procedures.
Tschopp et al. (1995)55 recognised the difficulties of performing computerised static perimetry
on children due to the problems of fixation stability, concentration, and reliability of results, and
so investigated using a familiarisation strategy for children aged between 5 and 8 years before
performing a one-level screening test (where one bright light is presented at each location) with
a 12 point visual field test pattern. It was found that this form of ASP examination could
provide reliable results (based on an analysis of false-positive catch-trials) in children as young
as five years old once a familiarisation procedure had been conducted and so long as the duration
of the familiarisation phase and test phase did not exceed the child’s capacity to remain task
focused.
A year later the same group extended this initial investigation with increased numbers of pa-
tients.30 The study involved 42 subjects aged 5 - 8 years with unremarkable ophthalmic history.
They used an Octopus 2000R perimeter, which uses the automated static perimetry technique
with central fixation and a button to press when light stimuli are seen within the visual field,
with a custom made test pattern consisting of 12 test locations within the central 15◦ of the
visual field and using a two level strategy, meaning that at each location both a bright and a dim
stimulus was shown during the test. A preliminary familiarisation phase specifically adapted to
the age group was introduced which demonstrated how to perform the test by showing the light
stimuli presented while the subject fixated centrally and how and when to press the buzzer.
False positive and false negative catch trials were used to evaluate the subjects’ reliability. The
familiarisation phase was found to be mandatory for the children to perform well with regard
to the duration of the examination and the reliability of the answers. The detection of stimuli
improved with age, but the difference between the age groups when considering the catch trials
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was not significant, allowing the group to conclude that children as young as 5 years were able
to give reliable answers to the two-level screening test.
Encouraged by these preliminary results, the same group conducted a study to first validate
a testing procedure involving a familiarisation phase, and to obtain normative visual field
threshold values in children 5-8 years old. This has been reported in the literature in two
parts.18,56
In part 1 the approach of the familiarisation procedure was introduced. To perform the tests,
the child was sat in a specially designed chair able to adjust and tilt appropriately to enable each
child to sit with their chin rested against a specially adapted support. The task was introduced
as a tale where an image of a little bear was used as a fixation target and the light stimuli
were described as stars. The children were instructed to press the button in response to seeing
the stars and were told that the bear was happy when the child looked at him, but very sad
when they looked at the stars. The familiarisation procedure consisted of 4 phases gradually
introducing different aspects of the test and using custom made field tests on the Octopus 2000R
perimeter. Phase 1: subject introduced to the task using bright stimuli. Phase 2: as phase 1 but
using supra-threshold stimuli. Phase 3: bright stimuli with the addition of catch trials. Phase
4: as phase 3 but using supra-threshold stimuli. The examination phase used a test consisting
of 12 supra-threshold stimuli, 12 false-positive catch trials and 3 false-negative catch trials. This
test was repeated up to a maximum of 15 times but the trial was stopped if the child showed
any signs of fatigue. The average total duration for familiarisation and examination was about
30 minutes. Age had a marked effect on reliability where, with the exception of the 5-year-olds
and one six-year-old, false positive rates were less than 20%. Endurance increased significantly
as age increased with a large increase in the number of tests that could be performed. It was
concluded that most children as young as five could undergo an examination by ASP. However
there are several factors which mean that reliability and endurance is a significant issue when
testing these younger subjects. Maintaining fixation on the central target while paying attention
to the peripheral stimuli was the most taxing requirement and high rates of no-response and
false-negatives demonstrated signs of fatigue. However, the amount of testing (although not
all done in a single test) which could be performed was impressive, and it was this which lead
the research group to perform a similar trial in order to obtain normative threshold values for
children within this age group.
In part 2 the children underwent a familiarisation which was the same as that described above
with the addition of one phase consisting of 12 supra-threshold stimuli, 12 false-positive catch
trials and 3 false-negative catch trials. A week later quantitative examination was performed
according to a specially designed schedule divided into three phases to build up a 76-point
threshold visual field test for the right eye. The three phases were designed in such a way that
a meaningful test pattern could still be produced should the participant not complete phase 2
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or 3. Normative threshold values were obtained for all the age groups. However, there were
less data for the younger subjects due to no 5-year-olds being able to complete phase 2 and
no 6-year-olds able to complete phase 3. It was suggested that 5- and 6-year olds had higher
threshold levels but these could have been inflated by non physiological factors.
It is impressive that this group were able to perform threshold testing on such a young age
group. However the testing procedure required lengthy familiarisation phases using custom
tests and multiple examination phases which would not be practical in a busy clinical setting.
There also was a clear worsening of reliability and endurance with the younger children in these
studies.
Several groups have investigated using ASP in children because of advances made to the al-
gorithms which control the way a test is conducted in order to shorten testing times without
sacrificing accuracy. The Swedish Interactive Thresholding Algorithm (SITA) is one such
algorithm.25,26,57 The SITA strategy was developed specifically for threshold ASP (on the
Humphrey Field Analyser) and uses a combination of the usual stair-case strategy with the
introduction of probability procedures. The principles are as follows. For each location the
initial stimulus is presented at an estimated sensitivity and subsequent presentations are de-
termined using a 4dB/2dB staircase (such that the presented stimuli are shown initially in 4dB
steps then once sensitivity threshold is crossed this changes to a 2dB change). In addition,
with the presentation of each stimulus and subsequent patient response, two probability func-
tions describing the likelihood of threshold levels at that location are created. One probability
function gives the probability for each threshold value assuming the location is normal, the
other describes the probability for each threshold value assuming the location is abnormal. The
location threshold is determined if either one of the probability functions has a small enough
variance between two subsequent responses or if two reversals are achieved in the staircase.
Another accelerated thresholding algorithm used to reduce test time (developed for the Octopus
2000R) is Tendency-oriented perimetry (TOP). Each test location is assessed such that the
subject’s response at that location is used to assess not only sensitivity at that location but
also to modify the current sensitivity estimate of neighbouring locations within the visual field.
This results in each threshold estimate being based on one direct response and three indirect
responses from neighbours.
Donahue et al. (2001)28 investigated using the SITA algorithm as a means of visual field assess-
ment on children by performing a retrospective review of all automated visual field assessments
performed on children (17 years and younger) over a period of 16 months. The patient age
range was from 73 to 227 months). In their ophthalmology department they originally used the
Humphrey Field Analyser with the full threshold test (FTT), (i.e. no time saving algorithm
used) and then converted to using SITA in 1999. They then also began using it on children as
well as adults based on their experiences with the adults. They performed the 24-2 field test
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which tests visual field sensitivity in 56 locations within the central 30◦ field. It was found that
SITA reduced the test time by over 50% to an average of slightly over 6.5 minutes when com-
pared with FTT. This study was focused on comparing experiences using SITA and FTT and
was not designed to look at reliability in the younger aged children. However, it is interesting
that this group have used ASP in children in the clinical setting, though it is clear that it is
not performed on children below 6 years and there were few results from 6- to 8-year olds.
Another group looked at using an improved version of SITA (the SITA Fast algorithm) in
children with prepubertal idiopathic intracranial hypertension.58 26 patients were included in
the study ranging from 2 to 11 years. The youngest age patient able to perform the SITA
Fast test was 4 years and it was reported that two patients (aged 4 and 5 years) were unable
to perform the test. They found that the reliability of the tests was not dependent on age
although stated that the small sample size could impact the results. It is not clear what test
pattern was employed or how many of each age group performed the testing, and although it
was concluded that SITA Fast testing can be performed from 4 years of age, it is clear that not
every young child has the ability to perform this type of testing.
Two groups have looked at using TOP in children. Morales et al (2001)20 performed visual field
testing using the Octopus TOP-32 program on 50 normal children aged 6 to 12 years. They did
not use any form of adaptations or familiarisation strategies and testing was performed in the
normal clinical setting. All subjects successfully completed all tests leading them to conclude
that TOP programs can be successfully performed on children as young as 6 years. However,
in children aged 6 and 7 years there was significant inter-individual variability and testing
success was more dependent on the child’s maturity and ability to communicate. Morales et al.
concluded that training and familiarisation to the test is needed before a real test is performed
on children.
Brown et al. (2005)29 performed visual field testing on 142 healthy children aged 6 to 13 years
of age. The study was designed to gain normative threshold values in children of this age group
and concluded that comparison against the programmed normal mean sensitivity values for
20-year-olds is appropriate but additionally found that both learning and fatigue effects were
evident across the subject group and that the false positive response rate was high irrespective
of the child’s age. Additionally, the 6-year-old children showed high inter-subject variability
and so were excluded.
Also recently, Wabbels et al. (2005)59 reviewed the use of two new test strategies, Continu-
ous Light Increment Perimetry (CLIP) and Fast Threshold (FT), in children in the standard
clinical setting. CLIP is performed on a Twinfield perimeter. Stimulus intensity is increased
incrementally (at a rate of 1 dB per patient reaction time) starting from a stimulus brightness
5 dB below the expected (age corrected) threshold value until the patient responds. The Fast
threshold technique is a full threshold technique staircase strategy which uses threshold values
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that have already been determined during the test to adjust the initial presentation brightness
for neighbouring points which are yet to be tested. In this study 28 children aged 5 to 14 years
were examined using these two techniques with a short teaching phase where a few stimuli were
presented under test conditions. Testing reliability was highly dependent on age, maturity and
ability to concentrate and reliable results could be obtained from many children upwards of 8
years of age. It was also found that testing using CLIP was easier than with the FT strategy
as it can be quicker and produces less false-positive errors. However, many of their results were
still found to be unreliable and further research was called for.
Akar et al (2008)60 investigated which visual field testing strategies on the HFA were most
appropriate for the paediatric population by assessment of false-positive, false-negative and
fixation loss scores when using Fast-Pac (another form of time saving algorithm which uses
a staircase strategy with 3dB steps and crosses threshold only once) and SITA Fast. Of 68
participants (aged 6-13 years) all but 8 participants successfully completed the tests. The
children older than 8 years produced significantly higher test reliability scores, but SITA Fast
seemed to be the more reliable method of visual field assessment and could be a promising
strategy for visual field assessment in the paediatric population.
The key points and conclusions of the literature involving children and ASP are summarised
in table 4.1. The use of familiarisation strategies can improve how well children are able to
perform ASP and the introduction of new faster thresholding algorithms has no doubt pushed
the boundary of the lower age limit for visual field testing. However, the introduction of
familiarisation phases introduces longer testing sessions increasing the chances of fatigue which
is also a reported problem when performing ASP in children. Despite the success of some of the
research groups in performing threshold and suprathreshold ASP, the technique has not found
its way to being used routinely for children in the clinic and is highly unlikely to be used in the
younger children (younger than 6 years) because of the widely reported problems of compliance
and variability. The normal drawbacks of ASP such as the need for continuous fixation on a
central target is still the main problem with these ASP methods.
4.1.1.2 Kinetic perimetry
Manual kinetic perimetry such as Goldmann and double-arc perimetry (a form of kinetic peri-
metry with LEDs located on arcs which can be rotated) are among the methods which have
been more popular techniques used to assess visual fields in children. This is because manual
kinetic perimetry gives more control and freedom to the examiner. The examiner can provide a
greater level of guidance and encouragement while continuously monitoring fixation, and tailor
the test to the child’s level of attention and comprehension. However, more recently these types





















































































































































































































































































































































































































































































































































































































































































































































































































































examiner bias and is dependent upon the examiner’s skills and knowledge.23 Test data does
also not provide quantitative information for serial comparison.
There are few publications in the recent literature exploring the lower limits of age when using
the manual kinetic approach. Instead, studies have either used the method of kinetic perime-
try for investigating specific visual field defects in children because it is the most appropriate
method for doing so. For example studying the type of field defects present in paediatric glau-
coma12, children who received cryotherapy as infants61, or those treated with Vigabatrin62–64
or for examining normative values of the visual field in children21,22. These studies have pre-
dominantly used Goldmann Kinetic Perimetry and while the youngest age tested was 4 years,
most studies did not attempt testing in children as young as this opting to test 6 years and
above only.
Studies which have involved even younger children have predominantly used the double-arc
perimeter.65–70 These studies were concerned with measuring the extent of the visual field only.
However, the technique could be performed in the very young (infants).
One study has looked at the use of more recent automated kinetic perimetry in children to
overcome the problems of examiner bias.71 They found that children as young as 5 years could
be reliably tested.
Both the ASP and manual kinetic perimetry methods still suffer from the same problems when
looking to examine the visual field in young children, in that they both require the need for
continuous fixation on a central target and high levels of concentration and endurance. As such
there is a distinct lack of perimetry testing in children below the age of 5 using these methods
even in research, and these are the main reasons why these methods have never been widely
introduced into paediatric clinical practice.
4.1.2 Recent “computer graphics” perimetry techniques
Several newer methods of perimetry which use a personal computer and a liquid crystal dis-
play (LCD) screen along with techniques which differ from the classical differential light sense
measurements, i.e. estimates of simple achromatic contrast thresholds, have emerged in recent
years. These can loosely be termed “computer graphics” perimetry techniques and each has
its own advantages which has led to the plausibility of using it in children or for exploring a
particular paediatric disease. As a result these “computer graphics” perimetry techniques have
been investigated for use with children. Each of the techniques and their use in children is
reviewed here in sections corresponding to each perimetry technique.
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4.1.2.1 Rarebit perimetry
In recent years, new methods of perimetry that use a personal computer with LCD screens
have emerged. Once such method is rarebit perimetry. The conventional “white-on-white”
perimetry, that is where white light stimuli are projected onto a white background screen, has
been shown to have poor sensitivity to early neural damage in glaucoma.72,73 One possible
contributing factor to this effect is that test targets are relatively large and so will be assessing
many overlapping visual receptors. Rarebit perimetry was developed in order to overcome this
issue.74 The test presents tiny light stimuli (“rare bits” or also referred to as “microdots”) half
the normal minimum angle of resolution. The microdots are presented in test areas (a total of
30 areas each 5 degrees in diameter) within the central 30 degrees of visual field. In each test
area two dots are shown at a time and the patient must report if they see none, one or two
microdots. Microdots are shown at different locations 5 times within each test area resulting
in 10 microdots for each test area. Rarebit perimetry does not return threshold values, but
rather, returns a hit/miss rate for each test area. A normal subject should return close to a
100% hit-rate implying that the visual neural architecture is complete, whereas in disease, loss
of connections of retinal ganglion cells or disconnection further along the visual pathways results
in a lower hit-rate. It is designed to enable the detection of mild visual functional damage and
so is useful in early detection of glaucoma.
Martin (2005)75 investigated the use of rarebit perimetry in children and adults. In addition
to rarebit perimetry, frequency doubling perimetry was also investigated on the same group of
participants but will be discussed separately in the next section “frequency doubling technology
perimetry”. There were 21 healthy children included in the study with an age range of 6.5 to
12 years and it was found that reliable results were obtained using rarebit perimetry in 76%
of the children. There was a significant correlation between age and fixation errors and it was
concluded that the test was suitable for children aged 7 years and older. A disadvantage of
rarebit perimetry is the high false positive response rate which reduces the reliability of the
test. Moreover, subjects need to possess fairly sophisticated motor skills to respond to the test
appropriately (i.e. single or double button presses to indicate the number of microdots seen).
However Martin found that rarebit perimetry was popular amongst many of the children due
to its similarities to a computer game and does not require the subject to place their head in
an immersive bowl screen but does use a chin rest.
Martin et al. (2007)76 again investigated the use of rarebit perimetry in children. Fifteen
children aged 6-15 years with paediatric glaucoma, and 15 age and sex matched healthy children
performed rarebit perimetry and were also examined by Goldmann manual kinetic perimetry.
All children in the control group showed a normal hit-rate with rarebit perimetry. 8 eyes from
the paediatric glaucoma group were found to have a normal rarebit hit-rate compared with
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15 eyes found to be normal using Goldmann Kinetic Perimetry. It was concluded that rarebit
perimetry was able to detect glaucomatous damage in various types of paediatric glaucoma
among children as young as 6 years.
4.1.2.2 Frequency doubling technology perimetry
Frequency doubling technology (FDT) perimetry is a technique also developed fairly recently.77–79
Frequency doubling refers to a perceptual effect seen when an achromatic sinusoidal grating of
low spatial frequency (less than 3 cycles per degree) undergoes counterphase flickering at a high
temporal frequency (larger than 7Hz), the apparent spatial frequency of the grating appears to
be doubled.80,81 FDT perimetry does not require a judgement on behalf of the patients as to
whether doubling is present, rather FDT simply measures grating contrast detection thresholds
for sinusoidal stimuli that fall within the frequency-doubling range. This is a technique which
has shown promise for detection of glaucomatous visual field loss in adults82 and has now more
recently been used in several studies to investigate its usage in children because it can have a
shorter test time than ASP (less than 6 minutes per eye), uses a larger stimulus target, has
tolerance to relatively large refractive errors and consists of a more convenient office setup. The
most notable advantage of FDT that is relevant in children is that the fixation target appears
to move and this attracts the child’s attention more effectively. The children’s head is placed
on a visor in front of an LCD screen and not in a bowl which can cause some children to feel
claustrophobic. Several studies have looked into how reliable FDT perimetry is in children, as
follows:
Becker et al. (2003)83 aimed to determine if children could complete a screening program of
FDT perimetry reliably. 259 normal children (mean age 10.7 years, range 4-17 years) were
recruited to perform a FDT screening test and results were analysed for reliability using the
false positive error and fixation loss counts and also the detection of visual field defects. False
positive errors were below 1 among all groups except the youngest (4 year-olds) and fixation
errors decreased as age increased. It was concluded that children aged 10 years and older can
reliably complete the FDT screening test.
Nesher et al. (2004)84 also tested the feasibility of FDT perimetry in children. 40 Children
aged 5 to 10 years were recruited to perform the C20 threshold test on the Carl Zeiss Meditec
FDT analyser in both eyes. In contrast to Becker et al. it was found that test reliability was
similar between children aged 5 to 7 years and those aged 8 to 10 years, possibly due to the
more stringent reliability criteria used by Becker et al.
Blumenthal et al. (2004)19 recruited 40 children aged 4 -14 years to also complete the C20
threshold test. Two consecutive tests were performed on one randomly chosen eye and the
better of the two examinations (as indicated by mean deviation from normal threshold levels)
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was used for analysis of reliability indices which again included fixation losses, and false positive
and false negative errors. In addition global indices of mean deviation (MD) and pattern
standard deviation (PSD) were recorded and used as an assessment of reliability. MD and PSD
are values which show how much the whole field departs from what is expected to be normal. At
younger than 8 years of age, 43% of the visual field tests were considered unreliable, compared
with 23% from children over the age of 8 years. Again, reliability as measured by the reliability
indices and MD were found to be highly correlated with an increase in age.
Martin (2005)75 investigated the use of FDT perimetry (and also rarebit perimetry as described
in the previous section) in children and adults. There were 21 healthy children aged 12 years
or younger included in the study with the youngest being 6.5 years. Also included in the study
were 30 teenagers and young adults (aged 14 to 20 years). Participants performed two types
of FDT tests: (i) a screening program (C-20-5), and (ii) a threshold program (N-30). 57% of
the children in the younger group produced reliable test results for the C-20-5 screening test
according to the criteria, defined by the manufacturer, of less than 30% erroneous responses as
measured by both fixation losses and false positives. However, all of the unreliable results in
this group were as a result of fixation errors and if the more strict criteria defined by Becker et
al was used,83 only 3 of the 21 children (14%) were able to produce reliable test results. The
reliability was vastly improved when considering the older group where 95% produced reliable
results. 57% of the younger group also produced reliable results when performing the FDT
N-30 threshold program, and 90% of the older group produced reliable results for the N-30
threshold test (when using the manufacturer reliability guidelines). The group had concluded
that children could reliably perform RB perimetry from 7 years of age. However, the children
found FDT perimetry more difficult to perform and the majority (88% of all participants)
preferred RB perimetry to FDT perimetry.
Most recently Quinn et al. (2006)85 aimed to test visual field thresholds of normal children using
FDT. They assessed testing times, fixation losses and MD with respect to age and used test
results to produce some normative paediatric threshold data for FDT perimetry. Ninety four
children (aged 5 to 17 years) participated in the study and were asked to perform a screening
test lasting approximately 1 minute (as a “practice” test), before performing threshold testing
in each eye with a break as appropriate. 9% of the children were deemed too unreliable at
performing the screening test to proceed with the threshold testing. These children amounted
to 21% of the total number of 5- to 9-year-olds. Testing time decreased with increasing age
(from approximately 7.5 minutes for the youngest children) as did fixation losses although with
some amount of variability in each age group. MD increased significantly with age (up to the
age of 14 years, where normal adult values were obtained).
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4.1.2.3 High pass resolution perimetry
High pass resolution (HPR) perimetry (also known as ring perimetry) is another form of peri-
metry using a standard computer display screen. It was developed as a method for providing an
estimate of retinal ganglion cell density.86,87 HPR uses ring shaped, spatially high-pass filtered
targets to determine resolution over the central 30 degrees of the visual field. The perimeter
determines resolution thresholds (the smallest ring able to be seen) for 50 locations. The pace
of the HPR test alters to the current reaction time of the subject. However, HPR still requires
the need for a continuous fixation on a central target during the test. HPR has been found to
be useful in the detection of visual field loss due to glaucoma and is a reasonably rapid test
(lasting approximately five minutes), and is well tolerated by patients.88
Marraffa et al. (1995)89 conducted a study involving 15 children (mean age 8.7 years, ranging
from 6 to 11 years) affected by congenital glaucoma to discover which of two perimetry tech-
niques, HPR and static computerised perimetry (using the Humphrey field analyser), were most
suitable for these younger patients. They concluded that HPR perimetry was more suitable for
children because of the shorter test time and following a questionnaire it was found that many
of the children liked the HPR task more as they found it easier and it appeared similar to a
game (in comparison to the Humphrey test). Tests were performed twice in order to measure
reproducibility. Two tests (of the same type) were considered reproducible if they showed the
same defect with an averaged threshold of no greater than ±2dB. The Humphrey test proved
reproducible in 47% of eyes tested while the HPR test was reproducible in 68% of the eyes
tested (this was without statistical significance).
4.1.2.4 Multifocal visual evoked potential
Visual evoked potentials (VEP), recorded using electroencephalography (EEG), are caused by
sensory stimulation of the visual field. Advancements in electrophysiology have made it possible
to evaluate the visual field by assessing a collection of VEP (multifocal VEP perimetry).90
Multiple locations of the visual field are simultaneously stimulated using a cortically scaled (in a
dart board type pattern) pseudo-randomly black and white reversing pattern stimulus and VEPs
corresponding to each visual field location can be recorded and analysed for amplitude where a
reduced signal amplitude has been shown to correlate with visual field defect.91 Multifocal VEP
in its current form requires little cooperation from the patient, is not dependent on subjective
responses and has a short test time (approximately 4 minutes per eye). Because of these
features, several groups have investigated using multifocal VEP in children.
Harding et al (2002)92 aimed to develop a field-specific VEP technique for identifying visual
field defects in epileptic children being treated with Vigabatrin who were unable to perform
other types of perimetry. A VEP “test stimulus” was specifically developed for detecting the
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visual field losses associate with the drug which used a central (0-5 degrees) stimulus and
peripheral (30-60 degrees) stimulus consisting of black and white checks increasing in size with
eccentricity. They enrolled 39 children (3 to 15 years) with epilepsy who were being treated with
Vigabatrin (for at least 3 months) and performed their field-specific VEP test and also, where
possible, they undertook formal static perimetry using the Humphrey field analyser 135-point
suprathreshold test to determine the diagnostic performance of the field-specific VEP test using
the Humphrey as a “gold standard” test. Of the 39 children, 35 were able to comply with the
field-specific VEP test but only 12 were able to comply with the static perimetry. The mean
age of the children able to complete both was 12.2 years (range: 8-15 years). Results from these
12 patients gave good sensitivity (75%) and specificity (87.5%) values for the field-specific VEP
test using comparison with the “gold standard” Humphrey test. It was concluded that the test
was well tolerated by children aged 3 years and older and is reliable at detecting Vigabatrin
associated visual field loss. This study highlights the lack of a good “gold standard” perimetry
technique in young children. Other studies have also found multifocal VEP to be useful for
monitoring the visual field in epileptic children taking vigabatrin.10,93
Balachandran et al. (2004)94 aimed to study the maturation of multifocal VEP in normal
children and to apply the normative results to determine visual field loss using multifocal
VEP in three clinical situations of optic pathway diseases. Normative VEP data (amplitude
and latency) was recorded from 70 children (aged 5-16 years) and it was found that a scaled
amplitude remained largely unchanged until 11 years where there was a sudden increase (40%)
until the age of 13 years and remained stable thereafter. Latency was found to decrease gradually
with age and plateau at 13 years. This data was then used to make an aged matched comparison
with three children with advanced optic nerve disease where results correlated well with existing
clinical findings. It was concluded that multifocal VEP is a test that can be performed by
children as young as 5 years and one which holds promise in being able to diagnose and monitor
visual field defects in children.
Kelly (2006)95 more recently looked at comparing pattern VEP to perimetry as a method
of detecting visual field loss in children with optic pathway gliomas. 40 patients with optic
pathway gliomas were recruited to perform VEP testing. 15 of the patients (8-20 yrs) were
also able to perform visual field testing using Goldmann Kinetic Perimetry and four of those
15 additionally performed ASP (SITA Fast). In those who performed both VEP and a form
of comparative perimetry, VEP amplitudes were significantly reduced at the midline electrode
in all eyes with visual field loss leading the authors to conclude that VEP may be a viable
alternative in children that are intolerant to standard visual field testing who have visual field
loss due to optic pathway gliomas.
Kim et al. (2006)96 assessed the use of mVEP tests to measure the visual field in epileptic
children 6-15 yrs. They collected normative mVEP measurement data from 21 healthy chil-
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dren and used normative latency and peak amplitude measurements to compare with mVEP
measurements made from 3 patients with epilepsy in whom standard perimetry testing was
not possible (aged 5-8 yrs). In each of the three patients abnormal waves measured by mVEP
were detected in the quadrants corresponding to lesion sites demonstrated by neuroradialogical
images and it was concluded that mVEP was useful in evaluating visual field defects in these
children.
4.1.2.5 Multi fixation perimetry
In order to solve the problem of fixation loss errors in static perimetry, one group has previously
developed a novel form of perimetry which uses a moving fixation target. The idea was first
described by Damato in 198597 where a simple method of perimetrytermed “oculokinetic peri-
metry” was described which used a paper test chart where the subject looks at 100 locations
on the chart in turn and records if they are able to see a central point on the chart each time.
The points are strategically placed so as to produce a map of the patient’s visual field when
the completed chart is rotated by 180 degrees. The test was designed to be a simple and very
low-cost method of self-test perimetry, but the idea was later extended in an effort to improve
perimetry testing in children.16 The same research group developed the idea to run automatic-
ally on a computer, where this time the fixation target moved across a display screen and the
subject must move a circle using a mouse or joystick in order to maintain it over the fixation
target while it moves across the screen. “Test stimuli” are displayed only when the circle is
correctly positioned over the fixation target, and the subject must respond to seeing the “test
stimuli” by pressing a button. Children enjoyed the game-like nature of the developed test and
the youngest child able to perform the test was 4 years of age.
The technique was later developed into a system named the computer assisted moving eye
campimeter (CAMEC) and was used in children by Mutlukan et al (1993).15 32 children were
examined using blind spot test programs of CAMEC and a commercial device (Dicon auto-
perimeter). Among those who completed both tests the blind spot was detected in 75% of
eyes tested by the Dicon auto-perimeter and 100% of eyes using CAMEC leading the authors
to conclude that fixation was greatly improved using CAMEC and therefore allows better
quantification of scotomas and the test is suitable for children aged more than 4 years.
4.1.3 Summary of perimetry in children literature
ASP is known to be unreliable in children and many previous research efforts have concentrated
on investigating ways to improve the lower age limit of children able to perform ASP. These
have been based around familiarisation strategies and use of faster testing strategies as they








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































children still able to produce reliable results are about 7-8 years of age. Given the nature of
ASP it is impressive that threshold visual field testing has been reliably performed in children
as young as this in some of the studies reviewed. However, the technique of ASP is still not
routinely used in children of this age clinically, perhaps because of the length of time required
to appropriately train them in the task.
In addition to these reported “youngest age” studies, other studies in the literature have used
the ASP technique to assess the visual fields in children as part of research looking at other
clinical aspects.98–103. However, these studies generally have not included children younger
than 10 years of age, presumably for the very reason that reliability is a problem.
Goldman kinetic perimetry is a more popular method of perimetry in children as the test can be
controlled by the examiner and adapted to the developmental age of the child. However, there
are significant disadvantages with this technique as it is dependent on a trained skilled examiner.
Both the ASP and kinetic perimetry methods still suffer from the same problems. They both
require the need for continuous fixation on a central target and high levels of concentration and
endurance. As such there is a distinct lack of perimetry testing in children below the age of 5
using these methods and these are the main reasons why these methods have never been widely
introduced in to young paediatric clinical practice.
Researchers have also assessed the use of other “computer graphics” perimetry techniques with
children, as they have emerged. A summary of the studies carried out using these techniques
with children is shown in table 4.2. The youngest age at which these techniques can be reliably
carried out by children varied depending on the reliability criteria used and the type of tests
being carried out. However, almost all studies reported a correlation with reliability indices
(predominantly fixation errors) and increasing age, and each of these tests still requires central
fixation, stationary head position and most importantly an understanding of the task required
to perform the tests reliably.
Multifocal visual evoked potentials have shown some promise in detecting visual field defects
in children because of the quicker nature of the test and more importantly the lack of any
subjective response from the patient. From the literature, the youngest ages able to carry
out some form of multifocal VEP has been from 3 to 5 years and it has been found to be
useful for monitoring the visual field in epileptic children taking vigabatrin. However, the
technique still requires a stationary head position, constant central fixation and also requires
the patient to wear electrodes. Additionally the waveforms of VEP traces can vary even for
normal subjects meaning that it can be difficult to interpret them as objective evidence for visual
field defects.104,105 Improvements have been made in multifocal VEP recording and analysis.
However, the technique has not been widely taken up.
Multi fixation perimetry has previously proved useful at assessing the visual field in young chil-
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dren (older than 4 years) after reducing the problem of fixation errors. This form of perimetry
still requires a subjective response from the subject in the form of pressing a button and sup-
pression of the natural gaze response of looking towards peripheral stimuli when seen as well as
a stationary head position which greatly inhibits using this technique with younger children.
There are virtually no commonly used perimetry techniques which are suitable for children
younger than approximately 8 years of age and there exists no form of perimetry which is
able to describe the visual field in a more accurate manner than confrontation in children
younger than 3 years old. Most of the research efforts described in this review do not address
the fundamental problems inherent in performing perimetry on children and it is a new, child
friendly technique which overcomes these issues, that is required.
A novel technique and system for assessment of visual fields in children has therefore been
developed and is the basis of this research thesis.31 The system makes use of relatively new
advances in eye tracking technology and is more suitable for use with children. The Technique
and system, named “saccadic vector optokinetic perimetry” (SVOP), builds on original ideas by
Damato et al. who first developed the idea of oculokinetic perimetry where the point of fixation
varies during a perimetry test.97,106 SVOP comprises a personal computer, display screen, an
eye-tracking device (Tobii x50, Tobii Technology, Danderyd, Sweden), and software developed
under this research program that controls the eye-tracking device, displays visual stimuli on the
display screen, and interprets eye gaze responses in “real time”.
A thorough search of the literature as to the novelty of using eye tracking to assist with perimetry
produced two articles from the proceedings of “Vision 2005”, both from the same research
group.107,108 The work included the collection of some basic early data on the possibility of
using saccade as an index for visual field measurement and it was concluded that an objective
measurement of visual fields is possible using the measurement of saccades in response to visual
stimuli. However, since these articles there has been no further work published.
4.2 Research proposal and aims
Given the problems that arise in the methods of perimetry used in children, a proposal for a
new method of perimetry for children is described here. Saccadic vector optokinetic perimetry
(SVOP) detects a child’s saccadic eye movement when a stimulus is presented in the periphery
of their visual field. The only task required of the child is to follow their natural reaction to
fixate on the stimulus of interest if they see it.
SVOP does not require any cooperation or understanding from the child. The child is not
required to learn any task nor to give any subjective response. When subjective responses
from the child are not used in the mapping of visual field, this removes the need for vigilance,
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endurance or understanding of the test method on the part of the child. SVOP does not restrict
the child’s movement (headrest not needed) and does not form any physical contact with the
child (e.g. no electrodes). A continuous fixation on a stationary central fixation target is not
needed in the proposed test.
There are two main stages to this research: (i) the development of the technique and system
of SVOP for assessment of visual fields in children, and (ii) an assessment of the validity of
the developed system as a diagnostic tool for visual field assessment. The aims associated with
each stage of the research are outlined below.
(i) Development of the technique and system of SVOP for assessment of visual
fields in children. The aims are to:
• develop the theory of operation of SVOP based on current eye tracking technology;
• assess eye tracking equipment suitable for developing SVOP;
• develop the algorithm which will assess patient eye gaze reactions to visual stimuli;
• create a suitable full SVOP system (hardware and software); and
• conduct a feasibility trial using the developed SVOP system.
(ii) Assessment of the validity of the developed system as a diagnostic tool for
visual field assessment. The aims are to:
• conduct a “validation trial” of the developed SVOP system using large number (n=120+)
of healthy volunteer children and adults, and child and adult patients with visual field
defects;
• compare the SVOP test with an equivalent test on an established perimeter, and com-
pare SVOP test results with patient clinical diagnosis and history in the cases where an
equivalent clinical visual field assessment is not possible or is inaccurate; and
• assess the variability of tests performed in the “validation trial”.
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Chapter 5
System development and feasibility
5.1 Theory of operation
5.1.1 Hardware and system setup
5.1.1.1 Eye tracking devicerequirements and specifications
The eye tracker must be non-contact, unobtrusive, allow freedom of head movement and be
able to provide data in “real time”. For these purposes “real time” can be considered a sample
rate of 30 Hz or greater. In addition, the two most important specifications are those related
to (i) the point of gaze data, and (ii) the 3D eye location data provided by the eye tracker.
A set of minimum requirements for the range, accuracy and resolution for each of these two
specifications are set out in table 5.1 and the reasoning is further discussed in the following
paragraphs.




Eye location volume: 200 x 100 x 200mm




Table 5.1: The minimum requirements for the range, accuracy and resolution of the eye tracker
characteristics of “gaze” and “3D eye location” data.
Gaze data requirements
The range of the gaze data is the largest gaze angle which an eye tracker is able to assess. The
proposed SVOP system must be able to assess the first ±30◦ of the visual field. The eye tracker
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will be located centrally, directly beneath a display screen which will present the visual stimuli.
Because the point of fixation will not be kept at the same central location, this reduces the
minimum horizontal range required to ±15◦ (e.g. to assess a visual field angle of 30◦ to the
right, fixation could be stationed at a location corresponding to 15◦ to the left of centre and a
test point could be located 15◦ to the right of centre) . However, the minimum required vertical
range must be +30◦ due to the fact that the eye tracker will be positioned below the display
screen.
The gaze data will be used to determine: (i) if a subject is looking at a “fixation stimulus”,
and (ii) if and when a subject changes their fixation point in response to the presentation of
a visual field “test stimulus”. The accuracy of the gaze data required for the proposed system
needs only to be within ±2.5◦. This is because at all stages the screen location of any visual
stimuli will be known, and also because there will only ever be a single visual stimuli on the
screen at any particular time. What is perhaps more important is the precision of the gaze
data when a subject has their fixation in one location. So long as the precision is to within
approximately 1.5◦, then it can be inferred that the subject is maintaining fixation at a known
“fixation stimulus” location. In addition, a change in fixation can be detected as a difference
between successive gaze data samples of greater than 1.5◦.
The resolution of the gazed data must simply be equal to or less than the required precision of
the gaze data.
3D eye location data requirements
The range of the 3D eye location data is essentially the volume of head movement allowance
the eye tracker will tolerate. Clearly the larger this is the better because the proposed SVOP
system is to be used with children who are potentially likely to move about. However, if a
child can be captivated by the testing procedure, then a relatively small volume would suffice.
A subject’s head is less likely to move up/down as compared to left/right and forward/back
(relative to the eye tracker position). Given these reasons, a minimum head movement box size
of 200mm x 100mm x 200mm (Width x Height x Depth relative to the eye tracker) is required.
Both accuracy and precision of the 3D eye location data are important because this data will be
used to calculate the position of “test stimuli” on the display screen. An error in this data will
result in an error in the screen position of specific visual field test points. A detailed assessment
of the effects of error in the 3D eye location is performed in section 5.5. Here it is sufficient to
say that the accuracy of this data should be within +/- 20mm to enable accurate positioning
of visual field test stimuli.
The requirements for the resolution of the 3D eye location data again relate to the required
55
precision. A precision of within 5mm is required so as not to induce further errors in the “test
stimuli” screen locations calculated.
The reasoning behind these minimum requirements may become clearer as the theory and
details of the proposed SVOP system are explained in the remainder of this “development”
chapter. However, it is important to provide a set of parameters here in advance of discussing
the eye tracker devices which are considered for this research.
At the commencement of this research project, non-contact, unobtrusive eye tracking devices
requiring no head or eye mounted equipment were beginning to become more commercially
available. Four of these commercially available devices were considered for their suitability in
this research. The four eye trackers were the Tobii x50 [Tobii Technology, Karlsrovägen 2D,
S-182 53 Danderyd, Sweden], SMI iView X- RED [SensoMotoric Instruments GmbH, Teltow,
Germany], ASL R6 [S. Oliver Associates, Northumberland House, Popes Lane, London W5
4NG, UK], Seeing Machines FaceLab 4 [GPO Box 782, Canberra ACT 2601, Australia]. The
main specifications and characteristics of each eye tracker (provided by the manufacturers) are
shown in table 5.2.
Specific to this project, there were several considerations to take into account when selecting the
eye tracking device to be used for developing a visual field assessment system for children.These
considerations are outlined below and are based on the specifications provided by the eye tracker
manufacturers.
Eye position
The position of the eyes must be known in real time if the subjects are allowed freedom to
move. In order to assess specific visual field angles during a test, the position of the eyes must
be known, so that each stimulus can be presented in the correct position. Each of the eye
tracking systems considered is able to provide data on the position of each eye in real time.
However, for the SMI iView X- RED and ASL R6 this requires the use of a magnetic head
tracking (MHT) device which requires the subject to wear a magnetic headband. There are
no details given regarding the accuracy of the eye position data and this information will be
determined experimentally (the methods and results relating to this are in section 5.2.2).
Freedom of head movement
Each of the eye trackers offer similar ability to allow head movement, and can all meet the
minimum requirements of 200 x 100 x 200mm (Width x Height x Depth). The Seeing Machines
FaceLab 4 has two modes: “classic” and “precision”. The classic mode allows more head move-
ment at the cost of eye gaze data accuracy. However, for movement to be possible with the
SMI device and the ASL R6, it was advisable to use MHT.
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Specification Tobii x50 SMI iView X-
RED
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According to the specifications, the accuracy of each of the eye tracking devices is within 1°
(with the exception of the “Classic” mode offered by the Seeing Machines FaceLab 4, which
has less accuracy at ±5◦),meaning that they would all meet the gaze accuracy requirements of
±2.5◦.
Maximum gaze angle (range)
The maximum gaze angle that the eye tracker is able to detect will be a factor in the maximum
visual field angle which could potentially be assessed. The range of maximum gaze angles which
the 4 eye trackers are capable of is ±35◦ to ±45◦ (horizontally) and ±25◦ to ±45◦ (vertically).
The FaceLab 4 is capable of the largest gaze angles but does not offer the greatest gaze accuracy
or resolution. All four eye trackers provide horizontal gaze ranges greater than the required
±15◦. The requirement of 30° vertical range in gaze angle is only met by the Tobii x50 and the
FaceLab 4.
Conspicuousness
The eye tracking device needs to be discreet so as not to attract the attention of any “inquisitive”
children. Neither the Tobii x50 nor Seeing Machines FaceLab 4 has any moving parts, unlike
the other two eye tracking devices which pan and tilt to follow the subject’s eyes. These moving
systems have the potential to distract the attention of a child during an examination of their
visual field.
Subject constraints
There is to be no constraints placed on the subject, i.e. there must not be any head mounted
equipment. This is true for all the systems considered. However, the SMI iView X- RED and
ASL R6 also require MHT if the position of the head is to be known. As head position data is
essential and there are planed to be no constraints placed on the subject, these two eye tracking
systems were not considered.
Raw data and software development
It is essential that the chosen eye tracking device is able to provide real time gaze and eye
position data. The Tobii x50 and Seeing Machines FaceLab 4 are able to do this without the
use of additional head mounted equipment. In addition the Tobii x50 comes with a software
development kit (SDK) which allows control of the eye tracking device through any desired
programming software. This is an important requirement of the eye tracking device if the
perimetry system is to be comprised within our own software.
Summary and suitability of Tobii x50 eye tracker
Considering the specifications and characteristics important for this research of each of these
eye trackers, it became clear that the Tobii x50 eye tracker was the most suitable. The Tobii
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x50 eye tracker is an eye tracker which uses infrared (IR) light and does not move (i.e. pan or
tilt) to maintain contact with a subject’s eyes as the camera has a relatively large field of view.
These features make the x50 eye tracker unobtrusive and discrete, which are important factors
considering the device will be used with children. Additionally, the x50 allows some freedom of
head movement (as it uses the pupil/corneal reflection technique described in section 3.2.2.2)
within the camera field of view, meaning that head restrictions do not need to be imposed on
the subject. Because the x50 eye tracker has allowance for an amount of head movement, it
also is able to provide “real time” data which allows the calculation of three dimensional eye
position which is measured using an optical technique rather than requiring any additional head
tracking equipment. The x50 can be used with a custom chosen display screen by defining the
size and relative position of the display to the eye tracker. It has also previously been used
with children (for research purposes other than perimetry) and additionally allows control of
the eye tracker through development of custom software through the use of the SDK.
5.1.1.2 Display screen requirements and specification
Display screen size is an important aspect of the visual field assessment system developed in this
research because the screen size (along with the maximum visual angle which the eye tracker
can tolerate) ultimately dictates the maximum size of the visual field which can be assessed
using the proposed SVOP system. The vast majority of visual field assessment tests carried
out clinically concentrate on the central 30°. This is because the most common reasons for
assessing the visual field are due to glaucoma and neurological diseases which can both be
diagnosed effectively with information about the first 30° of visual field.109–111 Additionally,
the Humphrey Field Analyser has a suprathreshold test pattern (C-40 test pattern) with a
maximum visual field angle of 25°, and also a threshold test pattern which contains test points
within the central 30° which is one of the most commonly used test patterns for threshold
testing, namely the 24-2 test pattern which has maximum visual field angle of 27°. With these
test patterns in mind, a display screen size was selected which would enable the replication of the
C-40 test pattern for comparative studies in this research, and also with future development
in mind the replication of the threshold 24-2 test pattern. These values also fall within the
maximum visual angle which the Tobii x50 eye tracker is able detect.
The largest visual field angle which can feasibly be used with any particular size display screen
depends upon the screen dimensions and how far away the subject’s “test eye” is. From figure 5.1,
the maximum visual field angle possible (φH and φV , horizontal and vertical angles respectively)



















where φH is the maximum visual angle in a horizontal direction, φV is the maximum visual
angle in a vertical direction, w is the screen width, h is the screen height and D is the screen
to eye distance, where:
D = L sin ε
Where ε is the angle which the eye tracker’s camera makes with the vertical. ε is adjusted such
that with the subject’s eyes at a distance L from the camera, they are also positioned centrally
(vertically) in front of the display screen (so ε is also dependent upon the screen size).
From these equations, for a standard 20 inch display screen which has the dimensions w=435mm
and h=274mm, ε =∼ 70◦ and the screen would be able to display a maximum horizontal visual
field angle of φH = 42.2° and a maximum vertical visual field angle of φV = 27.4°. These values
are calculated with the optimum eye tracker camera to “test eye” distance of (L) of 600mm,
but these angles could be further increased if we were to move the test eye closer to the display
screen.Therefore a 20 inch screen with the above dimensions will be adequate for the proposed
SVOP system.
The screen resolution will be related to the accuracy of visual stimuli location and size. The
size of stimulus which will be mostly used in this research is the Goldmann III size (table 2.2
on page 22) which corresponds to a subtended angle of 0.43◦. An angular screen resolution
of 0.04◦would represent a maximum error in the stimulus size of less than 10% which would
be an acceptable minimum requirement for the proposed suprathreshold perimetry application.
A typical screen resolution for the above mentioned 20 inch display is 1680x1050 pixels. The
angular screen resolution can be calculated using the horizontal and vertical screen dimensions,
and an approximate location of a test subjects eye. Using the above stated dimensions and
using a screen-to-eye distance (D) of 564mm (calculated using an eye tracker camera-to-eye
distance (L) of 600mm), the screen resolution of 1680x1050 equates to an angular resolution of
0.026◦ .
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Figure 5.1: Variable and constant values to consider for calculation of the maximum possible
visual field angle a display screen can display. a) Side view of an eye tracker and display screen
where the eye tracker camera is set up at an angle of 70 degrees to the vertical and a test eye
is located optimally from the eye tracker at a distance of 60cm. b) Front view of display screen
showing the maximum horizontal visual field angle possible considering a fixation point (F) at
one side and a stimulus test point (S) at the other side of the display screen.
The brightness uniformity of the chosen display screen and its capability to display brightness
values accurately and consistently was also a consideration when selecting a suitable display
screen. These characteristics are assessed in a later section (section 5.2.3).
5.1.1.3 Proposed SVOP system setup
Figure 5.2 shows a schematic of the proposed setup for the SVOP system. The primary display
screen is a 20” LCD monitor which the patient views and on to which the visual stimuli are
presented. The eye tracker (Tobii x50), set at an angle of 70° to the vertical, is located directly
below the primary display screen. A personal computer (PC) controls the eye tracker, collects
raw data about eye gaze position and eye location from the eye tracker and also controls what
is displayed on the primary display screen based on this data. The eye tracker and primary
display screen are located on a height adjustable surface to allow for different sized patients
(i.e. small children through to adults) and different seating arrangements. A secondary display
screen can be used to set up tests, input patient information and monitor patient position. The
values in figure 5.3 represent how the x50 eye tracker is set up for SVOP testing.
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Figure 5.2: Schematic diagram of SVOP system setup.
Figure 5.3: The positional setup of the X50 eye tracker for SVOP testing showing the positional
values used in the Tobii configuration tool and a photograph of the setup.
5.1.2 Calculation of eye position
Figure 5.4 demonstrates how the screen position for a visual field point being assessed is de-
pendent upon the 3D position of the subject’s eyes relative to the display. The figure shows two
examples, (a) and (b), which show the position of a stimulus on a display screen given a visual
field angle of φ. In each case φ and the point of fixation (F) remain unchanged, but the position
of the “test stimulus” (S) changes as a function of the position of the patient’s eye relative to
the point of fixation on the screen. Hence, to ensure that there is an accurate measure of the
patient’s visual field at a particular field angle, the 3D position in space of each eye has to be
known so that the stimulus can be positioned correctly.
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Figure 5.4: The effect of “test eye” to screen distance on the stimulus location. a) With the test
eye further from the display screen, the position of the “test stimulus” (S) is further from the
fixation point (F). b) With the test eye closer to the display screen, the position of S is closer
to F.
In addition to the position of any particular “test stimulus” varying as a function of the location
of the patient’s eye, the displayed size of a “test stimulus” may also differ in size. This is also
dependent on the distance between the subject’s eyes and the fixation point at the time at
which the stimulus is to be shown (figure 5.5).
In order for calculations to be made for the position and size of any “test stimulus” the 3D
position of the “test eye” (or “test eyes” for binocular visual field assessment) must be calculated.
This can be achieved using data provided by the eye tracker. All data fields provided by the
eye tracker are shown in Appendix B. The key data fields required for calculating the location
of the eyes are shown in table 5.3. In addition to this data, several constant values are required
to enable correct calculation of eye location. These constants are the horizontal and vertical
sizes of the camera’s field of view at a specific known distance from the eye tracker. This
information is detailed by the x50 eye tracker specifications as 200mm x 150mm (horizontal x
vertical size respectively) at a distance of 600mm, and so are known values. However, for this
section of theory these constants will be defined as CamH (= 200mm), CamV (= 150mm),
and CamD (= 600mm).
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Figure 5.5: The effect of “test eye” distance from screen on the size of the stimulus that is
presented (for a constant angular “test stimulus” size). a) With the test eye further away from
the screen the displayed “test stimulus” size is larger. b) With the test eye closer to the screen
the displayed “test stimulus” size is reduced.
Data Field Description (units)
Left eye horizontal position as
seen by eye tracker camera
X position of left eye in eye tracker camera field of view
(0-1, where 0 is furthest left point)
Left eye vertical position as seen
by eye tracker camera
Y position of left eye in eye tracker camera field of view
(0-1, where 0 is top most point)
Left eye distance Distance of the left eye from the eye tracker (mm)
Right eye horizontal position as
seen by eye tracker camera
X position of right eye in eye tracker camera field of view
(0-1, where 0 is furthest left point)
Right eye vertical position as
seen by eye tracker camera
Y position of right eye in eye tracker camera field of view
(0-1, where 0 is top most point)
Right eye distance Distance of the right eye from the eye tracker (mm)
Table 5.3: Data fields supplied by the Tobii x50 eye tracker (at a frequency of 50Hz) which are
used to calculate the 3D position of the eyes.
Figure 5.6 shows the eye tracker camera’s field of view (FOV) and an example location of an
eye within that field of view. Also shown in the figure is the horizontal and vertical size of the
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camera’s FOV at the specific distance of 600mm (CamD) from the camera and the location (E)
of an eye within the camera FOV, given by three values (ex′ , ey′ and ez′) which are the x, y
and z components of the eye position in a coordinate system with its origin at the eye tracker
camera, the positive z-axis extending out through the centre of the camera FOV, the positive
x-axis horizontal to the display screen and extending to the right of the display screen, and the
y-axis relative to the z- and x-axis. An additional point (P) is shown which corresponds to a
point which is related by a ratio to the eye position, but located within the camera FOV which
is at the specific distance CamD (600mm) from the camera. This point is described by three
values (px′ , py′ and pz′) which relate to the x, y and z components of the point P using the
same coordinate system. The distance D is the direct distance between the eye tracker camera
and the eye and this distance data is provided by the eye tracker. Also provided by the eye
tracker is the horizontal and vertical position of the eye within the camera field of view, these
values are given as a number between 0 and 1, with the zero values corresponding to the top
left of the field of view (when looking towards the eye tracker camera).
Figure 5.6: The eye tracker camera’s field of view and an example location of an eye within
that field of view. Also shown on the figure is the horizontal and vertical size of the field of
view at a specific distance (60cm) from the camera. D is the distance of the eye from the eye
tracker camera (this data is given by the eye tracker). ex′ and ey′ are the horizontal and vertical
components of the eye position within the camera field of view (considering a coordinate system
which has a z-axis with its origin at the camera and increases through the centre point of the
camera’s field of view).
In order to calculate the position of the eye (ex′ , ey′ and ez′) in the coordinate system described,
the x and y position of the eye within the camera field of view must first be converted so that
the zero values correspond to the centre of the field of view rather than the top left corner.
This can be done using the following:
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x′cam = 2xcam − 1
y′cam = −2ycam + 1
where xcam and ycam are the values given by the eye tracker, and x′cam and y′cam are these
same values converted so that a value of zero corresponds to the centre of the FOV, values of
-1 correspond to the bottom-left, and values of +1 correspond to the top-right of the camera
field of view.
















Next, using the fact that the geometry of the position of P and E has equal ratios, The position
of the eye can be calculated from:















where Dp is the direct distance from the camera to the point P and Dp =
√
6002 + p2x′ + p
2
y′
and D is the direct distance from the camera to the eye (data given by the eye tracker) in mm.
Finally, because the eye tracker is tilted at an angle, the camera field of view is also tilted
in this same direction and the calculated eye position (ex′ , ey′ , ez′) are coordinates of the eye
position in this same direction (figure 5.7). It is more desirable to have the 3D coordinates of
the eye position in a coordinate system which makes more sense relative to the display screen.
To calculate the eye position in a coordinate system with the x-axis along the horizontal of
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the display screen, the y-axis along the vertical of the display screen, the z-axis extending
horizontally out from the eye tracker camera, and the camera as the origin point, a rotation
matrix which will rotate the coordinate system about the x’-axis (into the page in figure 5.7)








0 cos γ sin γ








ey = ey′ cos γ + ez′ sin γ
ez = −ey′ sin γ + ez′ cos γ
Where γ = 90◦ − ε = 20◦ (from figure 5.1)
Figure 5.7: Side view of display screen and eye tracker. The eye tracker is positioned at an
angle to the horizontal and so its field of view is also at this angle.
5.1.3 Calculation of a “test stimulus” screen position
Once the 3D position of the test eye(s) has been determined, the position of a “test stimulus” can
then be calculated using this positional data. A point within the visual field can be described
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by two angles (figure 5.8):
• φ, which is the angle at the eye made by lines to the point of fixation (F) and the point
(S) - the eccentric visual field angle; and
• θ, which is the angle from the horizontal on the plane which has the line of gaze (from
the eye to F) as its normal - the rotational visual field angle.
Figure 5.8: A visual field point as described by two angles, φ and θ. Where φ is the angle at
the eye made by lines to the point of fixation (F) and the point (S) and θ is the angle from the
horizontal on the plane which has the line of gaze (from the eye to F) as its normal.
In standard perimeters stimuli are presented on a screen in locations which correspond to
specific retinal visual field locations and because the position of the patient’s eye is fixed, the
position on the screen at which a specific stimulus is shown is always the same. However, in
the system proposed for this research, the patient’s head is not maintained in a fixed position
and in addition, the fixation point location can also vary throughout the test. As a result the
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screen location for any particular “test stimulus” corresponding to a specific retinal location is
dependent upon the position of the eye relative to the point of fixation.
This section provides the theory behind the calculation of where a stimulus should be presented
on the screen based on the 3D position of the test eye (calculated in the previous section 5.1.2),
the position of gaze on the screen, and the two angles which describe the visual field point that
is to be tested (φ and θ).
The variables calculated in section 5.1.2 for the 3D position of a test eye from the eye tracker
(ex, ey and ez) can be transformed so that the values of these variables are described relative to
a point of fixation (which is a known screen location where a “fixation stimulus” is displayed).
Figure 5.9 shows this in terms of a coordinate system with the fixation point (F) at the origin,
the xy plane corresponding to the plane in which the screen is positioned and the point E is
the 3D location of the test eye relative to F. The vector EF (
−−→
EF ) is the line of sight.
Figure 5.9: Coordinate system with the fixation point (F) at the origin. The xy plane corresponds
to the plane in which the screen is positioned. The point E corresponds to the 3D location of
the test eye relative to F.
Now, imagining a plane surface perpendicular to the direction of gaze (the vector
−−→
EF ). This
plane lies on the x’y’ axis of a new coordinate system x’y’z’ where the line of sight lies along
the z’ axis, and the origin is still at the point of fixation, F (figure 5.10). The position of a “test
stimulus” (S’) on this plane within this new coordinate system can be calculated:
S′x′ = e tanφ cos θ (5.1)
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S′y′ = e tanφ sin θ (5.2)








Figure 5.10: A new surface, which is the x’y’ plane within a new coordinate system x’y’z’,
where the line of sight lies on the z’ axis. The position of a stimulus S’ on the x’y’ plane can
be described by the two angles φ and θ with respect to the position of the test eye (E) and the
point of fixation (F).
This gives the 3D position of the “test stimulus” relative to the point of fixation, with respect
to the 3D eye position (ex, ey and ez) and the point in the visual field we are testing (φ and
θ). However, this point is on the plane x’y’ and is described in the coordinate system x’,y’,z’.
It is now desirable to find the coordinates of S’ in the original coordinate system x,y,z before
being able to determine where the line ES’ intersects the plane xy to find the position of the
“test stimulus” on the display screen.
To find the coordinates of S’ in the coordinate system x,y,z, 3D rotation matrices can be used.
In general terms, the rotation matrices for rotating the x- and y-axes in a counterclockwise






0 − sinαx cosαx

Where αx is the angle by which the x-axis is rotated.
Ry(αy) =





Where αy is the angle by which the y-axis is rotated.
Figure 5.11: The rotation angles required to rotate the x’,y’,z’ coordinate system to the x,y,z
coordinates system. αxis the angle by which the x’-axis is to be rotated (counterclockwise in
the situation shown) and αy is the angle by which the y’=axis is to be rotated (clockwise in the
situation shown).
Figure 5.11 shows the angles by which the x’- and y’-axes need to be rotated and demonstrates
the direction of rotation of these axes to rotate the coordinate system x’,y’,z’ to the coordinate
system x,y,z. In the situation shown in figure 5.11 the x’-axis needs to be rotated in a coun-
terclockwise direction by the angle αx, and then the y’-axis must be rotated in a clockwise












− sinαy 0 cosαy

These rotation matrices hold no matter what the position of the eye (E) because when either
of the rotation angles αx or αy become negative due to the location of E, this also reverses the
direction of the rotation to be performed.
















































Using equation 5.4, the 3D position of S’ relative to the fixation point (F) after the first rotation
of the coordinate system (R1) can be described in terms of eye position and the visual field





= e tanφ cos θ (substituting equation 5.1) (5.10)
S′R1y = S
′
y′ cosαx + S
′
z′ sinαx




z (substituting equations 5.2, 5.3 and 5.7) (5.11)
S′R1z = −S
′
y′ sinαx + S
′
z′ cosαx
= −ey tanφ sin θ (substituting equations 5.2, 5.3 and 5.6) (5.12)
Using equation 5.5, the 3D position of S’ relative to the fixation point (F) after the second
rotation of the coordinate system (R2) can also be described in terms of the eye position and
the visual field angles (φ and θ):
S′R2x = S
′
R1x cosαy + S
′
R2z sinαy
= e tanφ cos θ cosαy − ey tanφ sin θ sinαy (substituting equations 5.10 and 5.12)
























z (substituting equation 5.11) (5.14)
S′R2z = −S
′
R1x sinαy + S
′
R1z cosαy
= −e tanφ cos θ sinαy − ey tanφ sin θ cosαy (substituting equations 5.10 and 5.12)














(eex cos θ + eyez sin θ) (5.15)
Now the coordinates of S’ in the original coordinate system (x,y,z) are known (as such the
notation of these coordinates is now changed to S′x , S′y and S′z). The next step is to find
where the visual field point stimulus will be displayed on the display screen. This new point
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(S) corresponds to the point where a line from the eye (E) to S’ intersects the xy plane (i.e. the
display screen). Figure 5.12 demonstrates this.
Figure 5.12: The position of the visual field point stimulus (S) on the display screen (which
corresponds to the xy plane in the original coordinate system. S is the point where a line from
E (the eye) to S’ intersects with the plane xy. We wish to find the position of S on the display
screen (i.e. the values Sx and Sy).
This intersection point (S), is the point on the screen which corresponds to the visual field point
we wish to test. The general equation of a line can be written as:
P = P0 + t(P1 − P0) (5.16)
Where P is the position vector of a point on the line which passes through two other points
with position vectors P0 and P1.
The general equation of a plane can be written as:
N · (P − P2) = 0 (5.17)
Where P is the position vector of a point on the plane which also has a point on it with position
vector P2 and N is a vector normal to the plane.
The point of intersection of the line and plane is (putting 5.16 into 5.17):




N · (P2 − P0)
N · (P1 − P0)
In the situation in figure 5.12, the normal to the plane, N = (0, 0, 1), a point on the plane,
P2 = (0, 0, 0), P0 = (ex , ey , ez) and P1 = (S′x , S′y , S′z). So:
t =
(0, 0, 1) · ((0, 0, 0)− (ex , ey , ez))











Substituting this into equation 5.16 gives:







z)− (ex , ey , ez)
)
S′z − ez
Where the point P corresponds to the screen position of the visual field point (S). So, the
coordinates of S are:




















, S′R2z respectively) so that these coordinates on the display screen are calculated
using the variables of visual field angles (θ and φ) and the 3D position of the test eye (ex , ey ,
ez).
5.1.4 Calculation of a “test stimulus” size and shape
The size of a “test stimulus” is described in terms of an angle subtended from the eye (section
2.2 on page 22). Traditional perimetry devices use a bowl shaped screen with stimuli projected
on to it. The bowl shape allows stimuli to be displayed as circular test points which are always
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presented at the same size and shape for a given subtended angle size (e.g. Goldmann III)
because each point on the bowl is theoretically equidistant from the test eye. Due to the fact
that the proposed SVOP perimetry system in this research uses a flat screen, and additionally
allows the patient freedom to move their head, each “test stimulus” will vary in displayed
size. Additionally, the shape of the each stimulus has the potential to vary, again because the
proposed SVOP system uses a flat display screen. As each stimulus is defined by a subtended
angle at the eye, this can be imagined as a cone, the tip of which is located at the eye. If each
stimulus is presented on a bowl shaped screen (as in traditional ASP) where every point on
the screen is the same distance from the eye, it can be seen that any location on the screen
(corresponding to different visual field locations) will result in a circular shaped stimulus of the
same size because the screen always intersects the cone at 90° (figure 5.13).
However, a flat screen acts as a plane intersecting the cone, potentially at an angle other than
90° (figure 5.14a). The flat display screen intersection with the cone creates a stimulus which
is a “conic section”. This results in an elliptical shape with the centre line through the cone at
one focus of the ellipse (figure 5.14b).
Figure 5.13: A bowl shaped screen (as in traditional ASP) where every point on the screen is
the same distance from the eye, resulting in a circular shaped stimulus of the same size at every
location.
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Figure 5.14: a) A flat screen acts as a plane intersecting the cone, resulting in a “conic section”
stimulus potentially with an elliptical shape with the centre of the cone at one focus of the ellipse.
b) the dimensions of the “conic section” and the variables used to calculate those dimensions.
To establish the dimensions of the ellipse, the major and minor semi-axis (a and b respectively
in figure 5.14b) must be found. These can be calculated by first finding the values of r1, r2 and
c which are the distances from one focus to either end of the ellipse, and to the centre of the
ellipse respectively.






Where σ is the angle made between the display screen and the line from the eye to the display
screen through the centre of the cone, φ is the visual field angle being assessed, EF is the
distance from the eye (E) to the point of fixation (F), and FS is the distance between the point
of fixation to the point of the “test stimulus” (S), which is defined as the point where the centre
line through the cone intersects with the screen.




The value of φ is known, and because the position of the eye (E) and the position of the stimulus
(S) have previously been calculated, both EF and FS are known. Hence a value for σ can be
found.














Where g is size of the stimulus described by an angle subtended at the eye and ES is the distance
from the eye to the stimulus point. Both of these values are known, and σ is given by equation
5.19.
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where r1 and r2 are given by equations 5.20 and 5.21.
Now, the distance from a focus to the centre of the ellipse (c) is given by:
c = a− r1





Thus, we have the dimensions of the stimulus to be displayed on the screen.
5.1.5 Proposed SVOP software
As described in section 5.1.1.3 the SVOP system comprises a personal computer, display screen,
and a Tobii x50 eye tracker. This section outlines the proposed software which will control the
eye tracker, display visual stimuli on the display screen and interpret eye gaze responses in real
time.
A test begins with a “fixation stimulus” displayed on the screen. The purpose of a “fixation
stimulus” is to provide a fixation point for the patient and to allow the system to confirm that
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the patient is indeed looking at a specific screen location by comparing the “fixation stimulus”
location with real time eye gaze location data. Once verification that the subject is looking at
the “fixation stimulus” is obtained, a visual field point to be assessed is selected and a visual
“test stimulus” corresponding to this visual field point is displayed on the screen while at the
same time the original “fixation stimulus” is erased. The “test stimulus” is displayed for 200ms
(which is the same stimulus presentation time used by the Humphrey Field Analyser) and is
presented at screen coordinates corresponding to a specific location within the patient’s visual
field. For each “test stimulus”, the task required of the patient is to follow their natural reaction
to fixate towards the area of the screen where the “test stimulus” was seen. By monitoring the
eye movements of the patient, changes in eye gaze position can be detected and the vector of
the saccadic eye gaze movements in response to the “test stimulus” will provide an indication
as to whether the patient has perceived it or not. The time interval between presentation of
the stimulus and the patient’s response (i.e. the patient’s reaction time) can also be used to
assist in confirming that the eye movements are, or are not, a reaction to the visual field “test
stimulus” presented.
In order to allow the calculation of the appropriate screen position for any particular visual field
point being assessed, the position of the eye(s) in 3D space relative to the display screen must
be known. The Tobii x50 eye tracker provides “real time” data (at a sample rate of 50Hz) for the
distance of each eye from the eye tracker’s camera and also provides values for the position of
each eye within the camera’s field of view. This information allows the “real time” calculation of
the 3D position of each eye relative to any point on the display screen and so provides the values
for determining the correct size, shape and screen location of the “test stimuli” to be presented
on the screen at any moment, for any particular visual field point that is to be assessed (as
described in the previous sections).
A subject’s eye gaze is to be monitored when “test stimuli” are shown in different positions on
the display screen throughout a test, each position corresponding to different points within a
subject’s visual field. A software algorithm is to be used to decide whether the subject was able
to see the new stimulus or not, based on the direction and magnitude of any eye movements
(i.e. the vector of a fixation change), in addition to the timing of that eye gaze movement.
If a subject perceives a “test stimulus” presented on the display screen, the natural response
is to gaze towards it. If the point is not seen there is a different type of eye gaze movement
response (or no response at all). It is the job of the algorithm to automatically distinguish
between these two types of responses in “real time” based on the vector of any fixation change
made following the presentation of a new visual field “test stimulus”, and the timing of any
such fixation change. To make this automated decision, the vector change in fixation point is
compared directly with the vector corresponding to the change in screen position of the “fixation
stimulus” to the “test stimulus”. In practice, there will be a natural variation in the difference
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between the vector change in fixation point and the vector change in the screen position of
the stimuli (i.e. the accuracy with which the patient can fixate at the location where the “test
stimulus” was presented). Hence, it is important to know how much variation is acceptable
before a “test stimulus” is labelled as “unseen”. To deal with this, parameters used within the
algorithm designed to make this decision will be based on eye response data collected as part
of this research program.
Figure 5.15 shows the software steps of a visual field test using the proposed SVOP technique.
In practice, this software is to be implemented using a custom developed computer program
running on a personal computer which also controls the eye tracker and display screen. At
the start of the test a visual “fixation stimulus” (for example a circular point or small cartoon
face for children) is displayed in the centre of the screen. When the initial “fixation stimulus”
is displayed the eye tracker’s gaze data are used to verify that the patient is gazing at the
“fixation stimulus”. In the event that the gaze data suggests that the patient is not fixating on
the correct point after a certain number of gaze samples, additional visual prompts could be
used to attract attention if required.
After it is determined that the patient is fixating at the first “fixation stimulus”, a new visual
field test location is selected (from a pre-selected list of visual field points) and the position, size
and shape of the associated “test stimulus” are calculated within one sample time period (20ms).
The position of the “test stimulus” is calculated using the distance from the current fixation
point (in this case the central “fixation stimulus”) to the subject’s test eye(s), as measured
using the eye tracker’s data, and the visual field point that is to be assessed. For any particular
visual field examination there will be a number of different visual field points to be assessed.
The order in which the selected points are assessed is randomised. Once the “test stimulus”
position, size and shape is determined, the “fixation stimulus” is erased and the “test stimulus”
is displayed in the calculated location for a period of 200ms. A countdown timer (which runs in
the background) is started as soon as the “test stimulus” is displayed. If the displayed stimulus
is not detected as “seen” within this time then the stimulus is categorised as “not seen”. The
countdown time is set to a pre-determined limit (for example 1 second) which will provide a
sufficient amount of time for a patient to react to a “test stimulus” if seen.
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Figure 5.15: Flow diagram of the proposed software program for an SVOP test. The step
“Test fixation change properties” relates to further software steps outlined in figure 5.16. FS =
“fixation stimulus”. TS = “test stimulus”. VF = Visual Field.
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As soon as a “test stimulus” has been displayed, gaze data are continually monitored every
sample (every 20ms). The gaze data are used to determine whether there has been a change
in the fixation point. If, for any particular gaze datum sample, there has been a considerable
change in the fixation point (which could be determined for example as a screen distance
between gaze data samples greater than a specified number of pixels), the very next gaze data
sample is used to determine whether there has been a further change in the fixation point, this
process continues until no considerable change in fixation point is found between consecutive
data samples. In this manner the movement of the user’s eye towards a new fixation point can
be found. If there is no significant change in fixation between subsequent gaze data coordinates
and the prior gaze data point did indicate a change in fixation then this indicates the end of
the subject’s fixation change and hence the vector of the fixation change can be found. Once
a fixation change vector is detected, the properties of the fixation change are tested to identify
whether the fixation change corresponds to the vector associated with the “fixation stimulus”
to the “test stimulus”.
Figure 5.16 illustrates the programmatic steps used to determine if the characteristics of any
fixation change found can be matched with the “test stimulus” which was displayed. The
direction of the fixation change is compared with the direction from the “fixation stimulus” to
the “test stimulus”. Additionally, the amplitude (measured as a visual angle subtended at the
eye) of the fixation change is compared to that of the visual field angle being tested. If these
two characteristics are in agreement (within a range of specific values) then the fixation change
is considered to relate to the “test stimulus” presented on the display screen and that point is
recorded as “seen”. A further check could be to assess the reaction time of the eye movement
to assist with the decision. If the reaction time is outwith certain limits a re-test of this visual
field point could be made. If either of the vector properties of the fixation change do not relate
to the corresponding properties between the “fixation stimulus” and “test stimulus” then the
fixation change is considered not to relate to the new stimulus and the system returns to the
capture gaze data step of figure 5.15 (note that upon this occurrence, the visual field point is
not labelled as “unseen” at this step in the program).
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Figure 5.16: Flow diagram for the assessment of fixation change characteristics following the
presentation of a “test stimulus”. This diagram represents the programmatic steps contained
within the “Test fixation change properties” step in figure 5.15.
Returning to Figure 5.15, in the event that the “test stimulus” is identified as having been “seen”,
this event is recorded and the countdown timer is reset. If any fixation changes are not recorded
as “seen” (or indeed if there are no fixation changes detected) before the countdown timer reaches
zero, this triggers the countdown timer “event” and the stimulus is initially recorded as “unseen”
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and this point will be flagged for retesting at a later stage during the test. Upon retesting any
initially “unseen” stimuli, if it is again “unseen”, then that will be the final result for that
stimulus point. If at any time a stimulus point is determined as “seen”, then “seen” is the final
result of that stimulus point. If not all points have been tested then the process is run again
with a new visual field point with the last “test stimulus” point becoming the location for a new
“fixation stimulus”. Otherwise, the test is completed. By way of example, figure 5.17 shows
an illustration of a visual field point being tested and “seen”. The solid lines indicate the gaze
location data changes every 20ms.
Figure 5.17: Illustration of a visual field point being tested and “seen”. The solid lines indicate
the gaze point changes every 20ms. a) The subject fixates on a “fixation stimulus”. b) A “test
stimulus” is displayed corresponding to a visual field point. c) A change in fixation is detected
(dashed line 1) and compared with the positional change in stimuli (dashed line 2). d) A new
“fixation stimulus” is displayed ready to repeat the process.
The “test stimuli” presented can be of the same type throughout a test (i.e. a defined angular
size and a defined brightness). However, to keep the test interesting for children, once a “test
stimulus” has been detected as “seen” it is changed to an interesting audio-visual animation
appropriate to their developmental age. For instance, small cartoon face animations are used
for younger children. This may help to motivate child patients to submit to the test. The
test can also be interrupted at appropriate times by additional visual prompts (with sound if
necessary) to draw the attention of a distracted child back to the screen.
In order to create this proposed SVOP system, the hardware components of the system will
need to be assessed. For example, the eye tracker’s gaze and distance data accuracy and the
display screen brightness uniformity will need to be investigated. Additionally, to create the
“decision algorithm” proposed above, the fixation change characteristics relative to displayed
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“test stimuli” must first be investigated so as to determine specific numerical limits which the
algorithm can use to make its automated decision. These aspects are discussed in the following
sections (5.2 “Assessment of SVOP Hardware” and 5.3 “Assessment of Eye Gaze Response to
Test Stimuli”).
5.2 Assessment of SVOP hardware
In order to develop the system proposed in the previous section of theory, the selected eye
tracking hardware must be capable of providing sufficiently accurate eye gaze data and eye
positional data so as to allow an accurate assessment of patient fixation, accurate calculation of
the “test stimuli” positions and accurate assessment of patient gaze response to the “test stimuli”.
The following sections detail the methods and results for assessing the eye gaze data and eye
positional data provided by the Tobii x50 eye tracker (sections 5.2.1 and 5.2.2 respectively).
In addition, another specification related to the Tobii eye tracker which is important to the
accurate functioning of the proposed SVOP system has been assessed as part of the methods in
section 5.2.2. This is the horizontal and vertical head movement box size at a known distance
(600mm) from the eye tracker’s camera. It is important to assess these specific constant values
as they are used in the calculations which determine 3D eye position relative to the eye tracker.
Another important hardware aspect of the SVOP system concerns how capable the LCD screen
is at faithfully reproducing different levels of luminance (brightness). The SVOP system should
produce “test stimuli” at a specific luminance level which will allow an SVOP test to be compared
directly with a clinically accepted automated static perimetry device (e.g. the Humphrey Field
Analyser). A method for displaying visual stimuli at specific luminance levels using LCD grey-
scale colour levels, is described and assessed in section 5.2.3.
5.2.1 Gaze data accuracy
Two methods were used to assess the gaze data accuracy of the Tobii x50 eye tracker. An initial
gaze accuracy assessment consisted of collecting gaze data while subjects fixated at 15 specific
screen locations and subsequently analysing the data for accuracy at each screen location. A
second, more detailed assessment was used to assess gaze data accuracy under conditions similar
to those expected during an SVOP test. The following sections present these two methods and
associated results.
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5.2.1.1 Methods and subjects
Method 1: Gaze accuracy at 15 specific screen locations
A computer program was written (using Visual Basic .Net within the Microsoft Visual Studio
2005 development environment) to assess the accuracy of the gaze data provided by the Tobii
x50 eye tracker. The hardware setup for these methods was the same as that described in
section 5.1.1.3 on page 61. The program was designed to display a visual stimulus (in the
form of a cross) on the display screen at 15 specific locations in a random sequence (figure
5.18 shows the screen positions used). Test subjects were instructed to fixate their gaze on the
centre of the cross when it stopped at each location. Whilst the subject’s gaze was fixating
at each location, the program collected 20 data samples (at a sample rate of 50Hz). Each
sample contains multiple fields of data and all available data fields were recorded (Appendix B
shows all the data fields available from the Tobii x50 eye tracker which were collected for each
sample). For each sample the program calculated the total gaze error, in pixels, using the X and
Y gaze location data and the X and Y screen location of the centre of the visual stimulus (the
cross). This was done for both the left and right eye data individually. From the 20 calculated
gaze error values at each screen location, the average and standard deviation was calculated.
The error could also be calculated in degrees of visual angle. This was done by using the “eye
distance” and “X and Y eye position” data to calculate 3D eye location (as described previously
in section 5.1.2) and subsequently calculating the error as a distance described by the angle
subtended at the eye. Only data with validity codes of 0 (corresponding to definitely valid data)
were used for these calculations. Data with validity codes other than 0 which could correspond
to the eye tracker’s inability to track one or both of the subject’s eyes or possibly the subject
blinking was analysed separately. These samples did not have any gaze data associated with
them and are defined as “dropouts”. Information on validity codes and their meaning is also
listed in Appendix B.
The Tobii x50 eye tracker requires that a calibration procedure be performed for any particular
subject’s eyes in order to subsequently produce accurate gaze point estimation data. The
calibration procedure presents a visual stimulus at a series of locations on the display screen.
The calibration point visual stimulus is, by default, a circle which moves to, stops and repeatedly
shrinks and grows at each defined screen location, but it can also be customised to be made
more child friendly. During this time, the subject must fixate on the calibration stimulus,
most importantly when it stops at any particular location. The number of points at which the
calibration stimulus stops can also be customised. The default is 5 screen locations and the
calibration procedure lasts for approximately 10 seconds.
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Figure 5.18: The 15 screen locations used by the gaze data accuracy program. Each screen
position is numbered (1-15) and associated with a specific X and Y screen position in pixels.
The screen has a resolution of 1680 by 1050 pixels in the X and Y direction respectively.
10 test subjects performed the 15 point accuracy test. All subjects performed a new default 5
point calibration prior to each of the 15 point tests. Each test was performed with a natural
head movement with the eyes starting location at approximately 600mm from the eye tracker’s
camera and in a central location within the camera’s field of view.
Method 2: Gaze accuracy under SVOP test conditions
The methods described above for the 15 point accuracy test were designed to give an early
indication of the gaze data accuracy capability of the Tobii x50 eye tracker. A more in depth
test was required which would assess gaze data accuracy at many more screen locations and
with a larger number of test subjects with a greater age range (including healthy volunteers
and also patients with visual field defects).
To do this, a first version of the SVOP software was created with the aim of data collection
(rather than attempting to make any automated assessment of visual field defects). The software
was written in Visual Basic .Net (within the Visual Studio 2005 development environment) and
was designed to simply display a “fixation stimulus”, then when a subject was gazing at the
“fixation stimulus” calculate the position of a visual field point “test stimulus”, display it (for
200ms) and repeat this procedure from the screen position of the last “test stimulus” while all
the data given by the eye tracker was continually exported to a text file and the screen location
of all the “fixation stimuli” were exported to another text file. The text files also contained time
stamp data so that the screen location values could be matched to the gaze data during post
test analysis. The software was designed so that it would import a series of visual field points
from another text file prior to starting the process. This text file contained a list of visual field
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points described by two values, φ and θ, which are the two angles used to define a visual field
point (as described in section 5.1.3 and figure 5.8 on page 68). In this manner, any visual field
test pattern consisting of any number of visual field points could be used with the software
(providing of course that the visual field locations are able to fit on the display screen from any
particular fixation location). The “test stimuli” corresponding to the various visual field points
were designed to be displayed in a random sequence so long as they could be presented on
the display screen based on the current “fixation stimulus” position. If a situation was reached
where no remaining “test stimuli” could be displayed (i.e. if they would be off the screen) from
a fixation point being used, a new “fixation stimulus” point would be displayed which would
allow at least one of the remaining “test stimuli” to be displayed, and the test would continue
in this manner until all the visual field test points had been displayed. The diagram in figure
5.19 gives a diagrammatic representation of the software program to accompany this written
description.
Figure 5.19: Flow diagram of an early version of SVOP software designed for data collection
only. FS = “fixation stimulus”. TS = “test stimulus”. VF = visual field.
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For these methods three different “test stimuli” test patterns were used. Two of the test patterns
were used for the left and right eye respectively and were matched to the HFA C-40 screening
test pattern. The third pattern used was a custom designed 40-point pattern, to be used as a
binocular test pattern, which consisted of 40 points located within the first 25 degrees of the
visual field and was based on a combination of the left and right eye test patterns. Figure 5.20
shows the three test patterns used. All “test stimuli” were presented at a specific luminance
brightness equivalent to the 14dB level on the HFA. The method for displaying “test stimuli” at
this specific brightness is detailed in a later section (section 5.2.3 on page 106), but essentially
the procedure used a specific background grey-scale colour and “test stimulus” grey-scale colour
to produce a “test stimulus” brightness corresponding to the HFA 14dB luminance level. All
“test stimuli” were presented at the Goldmann III size for a period of 200ms.
Figure 5.20: The three visual field test patterns used in the program for assessing gaze data
accuracy. a) A test pattern equivalent to the right eye HFA C-40 screening test. b) A test
pattern equivalent to the left eye HFA C-40 screening test. c) A custom test pattern designed
for binocular testing.
38 subjects were recruited with the aim of performing the procedure 3 times (using each of
the 3 test patterns once). When using the left and right eye test patterns the subject was also
instructed to occlude the opposing eye with a hand held eye occluder. The eye occluder was
custom built and was made out of a plastic material which was designed to transmit infrared
wavelengths but block visible light. Using this material allowed the occlusion of an eye while
still allowing the eye tracker camera to perceive the occluded eye. The reason this strategy was
used was because of an inability of the eye tracker to provide constant data when it could only
perceive a single eye. In reality not all subjects were able to perform all three tests, for example
younger subjects were unable to hold the eye occluder and so only performed the procedure
using the binocular test pattern. The subjects recruited and tests performed are outlined in
table 5.4.
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Subject groups Number Age (years) Tests performed
Mean Range Binocular Left Right
Healthy adult 14 35.1 21-68 14 14 14
Adult patient 6 57.0 17-74 6 5 5
Healthy child 9 8.8 5-16 9 9 9
Child patient 9 7.8 2-15 9 5 5
Total 38 29.7 2-74 38 33 33
Table 5.4: The test subjects recruited and tests performed for the gaze accuracy tests.
5.2.1.2 Results
Results of method 1: Gaze accuracy at 15 specific screen locations
Figure 5.21 shows the average (± 1 standard deviation) error between the location of the visual
stimuli on the screen (in the form of a cross) and the gaze data samples collected from the
eye tracker while each subject was instructed to look at the centre of the visual stimuli. The
15 screen locations (labelled 1 to 15) are shown in the previous methods section (figure 5.18
on page 87). The left and right eyes were assessed separately and the error was calculated in
degrees of visual angle. Figure 5.22 on the following page shows the average number of dropouts
(± 1 standard deviation). One dropout is defined as when the eye tracker is unable to produce
a sample which has gaze information, this occurs when the eye tracker is unable to detect the
eye for any reason. Again data were collected with each subject gazing at the 15 different screen
locations. At each location 20 data samples were collected, so the number of dropouts at each
location per subject could range from 0 (all samples provided gaze data) to 20 (no samples
provided gaze data).
90
Figure 5.21: The average gaze data error (in degrees) for each of the 15 screen fixation locations
for both the left eye and right eye data. Error bars are ± 1 standard deviation.
Figure 5.22: Average number of dropouts for either eye for each of the 15 screen fixation
locations. Error bars are ± 1 standard deviation.
Results of method 2: Gaze accuracy under SVOP test conditions
As an example of the gaze data available from a test, figure 5.23 shows the screen coordinates
of every gaze data sample collected from a single test. Also shown are the screen coordinates
of each “fixation stimulus” used during the test. From this figure, the nature of the gaze data
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which typically constitutes “fixation” can be visualised. There is typically a “cluster” of gaze
data coordinates in an area close to the “fixation stimulus”, with a varying degree of accuracy
of the gaze data. Gaze data coordinates which do not belong to any “clusters” (in figure 5.23)
are samples which happen to have occurred while the test subject was in the process of moving
their fixation from one screen location to another.
Figure 5.23: Example of all the gaze data coordinates and “fixation stimuli” coordinates from a
gaze data test.
From the data collected from each test, the average gaze data error (difference between the
fixation stimulus coordinates and the gaze data coordinates) was computed using 20 gaze data
samples following the presentation of each “fixation stimulus”, this data was then categorised
according to the screen location of the “fixation stimulus” such that the screen was divided up
into a grid of rectangular sections measuring 168x175 pixels each. All the error data values
(previously computed) which were located within each individual grid “square” was then aver-
aged. Figure 5.24 shows this data in contour plots (for both the average error values and one
standard deviation) separated into data from binocular, left eye and right eye tests.
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Figure 5.24: Average (left hand plots) and value of 1 standard deviation (right hand plots) of
gaze data error in pixels for locations across the display screen for binocular (top row), left eye
(middle row) and right eye (bottom row) tests.
The same procedure was used to calculate the average and standard deviation of the number of
dropouts during each of the 20 data samples collected such that the average number of dropouts
for different screen location grid “squares” are calculated for each type of test (left, right and
binocular). This data is shown in figure 5.25 as separate contour plots for the average values
and one standard deviation, for each type of test (binocular, left and right eye).
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Figure 5.25: Average (left hand plots) and value of 1 standard deviation (right hand plots) of
the number of dropouts for locations across the display screen for binocular (top row), left eye
(middle row) and right eye (bottom row) tests.
5.2.1.3 Discussion
The 15 point gaze accuracy test was designed as an initial test following the purchase of the
Tobii x50 eye tracker, and was performed with normal, healthy subjects. The main purpose of
these tests was to investigate the general performance of the eye tracker’s gaze data accuracy
and provide an early assessment of its suitability for the proposed SVOP system. The second
gaze accuracy test methods (gaze accuracy under SVOP test conditions) were designed to act
as a more detailed look at gaze accuracy under conditions similar to that of a SVOP test with
the inclusion of adult and child patients in addition to healthy adult and child volunteers.
The average gaze errors were measured to be less than the previously described minimum gaze
error requirement of ±2.5◦ ( 5.1 on page 54). Only when gaze location was fixating towards the
top left and top right corners of the display screen did the gaze error increase to a level above
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the minimum required gaze accuracy.
The results from both gaze data accuracy test methods showed similar results in terms of
screen locations where the eye tracker provided less accurate gaze data. Less accurate areas (or
“problem areas”) were mostly confined to the corners and vertical sides of the display screen,
in particular the top two corners, the left side of the screen when testing a subject’s left eye
and the right side of the screen when testing the right eye. However, not all subjects showed
reduced gaze data accuracy in these screen corner regions. This can be seen by the increased
variability in these areas (from the contour plots of the standard deviation of gaze errors in
figure 5.24). Decreased gaze data accuracy on the same side as the eye being tested in uniocular
tests was at first surprising but may be explained by the relative position of the eyes and the
eye tracker’s centrally located camera. Even with uniocular tests the eye being tested was not
located centrally in the camera’s field of view. Instead, it would normally be located slightly
to one side of the camera depending on the eye in question. As a result it is possible that it
becomes harder for the eye tracker’s camera to accurately identify the required reflections from
the eye when it is rotated more away from the direction of the camera’s field of view, and hence
harder to produce as accurate gaze data.
Dropouts (or areas where the eye tracker lost track of one or both eyes) also occurred in some
similar “problem areas” as those where the gaze data accuracy was reduced. It is not surprising
that dropouts had a greater tendency to occur when fixation was towards the vertical edge
screen locations. However, the side of the screen where dropouts occurred was predominantly
the opposite side the the eye being tested in uniocular tests. This was unusual but may simply
be due to a lack of data available for analysis on the sides which did not demonstrate a larger
amount of dropouts (as the low standard deviation in these areas indicates).
These tests have identified some approximate areas of the screen where eye-tracking may not
always be possible or where gaze data accuracy could potentially be reduced. These “problem
areas” were not consistent across all subjects tested. However, it is useful information to be
considered in the development of the SVOP testing system.
Using the eye tracker in these tests with some patients with visual field defects also highlighted
some potential problems with eye tracking in this patient population. With one patient, there
was no eye tracking data obtained for one of their eyes which had a persistent right enlarged
pupil. This highlights that eye tracking may not be possible in certain patients where the eye
shape has been changed in some way (for example due to surgical procedures). Further descrip-
tions and details of eye tracking problems within patients is described in a section dedicated to
the limitations of the SVOP system (section 5.5 on page 139) which appears at the end of this
chapter.
The gaze data results obtained here can be used to create a fixation algorithm for the proposed
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SVOP software which is designed to define when a subject is fixating at a particular stimulus.
Fixation data from the eye tracker consisted of a series of gaze data coordinates which corres-
pond with what was presented on the screen (i.e. the stimulus which the subject was fixating
on). From the data collected it can be seen that a series of gaze coordinates, which correspond
to a fixation point, vary in coordinates from sample to sample (samples occur every 20ms).
This is due mainly to small errors in the eye tracking in this situation (rather than naturally
occurring fixational “micro-saccades”). Two possible scenarios occur: (i) either a series of gaze
coordinates is well “clustered” at the screen coordinates of the “fixation stimulus”; or (ii) there
is an error in the location of the gaze coordinates, but they are still well “clustered”. In either
case it can be inferred that a subject is gazing at any particular known “fixation stimulus”
location if this “clustering” is within a certain range of the “fixation stimulus” coordinates and
remains well clustered for a set period of time. From these data, a fixation detection algorithm
was developed which used some simple rules to determine fixation. If, over a time period equal
to 20 consecutive gaze data samples (400ms), every one of those 20 gaze coordinates is within
±100 pixels (approximately equal to ±2.5◦ visual angle) of the “fixation stimulus” then this
constitutes fixation on that “fixation stimulus”.
5.2.2 Distance data accuracy
The proposed SVOP visual field assessment system allows the patient some freedom of head
movement during the test so long as they stay within the Tobii x50 eye tracker’s camera field of
view. This is made possible because the eye tracker provides data which allows the calculation
of the 3D location of the patient’s eye(s) in real time. This means that at any point during
the test the position of the subject’s eye(s) should be known. This 3D eye positional data
then allows the calculation of the “test stimulus” screen location for any particular point within
the patient’s visual field which is to be assessed (as described in the theory section 5.1.3). As
such, the accuracy of any particular “test stimulus” location (i.e. how well the calculated “test
stimulus” screen location corresponds to the intended visual field point which is to be assessed)
is related to the accuracy of the calculations which describe of the 3D position of the patient’s
eye(s). As described in section 5.1.2, the calculation of the 3D position of the eye(s) depends
primarily on the “eye distance” data provided by the eye tracker.
Because the accuracy of the screen position of the “test stimuli” are clearly a very important
aspect of the proposed SVOP system, the methods and results sections which follow describe
an assessment of the accuracy of the eye tracker distance data which can be used to assess how
this accuracy (or rather any error) impacts upon the accuracy of the calculated “test stimuli”
screen location.
There are two methods described in this section. The first is used to assess the accuracy of the
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distance data provided by the eye tracker, and the second is used to assess the accuracy of the
3D eye position calculated data (ex , ey , and ez).
5.2.2.1 Methods
Method 1: Stationary head
The computer program used in section 5.2.1.1 to assess the Tobii x50 eye tracker’s gaze data
accuracy at 15 specific screen locations was used, again with the same system setup as described
in section 5.1.1.3 on page 61. The program displayed a visual stimulus (in the form of a cross)
on the display screen at 15 different locations in a random sequence and a test subject was
instructed to fixate their gaze at the cross when at each of the 15 screen locations. However,
during this test subjects had their head maintained in a fixed position. Because the head
location (and hence 3D eye location with respect to the eye tracker) was kept stationary,
theoretically the distance data provided by the eye tracker should remain constant throughout
the test. As described in the gaze data accuracy methods, the computer program collected 20
data samples (at a rate of 50Hz) when a subject was fixating at each screen location. However,
this time the program was altered to calculate the average and standard deviation of the distance
data provided by the eye tracker (for both the left and right eyes) with fixation at each screen
location, rather than make gaze error calculations.
10 test subjects performed the 15 point test. All subjects performed a new default 5 point
calibration prior to each of the 15 point tests. Each test was performed with the eyes at a
location of 600mm from the eye tracker’s camera and in a central location within the camera’s
field of view.
Method 2: Head movement
In order to make an assessment of the 3D eye position data (calculated using data fields provided
by the eye tracker) while a subject is moving within the eye tracker camera’s field of view, a
secondary method of accurately monitoring 3D eye location and motion relative to a fixed
point is required. One method of gaining this secondary positional data is by using magnetic
tracking. Magnetic tracking uses a transmitter and a receiver (or sensor) to provide real-time
3D positional data (x, y and z coordinates) of the receiver relative to the transmitter which can
be kept at a fixed point.
Magnetic trackers operate by measuring the electromagnetic field strength, at a sensor location,
of magnetic fields generated by a transmitter.112,113 Usually the sensor is attached to some
moving object which is to be tracked, with the other placed at a fixed location, serving as a
reference point. Magnetic tracking devices function by measuring the strength of the magnetic
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fields generated by sending current through three orthogonal electromagnets in the transmitter.
The receiver also has three orthogonal wire coils embedded in it. By sequentially activating each
of the transmitter electromagnets and measuring the magnetic fields generated on each of the
three perpendicular sensor wire coils, the resultant set of data contains sufficient information
to determine both the position and orientation of the sensor relative to the transmitter.
A magnetic tracking device (WinTracker II from VR-Space Inc. Taiwan) hereafter referred to
as the Magnetic Head Tracker (MHT) was selected to be used as the secondary motion tracking
device which would enable an assessment of the accuracy of the Tobii eye tracker’s eye positional
data. Before the MHT could be used for this purpose an assessment of its own accuracy needed
to be made. If the accuracy of the MHT can be defined, this will allow accurate statements to
be made about the precision of the eye tracker positional data. The manufacturers specification
on the accuracy of the MHT state that it has a 1.52mm RMS (root mean square) static accuracy
at a distance of 750mm. This information is not particularly useful as it only provides accuracy
data when the receiver is stationary in one location. What would be more useful is knowledge
about the errors dependence on the distance between the transmitter and receiver.
The MHT accuracy was assessed by positioning the receiver at known 3D locations (x, y and z
coordinates) from the transmitter and collecting the MHT positional data, so providing a 3D
map of the MHT’s accuracy. The MHT was found to have the most accurate positional data
when the receiver was located within a specific volume of space with respect to the transmitter.
This error was found to be within approximately ±20mm when the transmitter to receiver
distance was greater than 100mm and less than 400mm. This fact was used to construct an
“add-on” for the SVOP system equipment such that the transmitter was positioned as shown
in fig 5.26 allowing the receiver (which would be attached to the subject’s head using a head
band) to be situated within this “accurate volume” when a subject’s eye(s) were positioned at
approximately 600mm from the tracker camera and located centrally within the camera’s field
of view.
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Figure 5.26: Experimental setup for distance data tests using a magnetic head tracker (MHT).
A computer program was written to continually collect positional data (x, y and z) from both
the eye tracker and MHT, each at the same rate of 50Hz. This was accomplished by using
the fact that new data from the eye tracker was known to be sent to the PC at the rate of
50Hz, and so each time the program received data from the eye tracker, it would also collect a
positional data set from the MHT. The 3D eye positional data (x, y & z coordinates) for the eye
tracker were calculated using the calculations outlined in the theory section 5.1.2 on page 62.
The program was designed to continually export both sets of 3D positional data to a text file
until the computer operator manually stopped the process.
A subject was positioned as shown in figure 5.26. They had one eye covered and were positioned
so that the uncovered eye was positioned at 600mm from the eye tracker’s camera and was
located centrally within the camera’s field of view. The MHT sensor was placed just above the
uncovered eye by the use of a head band. While the program was running and collecting the
positional data, with the subject kept stationary and fixating at a stimulus located centrally on
the display screen, the whole SVOP setup was moved in a horizontal direction perpendicular
to the direction in which the subject was facing. The direction of the horizontal movement was
reversed each time the eye moved outside of the eye tracker’s camera field of view. The SVOP
system was mounted on a movable trolley, allowing it to be moved in this manner. Secondly,
this process was repeated with vertical movements by raising and lowering the height of the
SVOP system (i.e. the eye tracker, display screen and MHT transmitter) again reversing the
vertical movement direction each time the eye moved outside the eye tracker Camera’s field of
view. These processes were repeated until several direction changes had been completed.
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The data collected using these methods:
1. allows a direct comparison of positional data between the eye tracker and the MHT; and
2. gives values for the box size at a specific distance of 600mm from the eye tracker. The
effect of keeping the subject’s eye stationary, but moving the eye tracker and MHT has
the effect of a moving subject but allowed the movement to be precisely controlled, thus
allowing an accurate measure of the box size lengths (while at the same time allowing an
assessment of the eye positional data accuracy).
5.2.2.2 Results
Results of method 1: Stationary head
Figure 5.27 shows an example of the distance data recorded with a fixed head position whilst
the eye gaze point is varied to fixate on the previously described 15 display screen locations.
The actual camera-to-eye distance was kept constant at 600mm, so this chart reveals the error
in this distance data when eye fixation is positioned at varying locations on the screen.
Figure 5.27: Distance data variation with stationary head position while varying the point of
fixation.
Results of method 2: Head movement - including MHT accuracy
Figure 5.28 shows four charts which represent the 3D location of the single eye, as it repeatedly
moves in a horizontal direction across the eye tracker camera’s field of view, as represented by
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the data (and subsequent calculation) collected from the eye tracker and data collected from
the magnet head tracker (the WinTracker). There are four charts, one each to represent the x,
y, and z coordinates from the eye tracker camera (charts a, b and c), and the absolute distance
(chart d). Theoretically, the x coordinate should increase and decrease about zero such that
the difference between the minimum and maximum values equals the horizontal size of the
eye tracker camera’s field of view (at a specific distance of 600mm from the camera). Also,
theoretically, the y and z coordinates should remain constant as the eye should be moving in
a horizontal direction only. The absolute value should increase as the eye moves away from
the centre horizontal point (where x = 0) and decrease as the eye moves towards the centre
horizontal point.
Figure 5.28: Horizontal eye movement x, y, z and absolute values as recorded by the eye tracker
and MHT.
Figure 5.29 also shows four charts which represent the 3D location of the single eye, this time
as it repeatedly moves in a vertical direction through the eye tracker camera’s field of view, as
represented by the data (and subsequent calculation) collected from the eye tracker and data
collected from the magnet head tracker (the WinTracker). There are four charts, one each to
represent the x, y, and z coordinates from the eye tracker camera (charts a, b and c), and
the absolute distance (chart d). Theoretically, the y coordinate should increase and decrease
about the zero value. The difference between the minimum and maximum values of y should
be slightly more than the vertical size of the eye tracker camera’s field of view (again at a the
distance of 600mm from the camera) because we are taking a vertical “slice” through the field
of view which is set at an angle of 70 degrees to the vertical. Also, theoretically, the x and
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z coordinates should remain constant as the eye is moving in a vertical direction only. The
absolute value should increase as the eye moves away from the centre vertical point (where y
= 0) and decrease as the eye moves towards the centre horizontal point.
Figure 5.29: Vertical eye movement x, y, z and absolute values as recorded by the eye tracker
and MHT.
Table 5.5 details the values of the horizontal and vertical box size as measured using the
maximum and minimum values obtained from the eye tracker data and the MHT data.
Tracking device Horizontal (X) direction
(mm)





Eye Tracker 199.6 3.1 159.6 3.8
MHT 197.5 2.2 172.7 3.1
Table 5.5: X50 eye tracker head movement box size at a camera-to-eye distance of 600mm.
5.2.2.3 Discussion
1. Stationary head
The Tobii x50 eye tracker uses a triangulation method to calculate the distance of the eyes from
the eye tracker camera.114 The distance is calculated using the known separation of the two
infrared light sources located either side of the centrally located camera, the distance between
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the reflections from the eye of each of the two separate infrared light sources (as seen by the
eye tracker’s infrared camera), and an assumed value for the radius of curvature of the eye.
The accuracy of this method for calculating distance was assessed in a simple manner using
the “stationary head” assessment methods with a subject’s eyes positioned at a known distance
from the eye tracker’s camera (through the use of a specifically positioned chin-rest). Distance
data from the eye tracker was recorded while the subject held their gaze at 15 different screen
locations in turn. The purpose was to investigate the accuracy of the distance data and also
to assess the effect of eye fixation location on the distance data accuracy. Figure 5.27 shows
clearly how the point of fixation has an effect on the accuracy of the eye tracker’s distance data,
with the most accurate data provided when the subject was fixating more towards the centre
of the screen (where the centre of the screen is located directly above the eye tracker’s camera).
As gaze position moved further towards the display screen left and right (and also to an extent
the top) edges, the distance data showed an increase in error.The effect is seen most notably
with fixation at the top corners of the screen where the distance data error increased by up to
40mm. However, the distance data errors when fixation was in these areas were significantly
larger than at any of the other fixation points. If these areas were to be excluded, the error
reduces to a maximum of 20mm and therefore will meet the minimum requirement for the eye
location accuracy outlined in table 5.1 on page 54.
These results suggest that if a subject was looking at far left or right areas of the screen
(in particular the top corners) and the distance data was used to make the calculation for a
visual field “test stimulus” screen location at that moment, there would be a larger error in the
calculated “test stimulus” screen location. As a result, these far left and right areas are not
used as “fixation stimulus” locations.
The implications of the errors in the distance data on visual field “test stimulus” screen location
are assessed in a separate section dedicated the assessment of “test stimulus” screen location
(at the end of this chapter) where the error values found here (excluding the extreme errors
with fixation in the left and right sides) are used to model and assess the implications on “test
stimulus” screen location error.
2. Head movement
The purpose of the “head movement” experiments was to make an assessment of the accuracy
of the 3D location data of an eye with respect to the eye tracker’s camera (as calculated using
the eye tracker distance data and horizontal and vertical eye location data within the camera’s
field of view. The details of this calculation are outlined in section 5.1.3). In addition, these
measurements were also designed to provide an assessment of the two constant values used
in the aforementioned calculations, namely the horizontal and vertical camera field of view
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size at the specific camera-to-eye distance of 600mm. These values are given in the Tobii x50
eye tracker specifications as 200mm and 150mm respectively, and these experimental methods
would also allow these values to be verified.
Figure 5.28 shows the horizontal eye movement x, y, z coordinates and absolute distance value
as recorded (and calculated) by the eye tracker and MHT. Chart a) of this figure demonstrates
that the x-coordinate of both the MHT and eye tracker calculated values are in close agreement
and the size of the horizontal camera field of view (measured as the average range between the
minimum and maximum x-coordinate values) are also in good agreement (table 5.5). Import-
antly, these values are also in agreement with the horizontal field of view size defined in the
eye tracker’s specifications (200mm). Charts b) and c) of figure 5.28 demonstrate possible error
values in the y-coordinate and z-coordinate directions respectively. Theoretically these values
should have remained constant during the experiment as only movement in the x-direction was
created. The error measured in the y-coordinate direction equates to just a few mm for both
the MHT values, and eye tracker calculated values, and up to 20mm in the z-coordinate dir-
ection for the eye tracker calculated values but almost double that for the MHT values in the
z-coordinate direction. This larger error with the MHT could indicate that there is increased
error in the MHT data when the receiver is located at these larger absolute distances from the
transmitter. This is also consistent with what was previously calculated when considering the
ideal transmitter location setup.
In figure 5.29, chart b) shows the y-coordinate values measured when the movement was in the
y-coordinate (vertical) direction, and again good agreement between the MHT values and the
eye tracker calculated values was obtained. However, the agreement was not as accurate as
that obtained with the x-coordinate values during horizontal movement. The average range of
the vertical movement calculated using the two measurement techniques (MHT and eye tracker
calculated values) were in disagreement by ∼ 13mm (∼ 160mm for the eye tracker values and
∼ 173mm for the MHT values, table 5.5) and neither of these values matched the stated Tobii
x50 specification of 150mm for the vertical field of view at 600mm from the camera. However,
the values measured under these experimental conditions were in fact a vertical slice through
the eye tracker camera’s field of view which was tilted at an angle of 20◦ to the horizontal (figure
5.30). When this is taken into consideration, the theoretical vertical “slice” length through the
camera’s field of view is 160mm which is in very good agreement with the eye tracker calculated
average value. Chart c) in figure 5.29 which shows the z-coordinate values again casts doubt
over the accuracy of the MHT values because in theory the z-direction values should remain
constant under the described experimental conditions. The eye tracker calculated z-coordinate
values show an error of ∼ ±13mm, whereas the MHT shows an error of ∼ ±15− 20mm which
appears to vary in a very well defined way, increasing as movement of the MHT receiver’s
absolute distance from the transmitter increases.
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Figure 5.30: Side view of display screen and eye tracker. The eye tracker is positioned at an
angle to the horizontal and so its field of view is also at this angle.
Some positive outcomes are seen from these results. There is good agreement between the eye
tracker calculated values for camera horizontal and vertical field of view sizes and relatively
small errors observed. The agreement observed between the eye tracker calculated values for
the camera’s horizontal and vertical field of view (at a distance of 600mm) and the values
stated in the x50 eye tracker’s specifications is perhaps not too surprising as the calculations
used these specified constant values. However, these results have given some confidence to the
3D eye location coordinates as calculated by the eye tracker distance data. The errors measured
here are later used in a detailed assessment of errors and their implications in section 5.5 at the
end of this chapter.
There is a question over whether the MHT technique can be used to accurately evaluate the
accuracy of the x, y and z eye location measurements of the eye tracker because the MHT also
has error associated with its data. Although the MHT error was measured to be less than
20mm when the transmitter was within approximately 400mm from the transmitter, the error
had a dependence on the transmitter to receiver distance. Additionally, there are other errors
associated with using the MHT. It is difficult to determine the exact location of the receiver
(worn on the subject’s head) relative to the subject’s eye. However, the MHT was practical for
the experimental methods used here to confirm the eye tracker’s horizontal and vertical camera
field of view dimensions. As with the “stationary head” methods these experiments were only
done with a single subject and a more detailed analysis would include additional subjects to
further verify the results obtained.
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5.2.3 Screen luminance
Another important hardware item to consider in the SVOP system is the display screen. To en-
able a comparative test (with the HFA) and also to obtain meaningful specific brightness values
for the “test stimuli” to be displayed, a method of presenting stimuli of specific known screen
luminance levels must be created, and the display screen’s ability to display them accurately
must be assessed. As discussed in section 2.3.2.4 on page 19, many of the well-known perimetry
devices use different luminance levels to display stimuli of varying brightness intensity. This
allows particular numerical values to be assigned to the “test stimuli” used and hence allows a
numerical description to be assigned to a patient’s visual field. The HFA for example, uses a
projection system and light attenuating filters to display stimuli at specific luminance levels on
a bowl shaped screen which is illuminated with a specific background luminance.
Because the proposed SVOP system uses a flat panel LCD screen rather than a projection
system (as seen in the HFA for example), the way in which different luminance levels are
displayed will be inherently different. LCD screens work by producing coloured images by
filtering a white back-light. The back-light is typically provided by fluorescent tubes positioned
at the back of the LCD screen.
An LCD is made of several layers. Light from the fluorescent back-light passes through a layer
of light polarising material, a layer containing the liquid crystal material, and another layer
of polarising material rotated by 90 degrees with respect to the first polarising material layer.
Light can pass through the arrangement of layers when the liquid crystal component has a
small electric current passed through it, forcing it to align with the orientation of the polarising
filters. LCD monitors allow each pixel to be activated individually. Individual liquid crystal
pixels, arranged in a grid, each allow a metered amount of the white light through. Each pixel
contains three sub-pixels which are each paired with a coloured filter to remove all but the
red, green or blue portion of the light from the original white source. The sub-pixels are small
enough that when the display is viewed from even a short distance, the individual colours blend
together to produce a single pixel of colour. The shade of colour for each pixel can be controlled
by changing the relative intensity of the light passing through each of the sub-pixels.
So, with an LCD screen, the light provided by the back-light (fluorescent lamps) is essentially
being attenuated and filtered to produce different colours. Because of this fact, different colours
will produce varying levels of luminance as more or less back-light is allowed to pass. This
property can be used to develop a method which comprises different colours to produce different
levels of luminance. Colour produced by pixels in a LCD screen can be expressed as an RGB
triplet (R,G,B), corresponding to a red, green and blue component. Each component can vary
from zero to a defined maximum value. If all the components are at zero the resultant colour is
black, if all values are at a maximum, the result is the brightest white that the screen is capable
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of displaying (which is related to the brightness of the florescent tube back-light). Typically in
computing the component values are stored as integer numbers in the range 0 to 255, which
is the range that a single 8-bit byte can offer (by encoding 256 distinct values). Bearing this
in mind, the most obvious method for generating various distinct levels of luminance would
be to use the luminance levels generated by different colours to produce a scale of increasing
luminance. Grey-scale level colours are produced by setting the R, G and B (red, green and
blue) levels equal to each other, and would be a simple method to employ. The maximum
luminance will have RGB level of (255, 255, 255) and the minimum will have RGB = (0, 0,
0). Grey-scale levels in-between will produce levels of luminance between the minimum and
maximum values.
In order to implement this method of using grey scale levels to present stimuli of specific
luminance in the proposed SVOP system, the luminance values of the grey-scale levels which
the display screen produces first needs to be assessed. Additionally, the uniformity of the display
screen must also be assessed in order to identify any uniformity variation in brightness across
the screen. This is important because the proposed SVOP system could feasibly present a “test
stimulus” almost anywhere on the display screen. Any display screen brightness uniformity
variation would result in a “test stimulus” being of a slightly different brightness in one screen
location as compared to another, even if both stimuli were presented at the same grey-scale
level (i.e. the same intended luminance).
The following sections detail the methods and results used to:
1. assess the LCD screen brightness values produced by varying grey-scale levels in order to
quantify the possible levels of brightness which the SVOP system can produce using an
LCD screen,
2. assess the LCD screen brightness uniformity in order to assess how a stimulus of a single
grey-scale level could potentially vary in brightness when displayed at different screen
locations.
These two assessments can be made using the same methodology and experimental setup which
is described in the next section.
5.2.3.1 Methods
A luminance meter (L203 photometer from Macam Photometrics Ltd. Livingston, UK) was
used to make luminance measurements from 77 different screen positions. A computer pro-
gram was written (using Visual Basic .Net within Microsoft Visual Studio 2005 development
environment) which would run on a PC which controlled the LCD display and which was also
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connected to the luminance meter via an RS232 serial port connection. The program was run
each time the light meter’s sensor was positioned facing toward each screen location. The pro-
gram displayed grey-scale level colours on the LCD screen from an R=G=B value of 0 up to 255
in steps of 15. While each colour was displayed on the screen the program would instruct the
light meter to start collecting luminance values. At each grey-scale colour level 20 luminance
values were collected and were exported to a separate text file. The program was run with the
luminance meter sensor directed at each of the 77 different screen locations, resulting in both
luminance values for varying grey-scale level values and also an indication of the luminance
variation across the display screen. This method was performed by positioning the photometer
sensor in two different ways. First, each of the 77 screen locations was assessed by placing
the sensor in direct contact with the screen at each location. Secondly, with the photometer
sensor placed at a central location in front of the display screen and at a distance of 600mm
from the eye tracker (resulting in a distance of 564mm from the centre of the LCD screen).
The photometer had a measuring angle of 6 degrees, so the screen positions were arranged such
that the screen area subtended by 6 degrees from the central photometer location would always
fully contain display screen pixels (i.e. all of the measured area would be from the display
screen) and adjacent screen positions overlapped by approximately 20mm. Figure 5.31 shows
this setup.
Figure 5.31: Experimental setup for luminance measurements.
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5.2.3.2 Results
Figure 5.32 shows the luminance measurements made when the photometer’s sensor was placed
directly on to the display screen at each of the 77 screen locations. Each chart within the
figure shows the luminance values (in Cd/m2) represented as a colour contour map based on
the 77 locations. The 4 charts represent the luminance measured from the screen while it
was displaying 4 different grey-scale colours across the whole screen. These grey-scale colours
correspond to RGB levels equal to 45, 105, 165 and 225. These luminance measurements were
performed with 18 different grey-scale RGB levels. However, only 4 are shown here as examples
of how the luminance from the display screen increases as the grey-scale RGB value increases,
and to demonstrate the variation in luminance across the display screen.
Figure 5.32: Four examples of across screen luminance variation from display screen using
direct measurements. The four examples are from different RGB screen grey levels of 45, 105,
165 and 225.
A more realistic situation, when considering the proposed SVOP system and technique, is the
display screen luminance viewed from a location in front of the screen which more closely
matches the approximate location of a patient’s eye(s) during an SVOP test. Figure 5.33
shows the luminance measurements made with the photometer’s sensor placed at a location
corresponding to a central location in front of the display screen and at a distance of 600mm
from the eye tracker, corresponding to the proposed starting location of a patient’s eye(s) at
the beginning of an SVOP test. Again, each chart within the figure shows the luminance values
(in Cd/m2) represented as a colour contour map based on the 77 measurements made. The
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4 charts represent the luminance measured from the screen while it was displaying 4 different
grey-scale colours across the whole screen. These grey-scale colours corresponded to RGB levels
of 45, 105, 165 and 225 to give four examples of how the luminance from the display screen once
again increases as the grey-scale RGB value increases, and also to demonstrate the variation
in luminance across the display screen when viewed from this specific location in front of the
display screen.
Figure 5.33: Four examples of across screen luminance variation from display screen using eye
perspective measurements. The four examples are from different RGB screen grey levels of 45,
105, 165 and 225.
Because both direct screen luminance measurements and luminance measurements from the
described central location in front of the display screen have been made, this allows for the
analysis of the bias between them. The resulting bias between the measured luminance’s at
each screen location (for each grey-scale level tested) would give an indication of how much of
the luminance variation seen in the measurements taken from the central location in front of
the screen, were due to factors other than the display screen luminance variation. The resultant
variation in the bias values must be related to other factors (most likely the angle at which an
area of the display screen is being viewed, as this is known to degrade the luminance as this
angle increases). Figure 5.34 shows the bias luminance measurements (in Cd/m2) represented
as colour contour maps based on the measurements made at the 77 screen locations. Again,
the 4 charts represent the bias luminance while the screen was displaying 4 grey-scale colours
across the whole screen, corresponding to the RGB levels of 45, 105, 165 and 225.
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Figure 5.34: Four examples of bias between direct and eye perspective screen luminance meas-
urements. The four examples are from different RGB screen grey levels of 45, 105, 165 and
225.
Using the luminance values measured with the photometer’s sensor at the centred location in
front of the display screen, the across-screen average values of luminance were calculated at each
grey-scale level. Figure 5.35 shows this data. Also shown on the chart (depicted using dashed
lines) are the grey-scale RGB values 66 and 223 which correspond to two specific luminance
values. The RGB value of 66 corresponds to a luminance value of 10Cd/m2. This value is
significant because it is equivalent to the background luminance used by the HFA. The second
RGB value, of 223, corresponds to a luminance value of 136.7Cd/m2. This luminance value
corresponds to a specific luminance level which the HFA is able to produce as a “test stimulus”
brightness and on the HFA is described as a decibel (dB) level of 14dB. The reason this value is
shown on the chart is because this “test stimulus” brightness level was selected to be used quite
widely in this research program (for example as the “test stimulus” brightness in the developed
SVOP test which will be compared directly with a HFA screening test which uses the 14dB
“test stimulus”).
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Figure 5.35: Average (±1 standard deviation) of screen luminance values from all screen posi-
tions, from eye perspective, across all grey scale RGB values.
Table 5.6 shows all the luminance dB levels which the HFA uses along with the associated
luminance values of each dB level. In addition, the table also shows the equivalent RGB grey-
scale level which corresponds (where possible) to each HFA dB level. The way in which these are
calculated is by taking the HFA level brightness (which corresponds to the difference between
the background and the “test stimulus” on the HFA) and adding the background luminance to
give the appropriate stimulus luminance value at which a “test stimulus” should be displayed
on the LCD screen in the proposed SVOP system in order for it to correspond to any of the
particular HFA dB levels.
Figure 5.36 on page 114 shows the luminance values vs grey-scale RGB values taken from two
specific screen locations. The two locations correspond to that which had the highest luminance
and that which had the lowest luminance (i.e. the brightest and dimmest screen locations
respectively) from the measurements taken when the photometer’s sensor was located centrally
with respect to, and in front of, the display screen. The brightest screen location corresponded
to the measurements taken at a screen location of (143,137) and the dimmest screen location
corresponded to the measurements taken at a screen location of (30,30) in (x,y) coordinates
from the top left of the screen. This chart allows a measurement of the range of luminance
values which a “test stimulus” displayed at a single RGB value could possibly have if it was
displayed at any location on the screen and was viewed from the location of the photometer
sensor. Table 5.7 on page 114 shows the calculated ranges of how “test stimuli” displayed on
the LCD screen could potentially vary in luminance difference, when considering the difference
between the “test stimuli” brightness and background brightness RGB levels, as a result of using
the brightest and dimmest locations of the display screen as viewed from the described location
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used for the photometer sensor (at a distance of 600mm from the eye tracker’s camera and
located centrally in front of the display screen).







0 3183.1 3193.1 -
1 2528.3 2538.4 -
2 2008.5 2018.6 -
3 1595.4 1605.4 -
4 1267.2 1277.2 -
5 1006.5 1016.5 -
6 799.6 809.6 -
7 635.0 645.1 -
8 504.5 514.5 -
9 400.8 410.8 -
10 318.3 328.3 -
11 252.7 262.8 -
12 200.9 210.9 -
13 159.5 169.5 243
14 126.7 136.7 223
15 100.6 110.6 206
16 79.9 89.9 190
17 63.7 73.7 173
18 50.6 60.6 159
19 40.1 50.1 147
20 31.8 41.9 136
21 25.1 35.2 120
22 20.1 30.1 110
23 15.9 25.9 102
24 12.7 22.8 96
25 10.2 20.2 91
26 8.0 18.0 87
27 6.4 16.4 83
28 5.1 15.1 81
29 4.1 14.2 78
30 3.2 13.2 76
31 2.5 12.6 -
32 1.9 11.9 -
33 1.6 11.6 -
34 1.3 11.3 -
35 1.0 11.0 -
Table 5.6: HFA stimuli luminance values and the corresponding grey-scale RGB values on the
LCD screen.
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Figure 5.36: Luminance values, from eye perspective, for all grey scale RGB values from two




















dB Cd/m2 Dimmest Brightest Dimmest Brightest
13 169.5 243 136.3 187.2 127.0 177.5 50.4
14 136.7 223 114.6 150.4 105.3 140.6 35.3
15 110.6 206 95.0 120.3 85.7 110.5 24.8
16 89.9 190 78.3 96.0 69.0 86.2 17.2
17 73.7 173 63.3 75.3 54.0 65.5 11.5
18 60.6 159 53.1 61.8 43.8 52.1 8.3
19 50.1 147 45.5 52.3 36.2 42.5 6.3
20 41.9 136 39.4 44.8 30.1 35.0 4.9
21 35.2 120 31.4 35.2 22.0 25.4 3.4
22 30.1 110 26.7 29.8 17.4 20.0 2.6
23 25.9 102 23.2 25.7 13.9 15.9 2.0
24 22.8 96 20.6 22.7 11.3 12.9 1.6
25 20.2 91 18.5 20.3 9.2 10.5 1.3
26 18.0 87 18.1 19.8 8.8 10.1 1.2
27 16.4 83 15.3 16.6 6.0 6.9 0.8
28 15.1 81 14.6 15.8 5.3 6.0 0.7
29 14.2 78 13.5 14.5 4.2 4.7 0.5
30 13.2 76 12.7 13.6 3.4 3.9 0.4
Table 5.7: The maximum range of luminance values, for each equivalent HFA stimuli level, on
the LCD screen when considering the brightest and dimmest screen locations (as measured from
a location 600mm from the eye tracker’s camera and centrally in front of the display screen).
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5.2.3.3 Discussion
The described method of using grey-scale colour levels for producing specific luminance level
“test stimuli” on a computer display screen relies to a certain extent on having screen luminance
uniformity of an acceptable level. There are two main aspects of display screen uniformity which
are of importance in this research program: (i) direct uniformity characteristics specific to the
display screen, due mainly to poor uniformity of the back-lighting of the screen; and (ii) the
uniformity “appearance” of the screen as a result of different viewing angles. It was expected
that both these factors would be a feature of the display screen being tested. Figure 5.32
demonstrates that the direct screen shows a non-uniformity in luminance measured directly
from the display screen with an increase in luminance on the left side of the screen. This
increased luminance was a consistent feature at all the grey-scale levels measured and so can
be considered to be a characteristic of the display screen used.
The more realistic situation (in terms of the proposed SVOP system) of screen uniformity
measured from a location which corresponds more appropriately with where a test subject’s
eye(s) would be located is shown in figure 5.33. The increased luminance area to the left side
of the screen which was revealed by the direct screen measurements is still observed. However,
in addition there is reduced luminance in areas towards the edges of the screen (in particular
the left and right sides). This additional reduction in luminance can be attributed to the effect
of reduced luminance with increased viewing angle. The effect of viewing angle alone is seen in
figure 5.34 by having the previously measured direct screen luminance uniformity subtracted
out, and demonstrates quite clearly that the reduction in luminance effect as a result of wider
viewing angles occurs more significantly towards the left and right edges of the display screen.
In addition to assessing screen luminance uniformity, the purpose of these experimental methods
was to obtain luminance values for different grey-scale levels which could then be used in the
proposed SVOP system. Because the LCD luminance was not uniform, the “across-screen”
luminance values at each measured grey-scale level were averaged. Each average value would
then represent a luminance value for each of the grey-scale levels measured (as shown in figure
5.35).
Using these averaged values it is possible to compare the display screen’s capability in displaying
“test stimuli” luminance’s which correspond to those which are used by the HFA. Table 5.6 shows
that from the wide range of luminance levels which the HFA is able to produce there is a range
of luminance levels which the display screen is capable of displaying. There are 12 luminance
levels on the HFA scale which are brighter than the display screen is capable of displaying.
This is because the display screen has a maximum brightness which is related to the back-light
used and there is no need for a normal computer screen to be any brighter than this maximum
luminance. There are also HFA stimulus luminance levels at the lower (or dimmer) end of the
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scale which the display screen has problems displaying correctly. The reason for this is that
at these lower brightness levels, the equivalent HFA stimulus luminance starts to lie between
two adjacent grey-scale levels. For the purposes of the proposed SVOP system these lower
brightness levels are not required as the system is designed to be a suprathreshold screening
test using a relatively bright level of “test stimuli”.
However, the problem of the screen non-uniformity still persists, and with each display screen
stimulus level which corresponds to a HFA stimulus level there is an associated potential error
in the luminance displayed in comparison with the specific HFA luminance. This is because an
“across-screen” average is used to describe each stimulus luminance level when in fact there are
a range of “possible” luminance levels which could be displayed for any particular “intended”
stimulus brightness level depending on the screen location of the “test stimuli”. The largest
potential errors using the measurements made are described in figure 5.36 and table 5.7. The
largest potential error is calculated by the luminance difference between the background and
“test stimulus” level from the brightest and dimmest screen locations. This reveals a luminance
“range” for each specific HFA stimulus level which could be reproduced using the display screen.
Taking the largest potential error to be ± 12 range, then the error is at an acceptable level for
this application (when assessing the measurements made) as the largest potential error for any
particular equivalent HFA level does not cross over into another adjacent (above or below)
brightness level on the HFA scale. These errors can be reduced further by making sure that
the far left and far right sides of the screen, where luminance is reduced further due to the
increased viewing angle, are not used as locations to present “test stimuli”. However, there
is also a risk of an increase to these errors because in the proposed SVOP system the test
subject is allowed to move their head. Head movement will change the viewing angle to each
part of the screen (increasing viewing angle to some areas while reducing it to others). The
effect of this could add further to the potential brightness level error. However, this variation is
tolerable for proposed suprathreshold system because a test subject only has a certain amount
of allowable head movement before they will move outside the eye tracker’s field of view (under
which condition the test would not be able to proceed). This prevents extremely large viewing
angles to occur.
5.3 Assessment of eye gaze response to “test stimuli”
In order to develop a software algorithm which is capable of automatically deciding, in real
time, whether or not visual field “test stimuli” have been seen or not, it is important to assess
the characteristics of eye gaze responses to the presentation of the “test stimuli”. An eye gaze
response can simply be described as a change in fixation position (i.e. from the “fixation
stimulus” point to a new point). So, an eye gaze response here is termed “fixation change” and
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it is these “fixation changes” which will be assessed in this section. The developed algorithm
will need to determine when fixation change eye movements correspond to a patient having
seen a visual field “test stimulus”. Three properties of any fixation change movement will be
assessed to make this decision:
• Direction - the direction in which fixation change movement takes place.
• Amplitude - the magnitude of the fixation change movement.
• Latency - the reaction time of the fixation change movement.
5.3.1 Methods
The first version SVOP software previously described in section 5.2.1.1 on page 87 was altered
to collect data on gaze fixation change movements in response to visual “test stimuli”. As a
reminder, the software program was designed to display a “fixation stimulus”, then when a
subject is gazing at the “fixation stimulus” calculate the position of a visual field point “test
stimulus” and display it for 200ms and repeat this process with a predetermined set of visual
field locations while constantly collecting gaze data. Figure 5.19 on page 88 shows the program
flow of this software. The program was altered slightly in terms of the data collection such that
in addition to collecting the raw gaze and distance data, it would also calculate and export data
about the characteristics of fixation changes which occur in response to the “test stimuli” which
were displayed. These characteristics and their associated data are described in the following
paragraphs (headed “Direction”, “Amplitude” and “Latency Characteristic”) which describe the
three properties associated with the fixation changes that are detected.
A total fixation change was defined by a start and end gaze location. The change in screen
position (measured in pixels) of all consecutive gaze data points was continually monitored.
The start of a fixation change was detected by looking for a change in gaze location between
consecutive gaze data samples (at the 50Hz sample rate) which was greater than 50 pixels (this
relates to an angular change of approximately 1.3◦). The start point of a fixation change was
defined as the start point of the >50 pixels gaze change. The end location of a total fixation
change was defined by the point at which 5 consecutive gaze data samples are separated by a
distance less than 50 pixels and must occur after the detection of a fixation change start point.
The software flow of this fixation change detection algorithm is shown in figure 5.37. In this
algorithm, it is possible that many data samples can make up a single detected fixation change.
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Figure 5.37: Flow diagram of the fixation change detection software algorithm.
Direction characteristic
The direction of any detected fixation change was calculated as an angle between an imaginary
horizontal line extending out to the right of the fixation change start point, and the line of the
fixation change. In addition, the direction between the centre of the “fixation stimulus” point
and the centre of the “test stimulus” point was calculated as an angular direction using the
same procedure (this angle is termed “stimulus change direction”). The bias between these two
direction angles was then calculated, with a positive bias value representing a fixation change
direction which is greater than the stimulus change direction. These values were calculated in
degrees. An example of this is shown in figure 5.38, with the bias value calculated as follows:
Direction Bias = θF − θS
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Figure 5.38: An example of values used to calculate the direction bias of a fixation change.
Amplitude characteristic
The amplitude (or magnitude) of any detected fixation change was calculated as a visual angle
subtended at the eye rather than by a distance in pixels on the display screen, in this way
it could be compared directly to the visual field angle which was used to display the “test
stimulus”. The visual angle corresponding to the fixation change was calculated by using the
eye positional data (x, y and z coordinates) at the start of the detected fixation change, which
could be calculated from the distance data provided by the eye tracker corresponding to the
start point data sample. As the eye position is known along with the position of the start
and end points of the fixation change, the angle of the fixation change (at the eye) could be
calculated. The bias between the fixation change angle and the “test stimulus” angle (which is
already known) was calculated and represented as a % difference. Positive values represented a
fixation change angle which was larger than the “test stimulus” visual field angle, and negative
values represented a fixation change angle which is less than the displayed “test stimulus” visual
field angle. An example of an amplitude fixation changes is shown in fig 5.39, with the % bias









Figure 5.39: An example of values used to calculate the amplitude bias of a fixation change.
Latency characteristic
The latency characteristic can also be described as the eye reaction time in response to the
“test stimulus”. Latency was calculated (measured in ms) simply by taking the time difference
between the time the “test stimulus” was initially presented on the display screen and the time
at the beginning of the first detected fixation change subsequent to a “test stimulus” being
displayed.
Test patterns, “test stimuli” and subjects
For these methods, as in section 5.2.1.1 on page 87, three visual field test patterns were used.
These were the test pattern for the left and right eyes as based on the HFA C40 screening
test pattern and a custom designed 40-point visual field pattern which consisted of 40 points
located within the first 25 degrees of the visual field which was based on the left and right eye
test patterns (figure 5.20 on page 89 shows the three test patterns used). The “test stimuli”
were presented at a specific luminance brightness of 136.7Cd/m2 HFA equivalent to 14dB.
One reason for doing this is that in future comparative studies, data on direction, amplitude
and latency of reactions to a specific luminance level will be used to create a test which can
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be compared to a screening test which can be created on the HFA for clinical feasibility and
validation studies.
The main aim of this data collection process was to produce a set of “normative” data to describe
gaze reaction characteristics in response to “seen” “test stimuli” so that an algorithm can be
created to detect when any particular “test stimulus” has been seen.
Healthy volunteers and also patients with visual field defects of a range of ages were recruited
to perform three tests each (corresponding to the three field test patterns described above).
The subjects and tests which were performed are outlined in table 5.8.
Subject groups Number Age (years) Tests performed
Mean Range Binocular Left Right
Healthy adult 14 35.1 21-68 14 14 14
Adult patient 6 57.0 17-74 6 5 5
Healthy child 9 8.8 5-16 9 9 9
Child patient 9 7.8 2-15 9 5 5
Total 38 29.7 2-74 38 33 33
Table 5.8: Subjects for fixation change characteristics tests
5.3.2 Results
Direction characteristic
Figure 5.40 shows five frequency distributions for gaze direction bias following the presentation
of “test stimuli”. The five different frequency distributions relate to five different eccentric visual
field angles (5◦ − 25◦ in steps of 5◦). These frequency distributions detail the direction bias
characteristics for gaze responses to “seen” “test stimuli”. These data can then be used to define
a set of limits of “permissible” direction bias values for use in an algorithm which automatically
decides, in “real time”, if a displayed “test stimulus” has been seen.
These limits were chosen to be the average direction bias values ±3 standard deviations using
the data for each eccentric visual field angle assessed (5◦ − 25◦ in steps of 5◦). Figure 5.41
shows a chart representing the chosen direction bias limits with increasing eccentric visual field
angle for use in the SVOP decision algorithm.
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Figure 5.40: Distribution of direction bias values at each of the tested visual field angles
Figure 5.41: Average, ±3 standard deviations (equivalent to the limits used), of direction bias
values for each of the tested visual field angles
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Amplitude characteristic
Figure 5.42 shows five frequency distributions for gaze amplitude bias following the presentation
of “test stimuli”. The five different frequency distributions relate to five different eccentric visual
field angles (5◦ − 25◦ in steps of 5◦). These frequency distributions detail the amplitude bias
characteristics for gaze responses to “seen” “test stimuli”. This data can then be used to define a
set of limits of “permissible” amplitude bias values for use in an algorithm which automatically
decides, in “real time”, if a displayed “test stimulus” has been seen.
Figure 5.42: Distribution of amplitude bias values at each of the tested visual field angles
These limits were chosen to be the average amplitude bias values ±3 standard deviations using
the data for each eccentric visual field angle assessed (5◦−25◦in steps of 5◦). Figure 5.43 shows
a chart representing the chosen direction bias limits with increasing eccentric visual field angle
for use in the SVOP decision algorithm.
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Figure 5.43: Average, ±3 standard deviations (equivalent to the limits used), of amplitude bias
values for each of the tested visual field angles
Latency characteristic
Figure 5.44 shows all the reaction times in response to “test stimuli” which were considered as
“seen”, and the average ±1 standard deviation. This chart demonstrates the range of reaction
times observed for each eccentric visual field angle. Clearly there is some erroneous data where
there are very short reaction times < 50ms. These fast reaction times can be attributed to the
method of reaction time measurement. A simple algorithm was deigned to detect a reaction
by calculating the difference between the presentation of the “test stimuli” and the first gaze
movement. The gaze movement was simply defined as a change in gaze coordinates of >50
pixels and it was likely that this could occur from the gaze data without the subject having
actually responded.
The reaction times were also assessed for gaze reactions to “test stimuli” which were considered
to be “unseen”. Figure 5.45 charts the average reaction times (±1 standard deviation) for each
subject who had “test stimuli” that were considered both “seen” and “unseen” as part of their
set of “tests” such that the “seen” and “unseen” reaction times could be plotted together.
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Figure 5.44: Spread and average (±1 standard deviation) of latency values for each of the tested
visual field angles
Figure 5.45: Latency values for “seen” and “unseen” points. (Average ±1 standard deviation).
5.3.3 Discussion
The methods described in this section were designed to collect and analyse data regarding
subject gaze responses to visual field “test stimuli” which will eventually be used in the proposed
SVOP system. A subject’s gaze response was defined as the first “fixation change” immediately
following the presentation of a “test stimulus”. A “fixation change” was defined as having a
start and end pair of fixation coordinates which were determined using the algorithm outlined
in figure 5.37. Data regarding three characteristics of each “fixation change” in response to “test
stimuli” were collected. These characteristics comprised: (i) the direction, (ii) the amplitude,
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and (iii) the latency of the gaze response. The direction and amplitude were compared directly
with the direction and amplitude of the direct vector between the “fixation stimulus” and “test
stimulus” screen coordinates to produce bias values. The purpose of collecting these data was to
enable the development of an algorithm which could use the data to make automated decisions
on whether any particular “test stimulus”, in the proposed SVOP system, has been “seen”.
The bias data collected about direction and amplitude characteristics of fixation changes were
expected to be in the form of normal distributions. This was shown to be the case. However
there was an influencing factor which had an effect on the shape of the normal distributions.
The eccentric visual field angle of the “test stimuli” used had an effect on the width of the
distributions for both the direction bias and amplitude bias characteristics (figures 5.40 and
5.42 respectively). As the eccentricity of the visual field angle used increased, the distributions
showed a reduced overall width. The reason for wider distributions of these bias characteristics
at smaller eccentric visual field angles is due to the natural error in the gaze data which is
sometimes seen (as discussed in section 5.2.1). There can sometimes be an error in the data
provided by the eye tracker which is generally not a problem for determining when a subject
is fixating on a “fixation stimulus” because, so long as the error is not too large, it can still
be inferred that the subject is looking at the “fixation stimulus”. An error in the gaze data
at either, or both ends of a “fixation change” could result in a wider range of direction and
amplitude bias values the closer the “fixation stimulus” is to the “test stimulus” (i.e. the smaller
the eccentric visual field angle is).
The average value for the direction bias was effectively zero for any eccentric visual field angle,
while for the amplitude bias the average values were slightly shifted below zero indicating that
subjects tended to slightly underestimate the position of the “test stimulus” when considering
the finishing point of their first fixation change in response to the “test stimulus”.
As a result of the varying distribution widths with eccentric visual field angle, data was analysed
separately according to the eccentric visual field angle of the “test stimuli”. The average and
standard deviation values for the direction and amplitude bias distributions could be used as
the basis for the “decision algorithm” to be used in the proposed SVOP system which would
make the automated decision about whether any particular “test stimulus” has been “seen”. The
“decision algorithm” will use a set of limits determined by the results gathered in these methods
such that a “test stimulus” will only be considered as “seen” if the “fixation change” response has
direction and amplitude bias characteristics which both fall within limits set at the average ± 3
standard deviations of the distribution data collected (as shown in figures 5.41 and 5.43). The
reason for using the ± 3 standard deviation level was to ensure that all appropriate fixation
changes are labelled correctly as “seen”. Because the algorithm must consider two separate
variables to make a “seen” decision it is necessary to increase the range of acceptable values.
As an added insurance, it is also proposed that any visual field points not considered as “seen”
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by the decision algorithm the first time the “test stimulus” is shown will be retested and only
finally be described as “unseen” if the test point is still not determined as being “seen” a second
time.
The third characteristic of any particular “fixation change” response following the presentation
of a “test stimulus” is the latency. Latency was recorded whether the responses were considered
to have been “seen” or “unseen”. The decision regarding whether a “test stimulus” was “seen”
or “unseen” in these methods was slightly subjective and was based on post test reviewing of
the gaze reactions. Generally, it was very obvious when a gaze response was in fact due to the
“test stimulus” presented having being “seen”. “Unseen” reaction times (latency) were really a
reaction to the disappearance of the “fixation stimulus” (rather than the appearance of the “test
stimulus”) and were generally significantly larger than those which were “seen” (figure 5.45).
This data provides another possible insurance method for automatically verifying that “test
stimuli” have been “seen”. Latency can not be relied on completely due to the large variability
in this value for any particular subject. However, a further rule to be implemented in the
“decision algorithm” could be that any particular visual field test point should be retested if
there was a significantly slower reaction time as compared to previously “seen” “test stimuli”
which have already been tested.
The described method of detecting “seen” stimuli using a vector of eye movement is poten-
tially more reliable than the detection method used in current automated static perimeters.
The method described here uses multiple data variables to accomplish a decision (direction,
amplitude and latency of eye movements) whereas standard automated perimeters have only a
single button press to signal that “something” has been seen and there is no way of verifying
that a patient has definitely “seen” the stimulus which was presented other than the timing of
the button press. The described eye movement vector detection method may be a considerable
improvement on the single button press used ubiquitously in many automated static perimeters.
5.4 Clinical feasibility study
5.4.1 Introduction
The developed SVOP system is so far described in a theoretical basis and by using data gathered
on eye gaze reactions to “test stimuli”. However it has not been assessed in any way against
another clinically accepted visual field assessment test. Before embarking on a large clinical
validation trial, it was important to test the feasibility of the developed system against a
comparative, clinically accepted visual field test device in healthy volunteers and patients with
visual field defects able to perform the comparative test reliably. In addition, it would also be
important to “try out” the developed system with its target age group of children, including
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healthy children and children with visual field defects whether or not they can perform a
comparative visual field test reliably or not.
5.4.2 Subjects and Methods
Four groups of children and adult subjects were recruited (table 5.9). Subjects performed
3 SVOP tests. In the first two tests, a subject’s left and right eye’s visual field was tested
by performing uniocular SVOP tests which replicated the Humphrey Field Analyser’s (HFA)
Central-40 point left and right eye suprathreshold screening test patterns (hereafter referred
to as HFA C-40 test) with the addition of a 41st point in the SVOP tests positioned at the
blind spot. Subjects also performed a custom made binocular SVOP field test which was based
on the HFA C-40 uniocular test patterns (figure 5.46). Exceptions to this procedure were very
young children unable to effectively hold the occluding eye cover which was used (two subjects).
These children performed the SVOP binocular visual field test only. There were 4 (1 child, 3
adults) subjects unable to perform one of the SVOP tests for various additional reasons (e.g.
very poor or absent vision in one eye), in which case tests were not performed on that eye.
Age (Years)
Subject Group Number of subjects Mean Range
Normal Adults 12 (5 m, 7 f) 29.8 16-61
Normal Children 4 (3 m, 1 f) 7.5 5-9
Adults with visual field defect 8 (5 m, 3 f) 63.3 17-77
Children with suspected visual field defect 5 (4 m, 1 f) 5.8 4-9
Table 5.9: Subjects and subject groups recruited for the feasibility trial.
Figure 5.46: a) The Humphrey Field Analyser (HFA) C-40 Point screening test pattern for
the right eye including blind spot (∆). The test pattern for the left eye is a mirror image of
this. b) The 40 point test pattern developed for binocular Saccadic Vector Optokinetic Perimetry
(SVOP) tests. Numbers displayed indicate visual field in degrees from point of fixation.
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Prior to each set of 3 SVOP visual field tests, each subject performed the calibration procedure.
Subjects were required to look at the display screen and follow a stimulus with their eyes to
5 different locations on the screen. The stimulus used for adults and older children was a
simple filled circle which moved to each location in turn (this is the Tobii eye tracker’s standard
calibration procedure). For younger children a custom calibration procedure was used. In these
cases, the circle was replaced with a cartoon character which moved to each of the 5 screen
locations where a simple animation with sound was played, lasting just a few seconds, in order
to keep the attention of the child.
The SVOP tests performed by adults and older children used a simple small cartoon face to
create a “fixation stimulus”. The visual field stimuli used during the test were of size Goldmann
III (0.43 degrees angular diameter) and duration 200ms. Adults and older children were given
the simple instruction “If you see anything on the screen just look towards it”. For younger
children the “fixation stimulus” of a cartoon face was replaced with a variety of small short
cartoon character animations with sound effects so as to encourage attention and generate
interest. Younger children were not given any instruction, but were merely encouraged to look
at the display screen.
The adults with visual field defects also performed the HFA C-40 test with the left and right
eyes. The HFA’s standard screening tests use an age matched hill of vision where stimuli are
presented at 6dB brighter than the expected hill of vision value. The HFA’s C-40 tests were
purposely altered so that all stimuli were presented at a constant intensity level of 14dB to
match the SVOP visual field tests which were also tailored to display stimuli at an intensity
level of 14dB (stimulus intensity of 429Asb and background 31.5Asb) as stipulated in the
HFA manufacturer manual. The stimulus size and duration used in the HFA C-40 tests was
Goldmann III and 200ms respectively. The SVOP tests performed by the normal adults and
children were compared with a normal healthy visual field, and the SVOP right and left eye
tests performed by the adults with visual field defect were compared with the equivalent HFA
C-40 left and right eye visual field tests.
5.4.3 Results
Normal adults
11 of the 12 normal adults performed all three SVOP tests (binocular, left eye, and right eye).
The remaining 1 adult performed the SVOP binocular visual field test and left eye visual field
test. All adults had normal visual fields confirmed by HFA testing. Figure 5.47 shows examples
of SVOP test results from a normal subject, where all points from each of the three tests were
correctly identified, i.e. all points were correctly identified as ‘seen’ except the blind spots
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present in the left and right eye tests respectively which were determined to be ‘unseen’. Table
5.10 gives a summary of the results obtained for the ‘normal adult’ group.
Figure 5.47: Example of SVOP test results from a normal subject depicting the ‘seen’ and
‘unseen’ points. a) Binocular visual field test, b) left eye test, c) right eye test.
Visual Field Test Type
Test Result Characteristics Binocular Left Eye Right Eye
Number of subjects performing test 12 12 11
Number of Visual field points in test 40 41 41
Mean (±SD) number of correctly diagnosed points 39.9 ± 0.3 40.7 ± 0.8 40.7 ± 0.5
% of correctly diagnosed points 99.8 99.2 99.3
Table 5.10: Results from the ‘normal adult’ group. Correctly diagnosed points are those which
correspond with a normal healthy visual field.
The blind spots were correctly identified as ‘unseen’ in all of the left and right eye SVOP tests
apart from one in which the subject was able to see the stimulus presented in the blind spot area.
This test was repeated in order to assess this anomaly and again the blind spot was recorded
as being “seen”. Currently, in the SVOP system, each subject’s blind spot is not “found” by
the system as is the case with the HFA, instead the point tested is specifically located at 15
degrees temporally and 1.5 degrees below the horizontal midline.
Normal children
The youngest subject (aged 5 years) in this group performed only the SVOP binocular test.
All other subjects performed all three SVOP tests. HFA tests were not attempted in the child
subjects because clinical experience has consistently reported its unreliability. Designation of
a normal child group was prospectively inferred from subject sampling. Table 5.11 summarises
the results for this subject group. All blind spot locations tested were correctly identified as
‘unseen’ for all of the right and left visual field tests performed in this group except for one
subject where the blind spot location was labelled as ‘seen’ in their right eye visual field test.
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Visual Field Test Type
Test Result Characteristics Binocular Left Eye Right Eye
Number of subjects performing test 4 3 3
Number of Visual field points in test 40 41 41
Mean (±SD) number of correctly diagnosed points 40.0 ± 0.0 40.7 ± 0.6 40.7 ± 0.6
% of correctly diagnosed points 100 99.2 99.2
Table 5.11: Results from the ‘normal child’ group. Correctly diagnosed points are those which
correspond with a normal healthy visual field.
Adults with visual field defect
Within this group the left and right eye SVOP tests were compared with the HFA C-40 left
and right eye visual field tests. The individual eyes with visual field defects and those with no
defects were compared independently. One subject did not perform the left eye test due to very
poor vision in that eye. Table 5.12 summarises the results for this subject group.
Visual Field Test Type
Abnormal Eyes Normal Eyes
Test Result Characteristics Left Eye Right Eye Left Eye Right Eye
Number of subjects performing test 3 7 4 1
Number of Visual field points in test 41 41 41 41
Mean (±SD) number of correctly
diagnosed points
35.0 ± 1.7 37.6 ± 2.6 40.5 ± 0.6 40.0
% of correctly diagnosed points 85.4 91.6 98.8 97.6
Table 5.12: Results from the ‘adults with visual field defect’ group. Correctly diagnosed points
are those which correspond with the HFA C-40 screening test visual field results.
HFA threshold examinations (test type 24-2) which had been performed on each subject were
obtained to act as a further visually-comparative test result in addition to the direct quantitative
comparisons performed. Figures 5.48, 5.49 and 5.50 show the SVOP 41 point test, the equivalent
HFA C-40 test and the most recent threshold test for three different patients within this subject
group. The patient in figure 5.48 was previously diagnosed with primary open angle glaucoma.
The patient in figure 5.49 was previously diagnosed with right normal tension glaucoma. The
patient in figure 5.50 was previously diagnosed with a tilted optic disc.
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Figure 5.48: Test results from a subject within the ‘adults with visual field defect group’. a) The
SVOP test result, b) the equivalent HFA C-40 test result, and c) the patient’s most recent full
threshold HFA 24-2 test result. This patient was previously diagnosed with primary open angle
glaucoma.
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Figure 5.49: Test results from a subject within the ‘adults with visual field defect group’. a) The
SVOP test result, b) the equivalent HFA C-40 test result, and c) the patient’s most recent full
threshold HFA 24-2 test result. This patient was previously diagnosed with right normal tension
glaucoma.
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Figure 5.50: Test results from a subject within the ‘adults with visual field defect group’. a) The
SVOP test result, b) the equivalent HFA C-40 test result, and c) the patient’s most recent full
threshold HFA 24-2 test result. This patient was previously diagnosed with a tilted optic disc.
Children with suspected visual field defects
As with the “normal children” group, no comparative HFA visual field testing was carried out
with these children because of known problems with HFA test reliability. Additionally, several
of these children only performed a binocular SVOP test for which there was no equivalent HFA
test. Figure 5.51 shows the binocular SVOP tests of the three youngest subjects (two 4 years,
and one 5 years of age).
The first patient (figure 5.51a) was a 4 year old boy with left hemiplegic cerebral palsy con-
sequent on a haemophilus meningitis at 3 years of age. He additionally had a left homonymous
hemianopic visual field defect which was detected on confrontational visual field testing prior
to performing the SVOP test.
The second patient (figure 5.51b) was a four year old boy who suffered a severe non-accidental
134
injury at 7 months of age with bilateral extensive retinal haemorrhage, rib fractures, encephalo-
pathy and raised intracranial pressure. This resulted in a cortical visual loss with a suspected
right visual field impairment, nystagmus and optic atrophy. Prior to performing the SVOP
test clinical visual field testing had proved difficult because of the marked nystagmus and short
attention span.
Figure 5.51: The SVOP binocular tests completed by the three youngest participants in the
‘children with suspected visual field defects’ group. Subject a) a 4 year old diagnosed with
suspected left homonymous hemianopia following confrontational visual field testing, b) a 4
year old with suspected right sided visual field impairment following previous raised intracranial
pressure from a non-accidental injury. c) a 5 year old with hypothalamic and optic nerve glioma
with chiasmal involvement and no vision in his left eye.
The third patient (figure 5.51c) was a five year old boy diagnosed with hypothalamic and optic
nerve low grade glioma previously treated with chemotherapy. At presentation he had total
loss of vision in his left eye and confrontational visual field testing suggested a loss of peripheral
vision on the temporal side of the right eye. Despite no changing evidence of enlargement of
the tumour an increased visual field defect was clinically suspected. The SVOP binocular test
(no vision in left eye) showed visual field loss in the superior right temporal quadrant.
A summary of the results obtained for normal adults and children, and adults with visual field
defects groups is shown in figure 5.52. The number of correctly diagnosed points in the normal
right and left eye tests is the number which agree with a normal visual field. The number of
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correctly diagnosed points in the eyes with visual field defects is the number of points which
agree with the equivalent HFA C-40 test. The left and right eye SVOP tests had a total of 41
points. The average percentage of points agreeing with a normal visual field in the normal adult
and normal child eyes was 99.2% and 99.1% respectively. The percentage of points agreeing
with the HFA C-40 screening test in the adult eyes with visual field defect was 89.8%
Figure 5.52: Number of tested visual field points corresponding to a normal visual field for the
normal adults and children, or corresponding to the equivalent HFA C-40 screening test. SD =
1 standard deviation.
There were varying test times for the different groups. The average time for normal subjects to
complete a 41 point SVOP test was 120 ± 42s. The average test time for patients with visual
field defects was 269 ± 125s. There was an average increase of 65s in tests incorporating the
animations designed for young children as compared to those without.
5.4.4 Discussion
This study’s aim was to determine the feasibility of the SVOP technique. In order to do this, a
variety of normal subjects and subjects with visual field defects were used. Adults were included
as they could provide comparable results by undertaking the HFA C-40 test in addition to the
SVOP test. Children were included to demonstrate that the technique is both feasible and
acceptable to them.
In both the normal adult and child eyes, good comparison with a normal visual field was found
with the SVOP tests. A good comparison was also found between the HFA C-40 screening test
and the equivalent SVOP test in the adult eyes with visual field defects. However, the number
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of correctly matched points between the two equivalent tests in this group was less than the
number for the normal groups. There are two possible reasons for this lower agreement: (i)
The brightness contrast level was matched between the two tests (SVOP and HFA C-40) as
closely as possible. However, when using a standard LCD display for the SVOP tests there
is inevitably some brightness variation across the screen depending upon the viewing angle of
the subject, resulting in a variation in the brightness contrast of the presented stimuli. This
effect is minimised by using an average level of brightness contrast corresponding to an averaged
measurement of brightness across the screen and by preventing stimuli being presented in the
far left and far right areas of the screen where there is a significant change in the brightness.
Despite this brightness variation, it was measured that the largest difference in brightness
contrast possible on the screen was less than 1dB on the HFA’s decibel scale. (ii) Potentially
it would be more difficult to achieve a pair of well matched visual field test results (SVOP and
HFA C-40) in patients with more complex visual field defects where reduced visual sensitivity
is relative rather than absolute.
At this point it is not known to what extent each of the two test types (SVOP and HFA C-40)
are repeatable. It is probable that there is some variation in repeatability of both the HFA
C-40 test and SVOP test, particularly in those patients with complex visual field defects. An
indication of this can be seen by comparing the suprathreshold tests performed with the HFA 24-
2 full threshold tests (figures 5.48, 5.49 and 5.50). There are areas of the suprathreshold (stimuli
presented as a constant 14dB) visual field test results which do not agree with the raw numerical
sensitivity dB values suggesting that repeatability may be an issue. The reproducibility of both
the HFA C-40 and SVOP tests will need to be assessed in future studies.
Despite the lesser agreement in the abnormal adult group, there was still a high percentage
of agreeing points and the fact that the defective areas were picked up is highly encouraging.
Similarly, identification of blind spots was obtained in virtually all the subjects. In addition, a
blind spot area was detected in one child subject while performing the binocular SVOP visual
field test, a correct finding attributed to the patient’s poor left eye vision (figure 5.53).
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Figure 5.53: The eye tracking binocular visual field test performed by a child subject. The vision
of the left eye in this subject was particularly poor resulting in the blind spot area being identified
during the binocular SVOP test.
The children in both the normal and visual field defect groups were easily able to perform
the eye tracking visual field test, and completed the test in between 1 to 6.5 minutes. it was
particularly encouraging to see that the younger children (age 4 years) were happy undertaking
the test. With the addition of the short animations during the test, it clearly became a fun
procedure for some of the children. The animations which are optionally used during a test
do not interfere with the testing of visual field points, but are used to maintain interest and
fixation during the test. Currently the animations used are of small cartoon faces but there is
no reason why different types of animation cannot be used to accommodate for different age
groups or child interests, the only important criteria being that the animations are kept small
so as to keep fixation to a small area.
ASP would be a very useful adjunct in the assessment of the visual fields of young children
and the presented technique allows this measurement where there is currently no satisfactory
alternative. Visual field defects were picked up in young children aged 4 and 5 years (figure
5.51). As there is no comparative “gold standard” visual field test for these age groups it is
difficult to comment on the accuracy of the results in this group. However, given the results
from the more compliant and older adult subjects and the suspected diagnoses of the children
it can be inferred that the defected areas were detected with a good degree of accuracy. The
test can be especially useful in refuting false positive results obtained from confrontation visual
field testing in young children. By way of example, two children in our series were clinically
diagnosed with complete hemianopias which were refuted by the SVOP test (figures 5.51a and
5.51c). Given the conflicting results between the clinical diagnosis’ and SVOP test’s in these
cases, in order to confirm that the SVOP test results were not bogus they were investigated
further by reviewing a video replay of the on screen test combined with the “real time” eye
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gaze displayed simultaneously (in the form of lines representing eye gaze changes every 20ms
overlaid on top of the screen replay). If these children had complete hemianopias, as was
clinically suspected, they would not have been able to immediately fixate on many of the points
that were displayed during the test. Review of the replays further confirmed the ability or
inability of these children to see each individual stimulus in the areas of interest.
From this early experience, the technique of perimetry using eye tracking is a sound method
of measuring visual fields in children and its advantage is that they are not required to look at
one particular point throughout the test, instead the only task required of them is to perform
a natural intuitive reaction in response to a visual stimulus. Neither are they required to place
their heads in a fixed position as data provided by the eye tracking system gives a real time
assessment of 3D eye position in space. Additionally, children take to the system well because
many children are already familiar with computer displays.
Currently, the SVOP system is developed in such a way so that a test will not proceed if there
is a conflict between the eye gaze data coordinates given by the eye tracker and the “fixation
stimuli” coordinates used during a test. This is so that the points tested are not inaccurate.
However, this is a potential limitation of the existing system because it will not allow the testing
of patients with eye movement disorders who could present with eccentric fixation.
From these results, the system and technique of SVOP shows promise as a more objective
visual field assessment method in young children when compared to the current confrontation
perimetry technique used in clinical practice.
5.5 Errors and limitations
5.5.1 Error in “test stimuli” screen location
5.5.1.1 Methods
Due to the complex nature of the equations which govern the calculation of the “test stimuli”
screen locations, and the number of variables involved, error analysis was performed using a
modelling method of analysis. A mathematical simulation was created to determine the main
factors which contribute to the “test stimuli” screen location errors and determine how the
errors behave under various situations.
The screen position of each “test stimulus” depends on the visual field angle to be tested
(described by the two angles φ and θ which are the eccentric and rotational visual field angle
respectively) and the 3D location of the eye with respect to the point of fixation (the “fixation
stimulus” location). The variables which largely contribute to the “test stimulus” screen location
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error is the 3D coordinates of the eye. These 3D coordinates are calculated primarily from the
distance data provided by the eye tracker. Through previous experimentation, the error in the
eye tracker camera-to-eye distance (D) provided by the eye tracker is known to be approximately
±20mm (from section 5.2.2 on page 96).
Using this approximate value for the error in D, the error in screen location can be modelled
and determined under various simulated situations. For example, different situations occur by
using various values for visual field angles (φ and θ), 3D eye location (x y and z coordinates)
and point of fixation on the screen. These errors were determined by using Microsoft Excel
to model the maximum and minimum errors in “test stimuli” screen location using an error
in D of ±20mm under the various combinations of the other variables to calculate the error
using the equations previously described for calculating visual field screen location. Through
an assessment of the situations which create the largest errors, a “worst case scenario” can
be established. Some examples of the various scenarios are described in the following results
section.
5.5.1.2 Results
Figure 5.54 describes the horizontal and vertical screen location error (in mm) for various visual
field points, with fixation at the centre of the test screen and with the location of the test eye
directly in front of the fixation point (as depicted in the small chart) and at a distance of 600mm
from the eye tracker camera. The upper left chart in the figure shows the location from fixation
(which in this situation is the centre of the screen) of 120 hypothetical visual field test locations
(corresponding to eccentric visual field angles of φ = 5◦ − 25◦ in steps of 5◦, and rotational
visual field angles of θ = 0◦ − 345◦ in steps of 15◦). This chart also shows the horizontal and
vertical error (shown as horizontal and vertical error bars) for each visual field point using an
associated camera-to-eye distance error of ±20mm. The lower charts show these error values
in greater detail by plotting the horizontal (left chart) and vertical (right chart) error values
against the rotational visual field angle (θ) for the five eccentric visual field angles (φ).
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Figure 5.54: Screen location error for various visual field locations associated with a camera-to-
eye distance error of ±20mm at 600mm. Fixation point is at the centre of the screen and the
eye is located centrally in-front of the screen.
Each of the subsequent figures describe the screen location error of visual field points in the same
way as figure 5.54, where the only things being varied are the fixation point and eye location
point in relation to the fixation point changed in each situation. Many different situations were
analysed as part of these modelling methods and the figures presented show just a selection of
these situations where the errors become slightly more amplified and so justify presentation in
this results section. The text accompanying each figure also describes each situation. However,
in all the situations presented the test eye is at a distance of 600mm and the distance error
used in each case is ±20mm.
Figure 5.55 shows the horizontal and vertical screen location error of 120 visual field points
under a situation where fixation is at the far left hand side of the screen and with the location
of the test eye as far right as the camera field of view will allow (shown by the small chart).
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Figure 5.55: Screen location error for various visual field locations associated with a camera-
to-eye distance error of ±20mm at 600mm. Fixation point is at the far left of the screen, and
the eye is located approximately as far right as the camera’s field of view will allow.
Figure 5.56 shows the horizontal and vertical screen location error for 120 visual field points
under a situation where fixation is at the top of the screen and the location of the test eye as
low down vertically as the camera field of view will allow (shown by the small chart).
142
Figure 5.56: Screen location error for various visual field locations associated with a camera-
to-eye distance error of ±20mm at 600mm. Fixation point is at the top of the screen, and the
eye is located approximately as low down as the camera’s field of view will allow.
Figure 5.57 shows the horizontal and vertical screen location error for various visual field points
for a situation where fixation is at the bottom of the screen and where the location of the test
eye as elevated as far as the camera field of view will allow (again shown by the small chart).
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Figure 5.57: Screen location error for various visual field locations associated with a camera-
to-eye distance error of ±20mm at 600mm. Fixation point is at the bottom of the screen, and
the eye is located approximately as high up as the camera’s field of view will allow.
Figure 5.58 shows the horizontal and vertical screen location error for the 120 visual field points
under a situation where fixation is at the left hand side, and bottom of the screen and with the
location of the test eye as elevated vertically and as far right horizontally as the camera field
of view will allow (shown in the small chart).
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Figure 5.58: Screen location error for various visual field locations associated with a camera-
to-eye distance error of ±20mm at 600mm. Fixation point is at the bottom-left of the screen,
and the eye is located approximately as far top-right as the camera’s field of view will allow.
Figure 5.59 shows the horizontal and vertical screen location error for the 120 visual field points
under a situation where fixation is at the right hand side, and top of the screen and with the
location of the test eye as low down vertically and as far left horizontally as the camera field of
view will allow (shown by the small chart).
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Figure 5.59: Screen location error for various visual field locations associated with a camera-to-
eye distance error of ±20mm at 600mm. Fixation point is at the top-right of the screen, and
the eye is located approximately as far bottom-left as the camera’s field of view will allow.
Thus far, all the example situations shown have been with the test eye at a distance of 600mm
from the eye tracker’s camera. Because the test eye can also potentially be at different camera-
to-eye distances (D), the modelling analysis was also performed at different values of D. Table
5.13 shows the largest error as seen by the modelling methods for three different values of D
and for each of the eccentric visual field angles (φ = 5◦ − 25◦ in steps of 5◦).
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Eccentric VF angle, φ Largest theoretical error at different eye distances, D (±mm)
(Degrees) Error when D =
500 mm
Error when D =
600 mm
Error when D =
700 mm
5 2.1 2.0 2.0
10 4.4 4.3 4.3
15 7.0 6.9 6.8
20 10.1 10.0 9.8
25 13.8 13.6 13.3
Table 5.13: Table of maximum screen location errors for different camera-to-eye distance values
(D) and different values of eccentric visual field angle.
The largest observed error for each eccentric visual field angle (as given in table 5.13) always
occurs as an error in y screen location, and also always occurs when fixation is at bottom of the
screen with the eye location at the top of the eye tracker camera’s field of view. This largest
error is for visual field points with a rotational visual field angle (θ) between 180 and 360 degrees
(i.e. below the fixation point), and as such cannot actually be displayed on the screen from
this described fixation point. Table 5.14 gives the largest possible errors in stimulus screen
position for those stimuli which can actually be displayed on the screen. Table 5.15 then gives
the corresponding eccentric visual field angle value for each of the maximum screen distance
errors given in table 5.14
Eccentric VF angle, φ Largest theoretical error at different eye distances, D (±mm)
(Degrees) Error when D =
500 mm
Error when D =
600 mm
Error when D =
700 mm
5 1.9 1.9 1.9
10 3.6 3.6 3.6
15 5.3 5.3 5.2
20 6.9 6.9 6.8
25 8.5 8.4 8.3
Table 5.14: Table of maximum screen location errors for different camera-to-eye distance values
(D) and different values of eccentric visual field angle, taking into account the location of fixation
on the screen.
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Eccentric VF angle, φ Largest theoretical eccentric visual field angle error at
different eye distances, D (±degrees)
(Degrees) Error when D =
500 mm
Error when D =
600 mm
Error when D =
700 mm
5 0.2 0.2 0.2
10 0.42 0.4 0.3
15 0.6 0.5 0.5
20 0.8 0.7 0.6
25 1.0 0.8 0.7
Table 5.15: Table of maximum eccentric visual field errors for different camera-to-eye distance
values (D) and different values of eccentric visual field angle, taking into account the location
of fixation on the screen.
5.5.1.3 Discussion
Using an error in D of ±20mm, the largest error in stimuli screen location was modelled as
8.5mm. The largest error values relate to the larger visual field angles (variable φ) with 25
degrees from fixation being the largest analysed here. Interestingly the error varies in such a
way that the x and y error values fluctuate as the visual field point being tested rotates through
360 degrees around the fixation point (variable θ). Fortunately this variation is in such a way
that the x error reduces to zero as it approaches 90 and 270 degrees, and for most situations the
y error reduces to zero as it approaches 0 and 180 degrees. This fact is very useful as it means
that the display position is not likely to cross the horizontal and vertical midlines even when
taking into consideration the induced error. This is of important clinical relevance because of
the way in which visual field defects resulting from cerebral visual impairment often respect the
horizontal and/or vertical midlines.
The modelling methods used in these methods take into account the main error inducing variable
which is the camera-to-eye distance (D) data. The error in D in turn induces errors in the
calculated x, y, and z eye location. This is all taken into account in this analysis. However this
analysis does not take into account the potential error in two other variables which are also used
in the calculation of eye position, namely x and y eye location in the camera field of view data
as it is provided by the eye tracker. It is likely that there would also be additional errors from
these camera values. However, the methods of error analysis performed here have taken into
account the most influencing factor (the error in D). Also, the way in which x and y locations in
the camera field of view is determined is purely by the relative position of the x and y locations
of the eyes as it is observed by the eye tracker, whereas the distance data are calculated by the
eye tracker using some assumptions (for example with regards to the shape of the cornea) and
as such it is more susceptible to error (as seen by experimentation in section 5.2.2 on page 96).
What are the implications of these calculated “test stimulus” screen location errors? The errors
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are small. However, it is feasible that the error may affect the comparative data of SVOP and
equivalent HFA tests if the border of a patient’s visual field defect happens to lie in the area
of a point or points that are being tested. However, there are also several other factors which
are expected to contribute to differences in comparative data. For example, the documented
problem of ASP test-retest variability.115–118. Additionally the known small variation in lumin-
ance of the presented “test stimuli” in the SVOP test may also contribute to any discrepancies
between SVOP and HFA tests. Given the factors which contribute to variability in visual field
assessment the errors in “test stimulus” screen location identified in these methods are not con-
sidered great enough to contribute significantly more than these other factors. Additionally,
because of the manner in which “test stimuli” location error reduces as the visual field midlines
are approached, the errors are considered acceptable for this application.
It was also interesting to note that through general observation during SVOP tests in progress
(when other methods of this research were being carried out), large positional errors in the “test
stimuli” locations do not seem to occur. It has often been very easy to identify which visual
field point is being tested based on its position relative to the last “fixation stimulus”. This has
also given confidence to these suggested small “test stimuli” location errors.
5.5.2 Limitations
There are no specific methods or results for this section. However, it is important to document
the known limitations of the developed system. The limitations for some aspects have been
found through experimentation in previous sections (such as screen luminance variation, and
distance data error for example). The limitations for other aspects have been found through
observation during testing (or attempted testing). Where appropriate the relevant experimental
section is referenced in the text. The main limitations of the developed SVOP system can be
divided into two categories associated with the two main hardware components of the system:
the eye tracker and the display screen.
The display screen has the obvious limitation due to its size. As outlined in section 5.1.1.2
on page 59 the size of the display screen imposes a limit of the maximum visual field angle
that can be assessed. The size used in the developed system (20” diagonal screen size) allows
standard visual field test patterns to be used (which encompass test locations within the first
30 degrees of visual field), including the 40 point screening test pattern used in this research.
However, it would not be capable of presenting “test stimuli” greater than approximately 30◦.
The other main limitation of the display screen used in the developed system is to do with the
screen’s ability to display appropriate luminance levels for the “test stimuli”. In addition to
the variability of luminance at any single “test stimuli” luminance level (as discussed in section
5.2.3), there is also a limit to the maximum and minimum luminance that the display screen can
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display. The maximum “test stimuli” luminance level is governed by the maximum brightness
of the display screen (which is determined by the back-light of the LCD screen). The minimum
“test stimulus” luminance level which can be displayed is governed by the screens ability to
display different levels of luminance at the lower end (darker end), which in this research is the
lowest luminance difference between two grey-scale colour levels (one being the background grey
level and the other being the “test stimulus” grey level. These maximum and minimum values
(equated to the HFA levels) were found for the screen used in the developed SVOP system and
each luminance level has its own error for displaying on the test screen.
Limitations due to the eye tracking device can be further categorised according to whether
or not the limitation allows any eye tracker data to be collected or not. Some problems will
simply not allow eye tracking data to be provided, or will only provide very limited data.
Other limitations will produce inaccurate data. Several of these eye tracking problems were not
observed until during the larger “clinical validation trial” which is detailed in the next chapter.
However, it is appropriate to group the known limitations of the eye tracker in a single section
within this thesis. These limitations are described under the two headings below relating to:
(i) situations where there is no or poor quality eye tracking, and (ii) where tracking is possible
but the data is potentially inaccurate.
Reasons for no or poor quality eye tracking
Poor quality or no eye tracking data occurs when there is something which interferes with
the pupil-corneal reflection technique. The eye tracker is expecting to see specific reflections
from the eye which relate to reflections from the cornea and a pupil. Anything which deviates
from these expected reflections means that the eye is not properly detected and data for that
eye is either non-existent or sporadic in nature. Below are some examples which have been
observed during this research program which have meant the eye tracker has been unable to
detect subject’s eyes.
Figure 5.60 shows a photograph of the eyes of a patient with a right persistent dilated pupil
which could not be tracked by the eye tracker, and the left eye for comparison. The eye tracker
is expecting to see a “nice” circular shaped pupil (or rather an elliptical shape pupil from the
point of view of the eye tracker camera) and as a result would not detect this patient’s right
eye.
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Figure 5.60: A patient’s right eye with persistent dilated pupil (left hand photo) and left eye for
comparison (right hand photo).
Similarly, other “visible” eye abnormalities can cause the eye tracker to not perceive an eye
correctly. An example of this was patients who had undergone surgical procedures for glaucoma
such as an iridectomy which involves creating a small hole in the peripheral iris. From the point
of view of the eye tracker, this can create an additional reflection from the eye which in turn
seemed to “confuse” the eye tracker. Figure 5.61 shows the eyes of a patient who had undergone
an iridectomy procedure in their left eye (circled in the right hand photo). However, with this
patient neither eye could be tracked with sufficient reliability and this could perhaps be related
to this patient’s previous anterior uveitis which had left slightly irregular shaped pupils in both
eyes. Although this patient had two visible abnormal features in their left eye which contributed
to poor quality eye tracking, there were other patients with poor quality eye tracking where the
only obvious issue was an iridectomy, so it is suspected that an iridectomy alone can disrupt the
eye tracking ability. However, it should also be mentioned here that yet another patient with
an iridectomy was able to complete the testing without any problems in eye tracking quality.
These iridectomy “holes” can vary in size and location, so it seems as though it could be that
with smaller sized, or more peripherally located “holes” eye tracking is possible. These results
are rather subjective at present. However, it is important to document them here as possible
limitations to performing SVOP tests. Future work should attempt to document these types of
eye tracking problems further.
Figure 5.61: A patient’s right (left hand photo) and left eye (right hand photo) showing area
of iridectomy (circled). This patient also demonstrated a slightly irregular shaped pupils as a
result of bilateral uveitis.
Further problems with eye tracking quality can be caused by objects coming between the eye
tracker camera and the eye, thus obscuring the camera’s view of the eye. Examples of this
include the frames of glasses, large “bushy” eye lashes, or drooping eye lids.
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Two other examples of poor quality eye tracking have been observed. One where a patient was
wearing heavy, dark mascara which is known to cause problems with eye tracking as it makes
it difficult for the eye tracker to detect accurately the boundary of the elliptical features of the
eye.119 Additionally, another patient was wearing large highly reflective ear rings which created
additional reflections, thus confusing the eye tracker. Once the ear rings were removed, there
were no eye tracking problems.
Reasons for inaccurate gaze or distance data
It may be that the eye tracker has no problems detecting the eye(s) and providing gaze and
distance data, but under certain situations the eye gaze data or the eye distance data may still
be unreliable. The main example of this is that with corrective lenses there is a false increase or
decrease in the distance data. This can be compensated for as the increase or decrease relates
directly to the power of the corrective lens, but would also require specialist spectacle frames
constructed in such a way as to not obstruct the eye tracker’s view of the eye.
Strabismus is a condition where the two eyes are not aligned correctly and therefore do not
fixate at the same location.120 The condition can affect one or both eyes, be intermittent and
vary in severity of miss-alignment. These factors all play a part in the accuracy of the gaze data
provided by the eye tracker. In some cases the eye tracker may actually be providing accurate
data, and instead it is the subject that is inaccurate with their fixation. In other cases (for
example if the strabismus is intermittent) it will depend on how the eye was behaving during
the calibration procedure. These effects can, in some cases, be compensated for by choosing to
use data from only one eye (an unaffected eye), or by patching of the opposite eye which will
then in many cases force the affected eye to adjust correctly.
Fortunately many of these described problems are less relevant for young children (certain
surgery procedures for glaucoma treatment, mascara, earrings). Unfortunately, strabismus can
be a prominent feature of children who attend ophthalmology clinics and of those who have
who may need their visual field tested. Further work may be required to quantify more fully





Following the promising early results of the “feasibility study” (section 5.4 on page 127), a clinical
trial with a larger cohort of participants was devised in order to more thoroughly evaluate the
developed SVOP testing system. This chapter details the subjects, methods and results for
the larger clinical “validation trial”. The aim of the validation trial is to assess the validity of
the developed SVOP test system as a diagnostic tool for suprathreshold visual field assessment
by comparing SVOP test results directly with equivalent suprathreshold screening test results
obtained using the Humphrey Field Analyser (HFA). The HFA was used as a “gold standard” for
comparison where its tests could be reliably performed by the participants. Where subjects were
unable to reliably perform the “gold standard” HFA tests, SVOP test results were compared with
other relevant clinical findings. The HFA was chosen to act as a “gold standard” comparison
test for this validation trial because there are currently no equivalent child perimetry devices
which assess the visual field in the same manner as SVOP (i.e. by the method of automated
static perimetry), and the HFA screening test could easily be customised and replicated (in
terms of test stimuli brightness, size and location) using the SVOP system developed, in order
to produce an equivalent test.
6.2 Subjects, methods and data analysis
6.2.1 Subjects
As with the previously completed feasibility study, subjects were recruited and assigned to one
of four subject groups:
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1. Children with suspected visual field defects (also referred to as “child patient” group).
2. Healthy children.
3. Adults with visual field defects (also referred to as “adult patient” group).
4. Healthy adults.
Adults were defined as subjects aged 16 years or older and children were defined as younger
than 16 years. “Normal” (healthy) adults and children were recruited for the study had an un-
remarkable ophthalmological history. Adults and children with visual field defects were defined
as having a known or clinically suspected possibility of visual field defects of sufficient depth
so as to allow them to be identified by the suprathreshold screening tests. Subjects that were
excluded from the trial were people with very severe visual impairment or with severe limita-
tion of eye movements for any reason which would preclude visual field testing. The exclusion
criteria were deliberately designed without well defined limits so as to gain an understanding
of the limitations of SVOP testing.
Table 6.1 outlines the subjects recruited for the trial within each of the subject groups.
Age (Years) Age (Months)
Subject Group Number of
subjects (males)
Mean (1 SD) Range Mean (1 SD) Range
Child patients* 35 (19) 6.7 (3.6) 1-15 84.3 (43.9) 13-181
Healthy children 18 (9) 8.7 (3.8) 0-14 109.4 (46.1) 8-178
Adult patients 41 (19) 57.3 (15.0) 16-78 - -
Healthy adults 28 (14) 30.4 (12.1) 16-61 - -
Total 122 (61)
∗Several of the child patients had multiple visits to participate in the study. The mean ages given for this group
are based on age at first visit.
Table 6.1: Subjects recruited for the validation study. SD = Standard deviation.
6.2.2 Methods
The methods are described here in terms of the visual field test types. First, an explanation of
the perimetry tests which were used (both SVOP and HFA) is given, then an explanation of
which tests were typically performed by participants from the different subject groups.
SVOP Tests
As with the feasibility trial, three different types of SVOP test patterns used. The test patterns
and number of tests performed by each subject depended upon the ability of the participant
(this is explained further in forthcoming paragraphs). However, the procedure for performing
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SVOP tests was the same whichever test pattern was used. The three test patterns available
are shown in figure 6.1 and are described as follows:
1. A right eye and left eye test pattern consisting of 41 test points each (figure 6.1 a) and
b) respectively). These test patterns are equivalent to the HFA’s C-40 right and left eye
screening test patterns (which each contain 40 test points each) with the exception that
the SVOP test has an extra test point located at the approximate average natural blind
spot location for the eye being tested.
2. A binocular test pattern consisting of 40 test points (figure 6.1 c). This test pattern has no
equivalent HFA test pattern and was custom made specifically for participants who could
not perform uniocular testing but it is similar in layout to the uniocular test patterns.
Figure 6.1: The three SVOP visual field test patterns used in the validation trial. a) A test
pattern equivalent to the right eye HFA C-40 screening test. b) A test pattern equivalent to
the left eye HFA C-40 screening test. c) A custom test pattern designed for binocular SVOP
testing.
Prior to performing any SVOP visual field test, the subject was positioned in front of the patient
display screen using appropriate seating for their age. If a uniocular test was to be performed,
the subject was asked to wear an occluding eye cover over the eye not being tested. Next, with
the subject looking towards the screen (with a fixation image, appropriate to the subject’s age,
displayed if required), the screen was moved to a location where the subject’s eyes were located
centrally (both horizontally and vertically) in front of the display screen and positioned at
approximately 550-600mm away from the eye tracker’s camera. This procedure was performed
using a “Tracking Status” dialogue box which gave a representation of the location of the
subject’s eyes to the examiner (figure 6.2).
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Figure 6.2: Image (screen shot) of the “tracking status” dialogue box. It shows the location of
the eyes in real time (the white circles) horizontally and vertically in front of the display screen
and also gives an indication of the distance to the eyes from the eye tracker’s camera.
Once the subject was located in an appropriate location, a calibration procedure was performed.
The calibration procedure is required in order to produce the most accurate gaze data. During
a calibration procedure subjects were required to look at the display screen and follow a visual
stimulus with their gaze to 5 different screen locations. The stimulus used for adults and older
children was a circle which moved to each location in turn (the Tobii eye tracker’s standard
calibration stimulus). For younger children a custom calibration procedure was used where the
circle was replaced with a cartoon character which moved to each of the 5 screen locations
where upon a simple animation with sound was played, lasting just a few seconds, in order to
keep the attention of the child.
Once the calibration procedure was complete, a SVOP test could be performed. Tests performed
by adults and older children used a simple small cartoon face as the “fixation stimulus”. For
younger children the “fixation stimulus” of a cartoon face was replaced with a variety of small
(similar in size to the adult “fixation stimulus”) cartoon character animations with sound effects
which lasted between 1 and 4 seconds, so as to encourage attention and maintain interest. The
visual field “test stimuli” were all of size Goldmann III (0.43◦ angular diameter), duration 200ms,
and luminance level equivalent to the HFA’s 14dB brightness level (stimulus and background
luminance of 429Asb and 31.5Asb respectively). Adults and older children were given the simple
instruction “If you see anything flash up on the screen just look towards or at it”. Younger




Two different types of HFA test patterns were used. These were the HFA’s left and right eye
C-40 screening test patterns. The right eye test pattern is shown in figure 6.3.121 The left eye
test pattern is a mirror image of the right eye test pattern. These test patterns use 40 visual
field test locations, and additionally the HFA goes through a procedure at the beginning of a
test to “find” the subject’s natural blind spot, this location is then identified using a triangle
symbol on the test results.
Figure 6.3: The HFA’s C-40 screening test pattern for the right eye. The left eye test pattern
is a mirror image of this.
To perform a HFA test, the subject had one of their eyes covered with an occluding eye patch
(depending upon the uniocular test being performed), was given the patient response button,
and was positioned on the appropriate side of the chin-rest (the opposite side to the eye being
tested). The height of the HFA bowl (with chin-rest) was adjusted so that the subject was at a
comfortable height. The subject was then asked to stare at the “fixation light” located centrally
in the bowl while the chin-rest was moved using the motorised “fine adjustment” movement
controls until the eye was located directly in front of the “fixation light” (this is made possible
using the live video image of the eye with centrally located cross-hairs shown on the examiner’s
screen).
The HFA’s standard screening tests use an age-matched “hill of vision” where stimuli are presen-
ted at 6dB brighter than the expected threshold value at each test location for the patient’s
age. These age-matched values are taken from a database of normative subject data. However,
the exact values are not disclosed by the manufacturer, so in order to create a pair of exact
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equivalent HFA and SVOP tests, the HFA’s C-40 tests were purposely altered so that all stimuli
were presented at a constant intensity level of 14dB, thus matching the SVOP visual field tests
which were also tailored to display stimuli at the HFA intensity level of 14dB (stimulus intensity
of 429Asb and background 31.5Asb as stipulated in the HFA manufacturer manual121). The
stimulus size and duration used in the HFA C-40 tests was Goldmann III and 200ms respectively.
Subjects were given the instruction “You must always stare at the central light and only press
the button when you see other lights flash up around about the central light. The lights which
flash up may be bright or dim.”
Tests performed
Ideally every participant would complete a full testing protocol consisting of a left and a right
eye SVOP test followed by a left and a right eye HFA test before taking a break. The type
of test to be performed first (be it SVOP or HFA) was randomised. Following the break, the
4 tests already completed were repeated but in a reverse order in terms of the device used.
This “ideal” protocol results in a total of 8 visual field tests comprising of 4 SVOP tests (2 left
eye and 2 right eye) and 4 HFA tests (again 2 left eye and two right eye). Not all subjects
were able to perform the full set of 8 visual field tests. In children where uniocular testing was
deemed not possible or not tolerable, two binocular SVOP tests were performed without any
HFA equivalent.
6.2.3 Data analysis
The main forms of data analysis to be performed can be described in three categories:
• direct comparison of SVOP and HFA tests,
• repeatability of SVOP and HFA tests, and
• other indirect comparisons.
Direct comparison of SVOP and HFA tests
A measure of sensitivity and specificity can be obtained for the SVOP test by using the HFA
test points as a reference or “gold standard”. Each visual field point in a subject’s HFA test is
classified as either “unseen” (a positive result) or “seen” (a negative result), and the equivalent
SVOP test can be used as a direct comparison to categorise each outcome as one of the following:
• True positive (TP) - “Unseen” points on a HFA test which the equivalent SVOP test also
“correctly” diagnosed as “unseen”.
158
• False positive (FP) - “Seen” points on a HFA test which the equivalent SVOP test “incor-
rectly” diagnosed as “unseen”.
• True negative (TN) - “Seen” points on a HFA test which the equivalent SVOP test also
“correctly” diagnosed as “seen”.
• False negative (FN) - “Unseen” points on a HFA test which the equivalent SVOP test
“incorrectly” diagnosed as “seen”.
Using these definitions, the sensitivity and specificity (and positive and negative predictive
values) can be calculated as demonstrated in table 6.2.


































Table 6.2: Calculation of sensitivity, specificity, and positive and negative predictive values.
The sensitivity is a measure of how good a test is at correctly identifying the presence of disease
(in this case visual field locations which are identified as “unseen”). The specificity is a measure
of how good a test is at correctly identifying those that are healthy (in this case visual field
points which are labelled as “seen”). The positive predictive value is a measure of the chance
that a positive test result is correct and the negative predictive value is a measure of the chance
that a negative result is correct. Sensitivity and specificity are unaffected by the prevalence of
disease in a tested population whereas the predictive values have a certain dependence on the
prevalence of disease, where a reduction in prevalence results in a fall of the positive predictive
value and a rise in the negative predictive value (in a test where sensitivity and specificity
remains the same).122
For each uniocular SVOP test with a HFA “gold standard” comparison test there were 41 points
which could be assessed (including the blind spot location). The sensitivity and specificity
outcomes can be applied to various situations by counting up the total true positive, false
positive, true negative and false negative points within different situations for example all tests
or specific subject groups. The types of analysis performed are described fully in the results
section.
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Repeatability of SVOP and HFA tests
Where tests have been repeated during the same visit (i.e. either SVOP or HFA tests of
the same eye(s) performed twice), Cohen’s kappa statistic was used to obtain a measure of
agreement between the repeated tests. Cohen’s kappa statistic is traditionally used as a measure
of agreement between two raters measuring something which has a binary output (i.e. two
possible outcomes).123 It was introduced as a measure of agreement which avoids the problem
associated with a simple percentage agreement analysis which has the potential to be inflated
due to chance agreement.
The kappa statistic, κ is given by:
κ =
P (a)− P (e)
1− P (e)
(6.1)
where P(a) is the relative observed agreement between two raters, and P(e) is the hypothetical
probability of chance agreement calculated using the observed data to determine the probabil-
ities of each observer randomly producing each result category.
In this visual field test repeatability situation, if we have data for two visual field tests of
the same type (i.e. two left, two right or two binocular tests on either the SVOP system or
HFA perimeter), we have a similar situation to the sensitivity and specificity analysis where we
have visual field points which either agree or disagree as shown in table 6.3. The labelling of
the outcomes in table 6.3 is perhaps slightly misleading because true and false positives and
negatives suggest that one of the tests is a “gold standard” result which is not the case here.
This labelling is used simply to illustrate the similarities to the outcomes used to calculate

















Table 6.3: Variables used in kappa statistic calculations




where N = TP + TN + FP + FN
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where N = TP + TN + FP + FN
And as stated, kappa, κ is given by equation 6.1.
κ is always less than or equal to 1. A value of 1 implies perfect agreement and values less than
1 imply less than perfect agreement. In cases where κ is negative, this is a sign that the two
observers (or visual field location results in this case) agreed less than would be expected just
by chance. There are different interpretations as to what a good level of agreement is. The
following is one widely used interpretation:124
• κ < 0.20, poor agreement;
• κ = 0.2 to 0.4, fair agreement;
• κ = 0.4 to 0.6, moderate agreement;
• κ = 0.6 to 0.8, good agreement;
• κ = 0.8 to 1.0, very good agreement.
Other indirect comparisons
SVOP test comparisons without a HFA equivalent will typically occur with child patients where
no equivalent HFA test was performed or the HFA test result proved unreliable. The data from
SVOP tests could still be assessed for repeatability if the test was performed twice. However,
in terms of comparative data available, this was in the form of what was already clinically
suspected on the basis of clinically performed confrontational visual field testing and other
evidence which would suggest the possible presence of visual field defects such as their clinical
diagnosis and results of brain scans.
6.3 Results
This results section is divided into further sections corresponding to the data collected. The first
section details the testing performed, the second section presents the comparison data between
SVOP and HFA tests and also the repeatability of the SVOP and HFA visual field testing.
The final section takes the form of a series of case studies consisting of the more interesting
visual field results (such as those children who had repeated testing over time) which had no
equivalent HFA test (or where the HFA equivalent tests were unreliable).
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6.3.1 Visual field tests performed
Before continuing to the main results, a summary of the testing performed is important. Ideally
all subjects would complete a full set of 8 visual field tests comprising 4 SVOP tests (2 left and
2 right eye tests) and 4 HFA tests (2 left and 2 right eye tests). Not all subjects were able to
complete a full set of 8 tests. In some cases participants would only partially complete a full set
of 8 uniocular tests, in these situations there would still usually be comparison tests available (i.e
at least 1 SVOP test with an equivalent HFA test). If a subject was deemed only able to perform
binocular testing, only SVOP tests were performed as there was no comparison HFA test for
this strategy. Finally, if subjects were unable to perform even the SVOP binocular testing, no
further visual field tests were performed. Table 6.4 shows a summary of the number of patients
which fell into each of the above categories, and figure 6.4 charts the data as a percentage of
subjects within each subject group to provide a visualisation of the type of testing performed
in each group. Table 6.5 shows a summary of the total number of tests performed within each
group, the number of direct comparisons available for analysis and the number of repeated tests
available for SVOP and HFA repeatability analysis.
Subject group Number of subjects performing visual field tests Totalsubjects











Child patients* 2 8 16 9 35
Healthy
children 12 0 6 0 18
Adult patients 30 5 1 5 41
Healthy adults 27 1 0 0 28
Total subjects 71 14 23 14 122
∗Several of the child patients had multiple visits to participate in the study. This table shows data from their
first visit only.
Table 6.4: Summary of the visual field tests performed by each subject group
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Figure 6.4: The percentage of subjects within each subject group who were able to complete a
full complement of 8 tests, a partial complement (but still including at least 1 HFA comparison
test), SVOP binocular tests only, and no visual field tests performed.
Subject

















patients* 41 46 32 30 34 12
Healthy
children 54 8 48 48 29 24
Adult
patients 130 1 130 130 63 63
Healthy
adults 110 0 110 110 54 54
Totals 335 55 320 318 180 153
∗Several child patients had multiple visits to participate in the study. The data shown here includes all their
visits.
Table 6.5: Total number of tests performed within each subject group and the number of “pairs”
of tests for comparison and repeatability analysis.
Within the adult patient group 73% of participants completed a full set of 8 uniocular tests. The
most common reason for an incomplete set of uniocular tests within this group was poor quality
or non-existent eye tracking data meaning that SVOP testing was not possible. Reasons for
poor quality eye tracking have been outlined in Section 5.5 but to summarise, the most common
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reason was due to an eye abnormality often resulting from a form of eye surgery (such as an
iridectomy). Other reasons for an incomplete set of tests included tiredness resulting in an
unwillingness to continue and computer problems during testing. Within the healthy adult
group 96% of participants completed the full set of 8 tests with only 1 subject not completing
all tests due to time constraints.
Within the child patient and normal children groups, due to the wide developmental age range
there was a larger percentage of participants only performing SVOP tests (typically those under
6 years).
6.3.2 Comparison data
This section details the results of comparative testing. This includes direct comparison of SVOP
test results with their equivalent HFA test results, and an assessment of the repeatability of
both SVOP and HFA test results (as outlined in Section 6.2.3 on page 158). In addition to
these measures, some further test parameters are also analysed. These include a comparison
of test times and also, in the following sub-section, analysis of “catch trial” responses recorded
from HFA tests.
6.3.2.1 HFA “catch trials” analysis
An important aspect of the HFA tests is the reliability indices (or “catch trial” data), which are
used to provide an indication of the reliability of each HFA test performed. There are three
reliability “trials” performed during a HFA test, these are: (i) “false positive” patient responses,
(ii) “false negative” patient responses, and (iii) patient “fixation losses”. These are outlined in
section 2.3.2.4. However, it is worth repeating their definitions here as follows:
• The “false positive” response rate measures the tendency of a patient to press the response
button even when no stimulus has been seen. During a HFA screening test false positive
responses are periodically tested by the HFA making the normal mechanical motions and
sounds of presenting a stimulus without actually doing so.
• The “false negative” patient response rate measures the tendency of a patient to fail to
press the response button even when a distinctly visible stimulus has been presented.
False negative responses are tested by presenting a stimulus at a considerably brighter
light level than one which has already had a positive response from the patient.
• The patient “fixation loss” rate is a measure how steadily the patient is gazing at the
central fixation stimulus. Fixation losses are estimated using the Heijl-Krakau method
in which stimuli are periodically presented at the patient’s pre-determined blind spot
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location. Positive responses to these stimuli are recorded as fixation losses and indicate
that the patient is not looking at the central fixation target.36
The HFA will periodically measure each of these throughout a test. HFA guidelines suggest
that a test should be deemed unreliable if the false positive or false negative response rates are
greater than or equal to 25%, or if the fixation loss rate is 20% or more.125
If a HFA test was deemed “unreliable” as a result of high reliability indices then it was not used
to make a comparison with its equivalent SVOP test. Equally, they would also not be used in
the assessment of HFA repeatability. In addition to providing a means of “catching” potentially
unreliable HFA results, the patient responses to these “catch trials” were recorded for analysis.
Figure 6.5 shows the averaged percentages of “catch trial” response rates per HFA test for
subjects who performed them. The data is arranged for each subject group and shows false
positive, false negative and fixation loss “catch trial” response data. Statistical significance
(p<0.01) was found between either of the child groups and either of the adult groups for both
“false positive” and “fixation loss” responses. Statistical significance was also found between the
child patients and healthy children for “false negative” responses (p<0.01) and “fixation losses”
(p<0.05).
Figure 6.5: The percentage (±1 standard deviation) of responses to “catch trials” (averaged for
all tests within each subject group). Catch trials include false positive responses, false negative
responses, and responses to fixation loss tests.
Further analysis of these “catch trial” responses within the child subject groups is shown in
figure 6.6. The chart shows the averaged percentage of false positive, false negative and fixation
losses for each test performed by all the children (including both patients and normal children),
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with the data split by age (those younger than 10 years and those 10 years and older). The
age of 10 years was chosen as this divides the children into two approximately equal groups
of tests performed (34 and 36 tests for the under- and over-10’s respectively) and into two
approximately equal age ranges of the children who performed HFA tests (5-9 and 10-15 years).
Additionally, the age of 10 years has frequently been quoted in the literature as the age at
which children can more reliably perform automated static perimetry. Statistical significance
was found between the two age groups for only the “fixation losses”, where the younger age
group had a significantly higher rate (p<0.01).
Figure 6.6: The percentage (±1 standard deviation) of responses to “catch trials” (averaged for
all tests within each age group). All children were included in this analysis (patients and healthy
volunteers). Catch trials include false positive responses, false negative responses, and responses
to fixation loss tests.
6.3.2.2 SVOP and HFA comparison tests analysis
All tests from all subject groups
Table 6.6 details the statistical measures of sensitivity, specificity, and positive and negative
predictive values for all visual field points from SVOP tests with an equivalent reliable HFA
test. This analysis includes data from all patient groups and as such has a prevalence of
“unseen” points (calculated from HFA test results) of just 8.4%. Figure 6.7 shows these same
statistical measures calculated for each individual test comparison pair (where the HFA test
was considered reliable) and averaged (±1 standard deviation) to provide an assessment of the
variability of each statistical measures per individual test.
166
























Table 6.6: Sensitivity, specificity and predictive values for all SVOP tests with a reliable HFA
equivalent test. These data includes all assessed points from all tests within all subject groups.
The prevalence of “unseen” points is 8.4%
Figure 6.7: Statistical measures of sensitivity, specificity, and predictive values for all individual
SVOP tests with a reliable HFA equivalent test (from all subject groups). Data shown are average
±1 standard deviation.
Adult tests
Tables 6.7 and 6.8 show two examples of a full series of 8 visual field test results (4 SVOP
and 4 HFA) performed by two adult patients with known visual field defects. Table 6.7 shows
the test results from a 61 year old male with pigmentary glaucoma and tilted optic discs
and demonstrates a large visual field defect in the left eye. This patient had also previously
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undergone a left trabeculectomy and left peripheral iridectomy. Table 6.8 shows the test results





Visual field test result





Table 6.7: A full set of 8 visual field tests (4 SVOP and 4 HFA) for an adult male with
pigmentary glaucoma and tilted optic discs. This patient had also previously undergone a left






Visual field test result





Table 6.8: A full set of 8 visual field tests (4 SVOP and 4 HFA) for an adult female with normal
tension glaucoma.
Tables 6.9 and 6.10 detail the statistical measures of sensitivity, specificity, and positive and
negative predictive values for all visual field points from SVOP tests with an equivalent reliable
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HFA test from the “healthy adult” and “adult patient” subject groups respectively. The preval-
ence of “unseen” points was 2.5% for the “healthy adult” subject group which are attributed to
the blind spot test locations only. For all the reliable tests performed by the “adult patient”
group the prevalence of “unseen” points was 12.4%.
Not all adult patients had visual field defects, or defects which could be picked up by the
suprathreshold testing performed, in both eyes. The tests which did not demonstrate any
“unseen” data points (excluding the blind spot location) were subsequently defined as results
from “normal” eyes. As a further form of analysis, the tests from the adult patient group
were also assessed with these “normal” eye comparative tests removed from the analysis. Table
6.11 shows the statistical measures under this situation. Under these conditions the “unseen”
prevalence increased to 17.8%
Figure 6.8 shows these same statistical measures. However, in this chart they have been calcu-
lated for each individual test comparison pair (where the HFA test was considered reliable) and
averaged (±1 standard deviation) to provide an assessment of the variability of the statistical
measures per individual test.
























Table 6.9: Sensitivity, specificity and predictive values for all SVOP tests with a reliable HFA
equivalent test from the “healthy adult” subject group. The prevalence of “unseen” points is 2.5%
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Table 6.10: Sensitivity, specificity and predictive values for all SVOP tests with a reliable HFA
equivalent test from the “adult patient” subject group. The prevalence of “unseen” points is 12.4%
























Table 6.11: Sensitivity, specificity and predictive values for all SVOP tests with a reliable HFA
equivalent test from the “adult patient” subject group with “normal” eye tests removed. The
prevalence of “unseen” points is 17.8%
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Figure 6.8: Statistical measures of sensitivity, specificity, and predictive values for individual
SVOP tests with a reliable HFA equivalent test from the “healthy adult” and “adult patient”
subject groups, and additionally the “adult patient” group with “normal” eye data removed.
Data shown is average ±1 standard deviation.
Child tests
Tables 6.12 and 6.13 detail the statistical measures of sensitivity, specificity, and the positive
and negative predictive values for all visual field points from SVOP tests with an equivalent
reliable HFA test from the “healthy child” and “child patient” subject groups respectively. The
prevalence of “unseen” points was 2.4% for the “healthy child” subject group (again attributed
only to the blind spot locations). For all the reliable tests performed by the “child patient”
group the prevalence of “unseen” points was 27.2%.
Again, not all child patients had visual field defects, or rather had defects which could be picked
up by the suprathreshold testing performed, in both their eyes. Eyes with reliable HFA test
results which did not have any “unseen” data points (excluding the blind spot location) were
subsequently defined as “normal” eye test results. As a further form of analysis, the tests from
the child patient group were assessed with the “normal” eye comparative tests removed from
the analysis. Table 6.14 shows the statistical measures under this situation, and under these
conditions the “unseen” prevalence was 38.5%
Figure 6.9 shows these same statistical measures. However, in this chart they have been cal-
culated for each individual test comparison pair (where the HFA test was considered reliable)
and averaged (±1 standard deviation) to provide an assessment of variability of the statistical
measures per individual test.
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Table 6.12: Sensitivity, specificity and predictive values for all SVOP tests with a reliable HFA
equivalent test from the “healthy child” subject group. The prevalence of “unseen” points is 2.4%
























Table 6.13: Sensitivity, specificity and predictive values for all SVOP tests with a reliable HFA
equivalent test from the “child patient” subject group. The prevalence of “unseen” points is 27.2%
























Table 6.14: Sensitivity, specificity and predictive values for all SVOP tests with a reliable HFA
equivalent test from the “child patient” subject group with “normal” eye tests removed. The
prevalence of “unseen” points is 38.5%
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Figure 6.9: Statistical measures of sensitivity, specificity, and predictive values for individual
SVOP tests with a reliable HFA equivalent test from the “healthy child” and “child patient”
subject groups, and additionally the “child patient” group with “normal” eye data removed. Data
shown is average ±1 standard deviation.
Summary of comparison data
Table 6.15 shows a summary of the statistical measures obtained for each of the patient groups,















Healthy adults 96.4 99.8 93.0 99.9 2.5




67.5 91.0 61.9 92.8 17.8
Healthy children 66.7 99.7 91.7 99.2 2.4




72.5 87.3 78.1 83.5 38.5
Table 6.15: Summary of the sensitivity, specificity, positive and negative predictive values (and
“unseen” point prevalence) for each subject group and also for the adult and child patient groups
with “normal” eye data excluded.
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6.3.2.3 HFA and SVOP test repeatability analysis
Table 6.16 details the kappa statistic values following assessment of repeated SVOP and HFA
tests using all visual field points from tests from each subject group and in total. Additionally,
the kappa statistic values were re-calculated with the visual field points of certain tests removed.
In the case of the SVOP tests the tests excluded from this analysis were those that had not
been 100% completed, and in the case of the HFA analysis, the “unreliable” (as stipulated by
the HFA reliability indices) tests were excluded from the analysis. The reason for including
both types of analysis in the case of the SVOP tests (inclusion and exclusion of “incomplete”
tests) was to identify if “incomplete” tests could be a source of unreliability. In the case of the
HFA test repeatability assessment, analysis was performed both including and excluding the
“unreliable” test data because after removing this data there were no tests available for analysis
in the child patient group and only one test available for analysis in the healthy children subject
group.
Kappa statistic, κ
SVOP tests HFA tests












All groups 0.65 0.64 0.74 0.75
Healthy adults 0.86 0.88 0.99 0.99
Adult patients 0.60 0.59 0.71 0.71
Healthy children 0.46 0.62 1.00 1.00
Child patients 0.61 0.58 0.53 -
Table 6.16: Kappa statistic, κ, of repeatability for SVOP and HFA tests, for each of the patient
groups.
6.3.2.4 Test time analysis
The test times of all SVOP and HFA test were recorded. Figure 6.10 shows the comparison of
test times between SVOP and HFA tests for all subjects who completed both types of test, and
how they compare in each subject group. Overall, in all subjects, HFA tests were on average
quicker but the difference was not significant (t(321) = 1.6, p=0.11). Similarly in the child
patients HFA tests were on average quicker but not significantly so (t(30)=0.7, p=0.49). In
both the healthy groups (children and adults) the SVOP tests were significantly faster than
the HFA tests (t(47)=3.1, p<0.01) for the healthy children, and (t(143)=7.0, p=<0.0001) for
the healthy adults). The HFA test was on average significantly quicker than SVOP within the
adult patient group (t(129)=4.5, p<0.001).
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Figure 6.10: Comparison of test times between SVOP and HFA tests for all tests and for each
of the subject groups. Data shown is the average (±1 standard deviation) of all tests with a
comparative pair, where both tests of the pair were completed.
A one obvious reason for an increase in test time in both the SVOP and HFA tests is due to the
retesting of “unseen” test stimuli. Figures 6.11 and 6.12 show the duration of SVOP and HFA
tests (only including tests which were completed and which had a comparative pair) plotted as
a function of the number of “unseen” points in the final test result.
Figure 6.11: Number of “unseen” points in each test plotted against the test time for both SVOP
and HFA tests from the “adult patient” subject group.
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Figure 6.12: Number of “unseen” points in each test plotted against the test time for both SVOP
and HFA tests from the “child patient” subject group.
6.3.3 Child patients with no reliable HFA comparison
The results in this section are presented as a series of cases. The child patients selected for
presentation are those of most clinical interest, those with repeated visits to participate in the
study and those with interesting results for any other particular reason. The majority of cases
where there has been multiple visits to take part in the study was young child patients with
visual pathway tumours. As a result this section is divided into three further sub-sections,
one discussing these visual pathway tumour cases, another discussing some children with other
types of cerebral visual impairment. A final case is presented in the last sub-section which
details the results of the youngest participant in the study - an 8 month old healthy infant.
Each patient case is presented with a table detailing the age, diagnosis, any previous treatment
and previous clinical visual function assessment prior to performing SVOP tests.
6.3.3.1 Visual field defects as a result of visual pathway tumours
Case 1
Table 6.17 outlines the diagnosis, previous treatments and visual function of a 5 year old boy.
All of this patient’s SVOP test results are shown in figure 6.13. He performed three binocu-
lar SVOP tests prior to the start of this validation trial (during the coarse of the previously
presented feasibility trial) which are also useful to present in this section, and then subsequently
participated in the validation trial on four separate occasions. The months since his first SVOP
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test are shown in the top left corner of each test (or set of two tests). During each of the
“validation trial” visits he performed two right eye SVOP tests and two right eye HFA tests (he
was blind in his left eye). On each occasion the HFA tests were not considered reliable using
the HFA criteria with a high percentage of false positives and fixation losses (average of 46%
and 75% respectively).
Case 1: A 5 year old (65 months) male
Diagnosis • Pilocytic astrocytoma in the hypothalamic optic nerve region,
World Health Organization (WHO) grade I.
Previous
treatments
• Complete surgical resection.
• The International Society for Paediatric Oncology (SIOP, Societé
Internationale pour Oncolgie Paediatrique) low grade glioma 2003
protocol (randomised to receive intensified induction
chemotherapy) completed 19 months prior to first SVOP test.
Visual function
prior to first SVOP
test
• Blind in left eye
• On confrontational visual field testing, right eye complete
temporal hemianopia, which was thought to improve slightly
before SVOP visual field testing.
• Visual acuity: Right 6/9
Table 6.17: Case 1 patient clinical details including age on first SVOP testing, diagnosis, pre-
vious treatments and clinical visual function assessment details.
Figure 6.14 on page 180 shows the change in visual field defect according to SVOP test results
by plotting the average number of “unseen” points from each visit as a function of time (in
months). Only fully completed test results have been used in this analysis. Also shown on the
chart is the repeatability statistic (Cohen’s kappa), for any of the visits during the validation
trial where there was two completed test results.
178
Figure 6.13: SVOP visual field test results from case 1 (see table 6.17 for details). Included
are three single binocular tests performed prior to the validation trial (during the course of the
feasibility trial), and 8 further right eye tests performed on 4 separate visits during the validation
trial.
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There was a decrease in the number of unseen points over time with the biggest change coming
after the second SVOP test (performed during the feasibility study). The area consistently
showing “unseen” visual field points was in his right upper quadrant. Prior to performing
SVOP tests confrontational visual field testing suspected that this boy had a complete tem-
poral hemianopia. This is clearly in conflict with the original SVOP result of an upper right
quadrantanopia. The fact that this child was able to deliberately and consistently able to orient
his gaze to SVOP visual field “test stimuli” presented in the lower right quadrant of his visual
field is proof enough that the previous confrontational visual field result of a total right hemi-
anopia was not entirely correct. The repeatability of SVOP testing was poor on the occasions
where both tests during a single visit were fully completed (visit 2 and 4 of the validation trial
results). This poor repeatability was due to one of the test results showing an upper right defect
and the other during the same visit showing almost no defect in that same area. This finding are
somewhat strange, but interestingly although the HFA test results were not considered reliable
enough for their data to be analysed, they also showed a similar finding. Figure 6.15 shows the
HFA test results from visit 1 and 2 during the validation trial. Despite the poor repeatability
on these two occasions, the SVOP tests almost always showed a visual field defect in the upper
right quadrant which adds credibility to the defects identified in this area from SVOP testing.
Figure 6.14: Chart of the average number of “unseen” points (±1 standard deviation where more
than one test was completed in a single visit) from each visit for case 1. Only data for completed
tests is shown. Where two completed tests were performed on one visit, the kappa statistic for
assessment of repeatability was performed and is also shown on the chart.
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Figure 6.15: HFA test results for case 1 from two of the four visits (upper panel shows results
from visit one and lower panel shows results from visit two). On each of the visits this patient
performed two HFA right eye tests.
Case 2
Table 6.18 outlines the diagnosis, previous treatments and visual function of a 2 year old girl. All
of this patient’s SVOP test results are shown in figure 6.16. She performed two binocular SVOP
tests prior to the start of this validation trial (during the course of the feasibility study), and
then subsequently participated in the validation trial on five separate occasions. The months
since her first SVOP test are shown in the top left corner of each test (or set of two tests).
During each of the “validation trial” visits she performed two SVOP visual field tests which on
some visits was with a binocular test pattern and on other visits was with a left eye test pattern
(this test pattern variation was not intended for any particular reason). This young girl did not
perform any HFA visual field testing.
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Case 2: A 2 year old (34 months) female
Diagnosis • Hypothalamic pilocytic astrocytoma, WHO grade I.
Previous
treatments
• Right frontal craniotomy with subtotal removal of tumour.
• SIOP low grade glioma 2003 protocol (randomised to receive
intensified induction chemotherapy). Completed 69 weeks 9
months after performing first SVOP test.
Visual function
prior to first SVOP
test
• Blind in right eye.
• On confrontational visual field testing, left eye complete temporal
visual field defect but not possible to get reliable nasal visual field
information.
• Visual acuity: Left 6/7.5
Table 6.18: Case 2 patient clinical details including age on first SVOP testing, diagnosis, pre-
vious treatments and clinical visual function assessment details.
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Figure 6.16: SVOP visual field test results from case 2. Included are two single binocular tests
performed prior to the validation trial (as part of the feasibility trial), and 10 further tests
completed on 5 separate visits during the validation trial.
183
Figure 6.17 shows brain scans of this patient. The left panel shows a scan taken prior to the
frontal craniotomy operation, while the right panel shows the post-operative scan.
Figure 6.17: Case 2 brain scans. This patient underwent a right frontal craniotomy with subtotal
removal of the tumour. Left and right panels show the pre- and post-operative scans respectively.
Figure 6.18 shows the change in visual field defect according to SVOP test results by plotting
the average number of “unseen” points from each visit as a function of time (in months). Again
only fully completed test results have been used in this analysis. Also shown on the chart is the
repeatability statistic (Cohen’s kappa), for any of the visits during the validation trial where
there were two fully completed test results.
On confrontational visual field testing performed prior to the first SVOP test this young girl
was believed to have a left eye complete temporal hemianopia and was known to be blind in
her right eye. SVOP test results consistently showed a left sided defect in accordance with
confrontational visual field testing. However, there was an additional consistent finding with
the left side of this patient’s visual field. On every single SVOP test there were two areas of
the previously suspected complete left hemianopia that were consistently showing as “seen”.
These areas included points next to the vertical midline and towards the top of the upper left
quadrant, and also some points in the lower left quadrant closer to the point of fixation. The
points which were showing as “seen” in the lower left quadrant seemed to grow in number with
each visit (figure 6.18). The Cohen’s kappa statistic for the repeated tests with this patient
were good with an average of 70.2 ±9.8% (1 standard deviation).
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Figure 6.18: Chart of the average number of “unseen” points (±1 standard deviation where more
than one test was completed in a single visit) from each visit for case 2. Only data for completed
tests is shown. Where two completed tests were performed on one visit, the Kappa statistic for
assessment of repeatability was performed and is also shown on the chart.
Case 3
Table 6.19 outlines the diagnosis, previous treatments and visual function of a 4 year old girl.
This patient’s SVOP test results are shown in figure 6.19. She performed 10 binocular SVOP
tests in total (2 tests at each of 5 visits during the coarse of the validation study). The months
since her first SVOP test are shown in the top left corner of each set of two tests. This girl did
not perform any HFA visual field testing.
Case 3: A 4 year old (52 months) female
Diagnosis • Left temporal pilocytic astrocytoma, WHO grade I.
Previous
treatments
• Left temporal burrhole and evacuation of cyst.
• Left fronto-temporal craniotomy and debulking of tumour.
Visual function
prior to first SVOP
test
• On confrontational visual field testing, right homonymous
hemianopia.
• Visual acuity: Right 6/7.5, Left 6/9.5
Table 6.19: Case 3 patient clinical details including age on first SVOP testing, diagnosis, pre-
vious treatments and clinical visual function assessment details.
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Figure 6.19: SVOP test results for case 3 including 10 binocular SVOP tests completed on 5
separate visits during the validation trial.
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Figure 6.20 charts the changes in the average number of “unseen” points in SVOP tests over time
(in months). As with previous charts of this type, only fully completed test results have been
used in the analysis. Also shown on the chart is the repeatability statistic (Cohen’s kappa), for
any of the visits during the validation trial where there were two fully completed test results.
The SVOP test results demonstrate a consistently occurring right homonymous hemianopia
which is in agreement with her clinical confrontational visual field testing. Harder to explain
are the “unseen” points which were a regular occurrence on the left side of her visual field.
However, these “unseen” points did not seem to follow a consistent pattern and were the main
source of the variability in the repeatability statistics. On reviewing the post-test gaze replay of
these tested points, it was became clear that the two main reasons for them not being labelled
as “seen” by the SVOP software algorithm was down to either: (i) the patient did not react
to the stimuli, or (ii) the patient reacted in what seemed like an appropriate manner but the
decision algorithm did not correctly identify the fixation change. Reason (ii) is understandable
and is a feature of many of the SVOP tests performed (throughout all subject groups) and will
be discussed further in the discussion section of this chapter. Reason (i) was perhaps more
puzzling due to the inconsistency of the “unseen” points which did not invoke a reaction. It is
suspected that although this child would submit to performing the test, she would often become
bored or disinterested as time went on. This was due in most part to the number of points
which she genuinely wouldn’t have seen (to the right side of her visual field), which would create
long periods of inactivity during the test (from her perspective). In this scenario, there would
become less incentive for her to actually react to the stimuli.
Figure 6.20: Chart of the average number of “unseen” points (±1 standard deviation where more
than one test was completed in a single visit) from each visit for case 3. Only data for completed
tests is shown. Where two completed tests were performed on one visit, the kappa statistic for
assessment of repeatability was performed and is also shown on the chart.
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Case 4
Table 6.20 the diagnosis, previous treatments and visual function of a 3 year old girl. This
patient’s SVOP test results are shown in figure 6.21. She performed 7 binocular SVOP tests in
total (2 tests at each of 3 visits during the course of the validation study, and one test prior to
those). The months since her first SVOP test are shown in the top left corner of each of the
tests (or set of two tests). This girl did not perform any HFA visual field testing.
Case 4: A 3 year old (38 months) female
Diagnosis • Diencephalic syndrome
• Hypothalamic ependymoma tumour, WHO grade II.
Previous
treatments
• Left frontal temporal craniotomy and biopsy of suprasellar mass
(at 10 months of age)
• Baby brain chemotherapy protocol commenced at 10 months of
age (received 44 cycles)
• Left temporal craniotomy and excision of hypothalamic
ependymoma 4 months prior to first SVOP testing
Visual function
prior to first SVOP
test
• Blind in left eye
• Right eye difficult to assess reliably, confrontational visual field
testing suggested right sided defect.
• Visual acuity: Not known.
Table 6.20: Case 4 patient clinical details including age on first SVOP testing, diagnosis, pre-
vious treatments and clinical visual function assessment details.
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Figure 6.21: SVOP visual field test results from case 4. Included is one single binocular test
performed prior to the validation trial, and 6 further tests completed on 3 separate visits during
the validation trial.
Figure 6.22 shows the changes in the average number of “unseen” points in SVOP tests over
time (in months). Again, only fully completed test results have been used in this analysis. Also
shown on the chart is the repeatability statistic (Cohen’s kappa), for any of the visits during
the validation trial where there was two fully completed test results.
As with several of the other large visual field defect cases discussed in this section, there was an
improvement over time in the number of “seen” points. However, with this patient’s SVOP test
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results there was also a sudden, more obvious change to the lower right quadrant of her visual
field in her last visit results as compared to any others. Upon reviewing the post-test gaze
responses to “test stimuli”, it was thought possible that they could have been falsely labelled as
“seen” due to a “standard” eye movement which this child performed when “test stimuli” were
thought to be “unseen”. This “standard eye movement appeared to be in a direction to the right
and below the previous fixation point. As a result it is possible that some “test stimuli” presented
in this area could have had a reaction in an appropriate direction which the software algorithm
decided made them “seen” when actually the gaze movement was a “standard” reaction of this
patient when nothing was seen on the screen (from her point of view). It is understandable
that she may have a reaction of this type due to the right sided defect she has. It is perhaps a
compensatory movement which allows her to view more of the screen. Figure 6.23 shows some
examples this patients gaze movements following the presentation of some “unseen” points.
Figure 6.22: Chart of the average number of “unseen” points (±1 standard deviation where more
than one test was completed in a single visit) from each visit for patient case 4. Only data for
completed tests is shown. Where two completed tests were performed on one visit, the Kappa
statistic for assessment of repeatability was performed and is also shown on the chart.
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Figure 6.23: Examples of gaze reaction to “unseen” points in SVOP tests from final visit for
patient case 4. The solid lines represent gaze changes every 20ms. The circles and dashed lines
between them represent the relative positions of the “fixation stimulus” (white circle) and “test
stimulus” (filled circle).
6.3.3.2 Visual field defects as a result of other CVI
Case 5
Table 6.21 shows the details of a 3 year old boy diagnosed with haemophilus meningitis. Con-
frontational visual field testing revealed a left homonymous hemianopia. Figure 6.24 shows 4
binocular SVOP visual field tests. Two of the SVOP tests were performed on separate occasions
prior to the validation study, and the other two were performed during a single visit as part
of the validation study. The first two test results demonstrate a large left sided homonymous
defect, but not a complete hemianopia as was previously thought on confrontation. The final
two SVOP tests (completed on the same visit) show an improvement to this boys visual field
since the first SVOP testing, but still demonstrated defect in a similar area, although with a
small amount of variation between the two tests. Figure 6.25 shows this patient’s brain scan
taken prior to first SVOP visual field testing and demonstrates right occipital and superior
parietal cortical and subcortical enhancement which would be consistent with the a left sided
homonymous visual field defect.
Case 5: A 3 year old (47 months) male
Diagnosis • Previous haemophilus influenza meningitis.
• Mild left hemiparesis.
Visual function
prior to first SVOP
test
• Left homonymous hemianopia on confrontational visual field
testing.
• Visual acuity: 6/7.5 in each eye
Table 6.21: Case 5 patient clinical details including age on first SVOP testing, diagnosis, pre-
vious treatments and clinical visual function assessment details.
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Figure 6.24: SVOP visual field test results from case 5. Included are two binocular tests per-
formed prior to the validation trial, and 2 further tests completed on 1 visit during the validation
trial.
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Figure 6.25: Case 5 brain scan demonstrating left frontal subdural collection of fluid with right
occipital and superior parietal cortical and subcortical enhancement. This scan was taken prior
to first SVOP visual field testing.
Case 6
Table 6.22 shows the details of a 3 year old boy diagnosed with possible periventricular leucomalasia
(PVL). Confrontational visual field testing was suggestive of less good vision on the right side.
Figure 6.24 shows 2 binocular SVOP visual field tests performed during a single visit as part
of the validation study. The two SVOP tests, although not identical, do show similar areas of
“unseen” visual field locations towards the lower portion of the visual field measured by SVOP.
Case 6: A 3 year old (43 months) male
Diagnosis • Possible periventricular leucomalasia.
Visual function
prior to first SVOP
test
• Confrontational visual field testing difficult. The impression was
that vision was less good on the right side.
• Mild visual impairment.
• Visual acuity: 6/8 in each eye.
Table 6.22: Case 6 patient clinical details including age on first SVOP testing, diagnosis, pre-
vious treatments and clinical visual function assessment details.
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Figure 6.26: SVOP visual field test results from case 6. Two binocular tests performed on a
single visit during the validation trial are shown.
Case 7
Table 6.23 shows the details of a 4 year old boy who suffered a severe non-accidental injury
at 7 months of age with bilateral extensive retinal haemorrhage, encephalopathy and raised
intracranial pressure. This resulted in CVI, nystagmus and optic atrophy. Prior to performing
the SVOP test confrontational visual field testing had proved difficult because of the marked
nystagmus and short attention span but it was thought that he had some probable right-sided
visual field impairment. He performed 3 binocular SVOP tests from two separate visits. One
visit prior to the validation study (as part of the feasibility study) and on the other visit
performing two SVOP tests as part of this validation study. A right sided defect was a common
feature of the SVOP tests performed. However, the repeatability of the two tests performed
during the single visit was low at 20%
Case 7: A 4 year old (53 months) male
Diagnosis • Previous non-accidental head injury with bilateral sub-dural
haemorrhage.
• Cerebral visual impairment.
Visual function
prior to first SVOP
test
• Right sided visual field loss on confrontational visual field testing.
• Miopia with astigmatism.
• Nystagmus
• Visual acuity: 6/20 (binocular)
Table 6.23: Case 7 patient clinical details including age on first SVOP testing, diagnosis and
clinical visual function assessment details.
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Figure 6.27: SVOP visual field test results from case 7. Included is one binocular test performed
prior to the validation trial and 2 further binocular tests completed on a single visit during the
validation trial.
6.3.3.3 Case 8 - A healthy infant
This subject is included here because he was the youngest participant in the study. A healthy 8
month old boy completed a single binocular SVOP test (test result shown in figure 6.28). The
SVOP test result showed 37 visual field stimuli identified as “seen” and 3 as “unseen”. On post
test analysis of this infant’s gaze movements following the three stimuli labelled as “unseen”,
two of them did in fact show an eye movement reaction in the direction of the “test stimuli”, but
the reaction was not correctly identified by the software algorithm. The final “unseen” point
(located as 25◦ eccentricity) was the only point which did not initiate an eye gaze reaction.
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Figure 6.28: SVOP test result from a healthy 8 month old male infant.
6.4 Discussion
6.4.1 Comparison data
The results section “comparison data” (Section 6.3.2 on page 164) was divided into four further
subsections. In addition to the data comparing SVOP directly with the “gold standard” HFA
device and the analysis of SVOP and HFA repeatability, there were also sections which presented
“catch trial” and “test time” data.
The catch trial data analysis was not designed to be a main outcome of this validation study
but it was useful in demonstrating some of the issues with performing ASP in children. Many
of the HFA tests performed by children were rejected due to high rates of fixation losses and
false positive responses to the catch trial stimuli. The average in both child groups (patients
and healthy volunteers) for fixation losses and false positive responses was greater than the
previously described HFA reliable limit of 20% (figure 6.5 on page 165). Children had low
rates of false negative responses. The high false positive, and lower false negative responses is
representative of children tending to be more “trigger happy” with the HFA button and far more
likely to press it even when there has been no stimuli presented. The high rates of fixation losses
are suggestive of problems continually looking at the central fixation target. These problems are
frequently noted when using ASP with children.15,16,18–20 The data recorded during this study
may be higher than some of the referenced papers where training or familiarisation strategies
were used to reduce these problems. In this validation study there was no training provided for
either the HFA or the SVOP test, merely encouragement during the tests. For example, during
a HFA test, a child was reminded to keep staring at the “middle light” if it became clear that
their fixation was wavering, or they were told to make sure to only press the button if they
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see other lights flash on. And obviously many (if not all) the child subjects had not performed
any HFA testing before. Perhaps in future studies it may be useful to give a child more time
to practice the HFA test to enable the collection of better (or a greater amount of usable)
equivalent data. These catch trial data results demonstrate very well the inherent problems
with children performing ASP and some of the reasons why SVOP has been developed.
In total there was over 8000 SVOP test points directly compared to the same amount of HFA
test points from almost 200 visual field equivalent test “pairs” across all subject groups leading
to a good overall sensitivity and excellent specificity values (72.7% and 96.8% respectively).
This means that overall, from this data, SVOP tests are better at correctly diagnosing “seen”
points (i.e. no disease) than “unseen” points. However, the sensitivity value changed depending
upon the subject groups, ranging from 66.7% in the healthy children to 96.4% in the healthy
adults. Generally the sensitivity reduced in the patients with visual field defects and increased
in the healthy subject groups, with the lowest value of 66.7% possibly due to a lack of usable
comparative data in the healthy child group. Indeed, when taking out “normal” eyes within the
patient groups, the sensitivity and specificity values decreased further, enforcing the result that
the sensitivity values are different in different subject groups. Specificity also showed variation
between subject groups, again reducing in the patient groups as compared to the healthy subject
groups. However, this variation was small (5-7%) and the values remained above 90% across
all groups.
Why should there be a reduction in sensitivity and specificity in patients with visual field defects
as compared to healthy subjects? There are several variables which could contribute to this
effect. Increased variability in both HFA and SVOP testing within the patients with visual
field defects as compared to the healthy subjects is one such contributor. There is an inherent
variability in the tested visual field (This is demonstrated by the HFA repeatability results). It
is difficult to call the HFA a “gold standard” as it is itself not 100% repeatable. However, it was
the most appropriate comparison test available and did show a better repeatability statistic
than did the SVOP testing. The very nature of certain visual field defects means that the
test-retest variability increases. For instance a visual field with a complex glaucomatous defect
which varies in retinal sensitivity across several areas of the visual field is much more susceptible
to test-retest variability than say an absolute hemianopic defect. This could be one reason why
the sensitivity results of the child patient groups was slightly improved in comparison to the
adult patient group, because of the likely types of visual field defects present within the two
groups. This is due to the very nature of CVI being the largest contributor to childhood visual
impairment, and glaucoma in adults.
Due to the natural test-retest variability in visual field testing, the point-by-point sensitivity
and specificity analysis performed in this research may not have been the most appropriate
method of comparative analysis. Although the results give a good indication of sensitivity
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and specificity of the SVOP equipment, from a clinical standpoint it may be more appropriate
to analyse each test outcome rather than an assessment of individual points. An appropriate
question could have been “is there a visual field defect in each SVOP and HFA test comparison
“pair” which would lead a clinician to suspect the same visual field diagnosis?”, rather than
“how well do all the individual points match up?”
For this reason, a more clinically relevant measure of sensitivity and specificity might be to
present the test results to a number of expert clinicians who would be blinded to the device
which produced each test result, and to ask them to judge on the presence or absence of visual
field defect. Further, if they determine the presence of a defect they could then be asked to
categorise the type of defect according to a set of previously defined types. Sensitivity and
specificity would then be calculated based on how often SVOP and HFA test results from
the same subject were placed in the same categories. Methodology of this type introduces
an element of subjectivity to the analysis and an assessment of the clinicians interobserver
agreement may also need to be performed.126
A further alternative, which would rely less on interobserver agreement discrepancies, would be
to compare SVOP and HFA test result “pairs” with reference to more general areas within the
visual field rather than the individual points. For example using the four quadrants of the visual
field (separated by the horizontal and vertical midlines). Any defect identified in one quadrant
of an SVOP test could be judged a “true positive” if there is also a defect within the same
quadrant on the equivalent HFA test result.127 As alternatives, and to make the assessment
more rigorous, the visual field areas used could be further reduced (for example each quadrant
could be divided into two or more sectors).
The lower repeatability in the SVOP tests will have also contributed to the lower sensitivity
values. There are some failings in the SVOP software decision algorithm which have become
apparent during this validation trial. Throughout all subject groups there are often points
labelled as “unseen” in SVOP testing when, on post test review of gaze data there has been
a clear gaze movement in the direction of the presented stimuli. The main reason that these
points have been incorrectly determined to be “unseen” is because the “end point” of the fixation
change has not been correctly detected. At present the algorithm looks for the very first change
in fixation following the presentation of a “test stimulus”. If, for any reason the patient moves
their fixation in a different initial direction before readjusting to look towards the correct area,
or if they happen to momentarily fixate while on the way to the correct area, this is the end
point of the gaze change vector which is measured which could easily be incorrect or outside
the previously set algorithm limits. However, this problem is fairly simple to fix by making the
algorithm analyse all fixation change vectors individually and also as a whole to see if there is an
appropriate gaze response. Repeatability of SVOP tests may have been increased as compared
to HFA tests because of this factor.
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6.4.2 Child patients
Despite the lower repeatability in SVOP testing as compared to HFA, SVOP still has the
potential to measure the visual field in young children, which the HFA does not. SVOP testing
in children appears to have been most useful in this study for identifying and monitoring the
visual field in patients with visual pathway tumours. In several of these patients SVOP tests
have repeatedly returned results which are consistent with what was previously thought by
using confrontation visual field testing, but with greater detail to allow the detection of “seeing”
areas of the visual field where it was previously thought there was none. SVOP clearly has
the potential to detect more subtle characteristics of visual field defects in these patients than
does confrontation and therefore allows better monitoring of any potential changes to visual
field defects. The child patient results highlight the failings of the confrontation technique
which uses a stimulus which comes in from the edge of the visual field. The confrontation
method is not able to determine specific areas or “pockets” of “seen” locations, or smaller areas
of scotomata closer to the central visual field.
There are some interesting issues which have arisen when testing child patients with SVOP. In
almost all of the patients who had repeated visits to participate, they showed an improvement in
their visual field defect over time. It is unrealistic to think that SVOP has a therapeutic effect,
instead the likely cause for an improvement to these children’s visual fields is a genuine one
with development or more likely a learning effect with SVOP. As a child begins to understand
what is happening in an SVOP test, they likely become more aware of what they are looking
for (in terms of the visual “test stimuli”). It is plausible that in certain areas of reduced retinal
sensitivity (but not absolute defect) that the bright “test stimuli” used in the SVOP tests appears
dimmer, and it is not until the child has had a few goes of SVOP that they understand that
they are actually looking for any brightness of stimuli. However, there was one patient where
there seemed to be an improvement in the number of SVOP “seen” points in a false manner
(case 4) who had an instinctive compensatory gaze response which was regularly in a specific
direction, potentially causing several points in that direction to be labelled as “seen” when this
may not have been the case. It will be important to identify such compensatory eye movements
in subjects with large visual field defects so as to understand this potential limitation of SVOP.
Another point to discuss is the issue of boredom with SVOP tests. In older young children
(say 5 years and above) it would sometimes be the case that that the testing procedure was
not engaging enough. Many children who were tested on the HFA, although not reliable at it,
enjoyed the button pressing aspect of it. With SVOP there is no obvious interaction with the
test (from the point of view of the child) and this could easily lead to boredom and increased
false positive results as the child “switches off” from the test. Many children are used to playing
computer games with games controllers. It would be prudent to make a future version of SVOP
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which also has an element of game style interaction.
So, there are several improvements which can be made to SVOP. However, in its present state
is has still proved extremely useful. From a clinical point of view repeating tests as part of this
validation trial protocol has been useful to eliminate false “seen” and “unseen” points but the
test has proved very useful in monitoring the visual field in several patients.
Finally, the SVOP testing on the 8 month old infant should be discussed. It was thought that
it may have been necessary to “try out” a few different strategies with an infant of this age. For
example, larger sized “test stimuli” and “fixation stimuli” were prepared in advance. However,
on attempting our standard binocular SVOP test it became clear that these other strategies
would not be necessary. Out of the three points labelled as “unseen” only one appeared not to
have any gaze movement reaction to it and it is interesting that this was one of the peripheral
test stimuli. A child of this age certainly needs to be awake and in a reasonably attentive mood
to perform an SVOP test, but the results from this infant demonstrate that it is clearly possible
to obtain a measure of the visual field in infants. More infants will need to be tested using
SVOP in future studies to identify how widely usable SVOP is in this age group and to identify




The aims of this research program were to develop a technique and system for ASP in children
and to assess the developed system through direct comparison with an established ASP device
and an assessment of test repeatability where possible. The technique and system was designed
to overcome problems associated with performing ASP (the usual choice of perimetry in adults)
in children by using the advantages of some fairly recent advances in eye tracking technology.
The two main chapters of this thesis comprised: (i) the theory and development of the system
(Chapter 5), and (ii) a clinical evaluation of the developed system (Chapter 6).
The system, named “saccadic vector optokinetic perimetry” (SVOP) was built around the idea
that by monitoring a child’s eye movements following the presentation of visual stimuli, it
would be possible to determine whether or not the visual stimuli have been “seen” based on the
direction of any gaze movement response. The system was designed to be automated to enable
these decisions to be made in “real time” and the visual stimuli (or “test stimuli” as they have
been referred to throughout this thesis) can be appropriately displayed at specific locations
within their visual field so that testing of a number of locations during a test would reveal a
plot of the child’s visual field. The technique has advantages over current adult ASP techniques
as it does not require the patient to stare straight ahead at one single location throughout a
test and it does not require them to press a button when they perceive the “test stimuli”. Hence
they do not necessarily need to understand the test as there are no requirements other than to
follow their natural gaze reaction to look towards visual stimuli if they see them. There is also
no need for the child to have their head in a fixed position. The eye tracker provides data on
the location of the child’s eyes and so allows “test stimuli” to be appropriately positioned at
specific visual field locations based on this positional data. All these elements were designed to
be introduced as ways of overcoming the problems associated with current ASP techniques.
The SVOP system comprises a personal computer, 20” display screen, and an X50 eye tracker
(Tobii Technology). The eye tracker was assessed to ascertain its suitability for use in the
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proposed SVOP system. In relation to this research, the two most important data fields provided
by the eye tracker were the point of gaze data, and the camera-to-eye distance data. The
accuracy of both these types of data were assessed and both were found to have a dependence
on subject display screen gaze location. An increase in error was found most often when a
subject was gazing at certain screen location areas. These “problem areas” (as they have been
referred to in previous sections) were generally confined to areas of gaze fixation towards the
top corners or towards the left or right hand sides of the display screen.
The display screen itself was also assessed. The most important characteristic of the screen was
its luminance uniformity, and based on that how faithfully it could reproduce specific luminance
levels in all screen areas. Due to the natural characteristics of standard LCD screen technology,
it was expected that the screen would not be perfectly uniform and in addition that the viewing
angle would likely contribute to luminance variability. Indeed, this was found to be the case
with areas to the far left and right hand sides of the display screen being most affected due to
a reduction in luminance at increased viewing angles.
Because varying screen gaze location had these effects on gaze data accuracy, distance data
accuracy and luminance uniformity, the far left and right areas of the display screen were not
used to display “fixation stimuli” or “test stimuli” in the SVOP system. Once these screen areas
were excluded, the level of variability and error in the eye tracker data and screen luminance
were considered more tolerable for the suprathreshold test developed. However, since the de-
velopment and evaluation of SVOP, there have been ideas about how it may be possible to
reduce these errors which would be of use for future versions of SVOP. A newer model of eye
tracker (Tobii IS-OEM) was taken on a short term loan from Tobii Technology. One of the
main improvements in relation to this research was the improved camera-to-eye distance data.
Figure 7.1 shows the distance data variation with different screen fixation points for the X50
and IS-OEM eye trackers (upper and lower charts respectively). The upper chart uses the same
data from figure 5.27 in section 5.2.2.2 on page 100. Comparison of the two charts, which have
the same y-axis range, clearly demonstrates the improvement in the amount of distance data
variation provided by the newer model of eye tracker.
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Figure 7.1: Comparison of Tobii Technology X50 and IS-OEM eye trackers in relation to dis-
tance data.
The display screen used in the developed SVOP system was a standard 20” LCD monitor.
Other flat panel display technologies exist which may overcome many of the display screen
issues relevant to developing this research in the future. For example radiology imaging display
screens are designed to have higher maximum luminance levels (which would allow the displaying
of brighter “test stimuli”), increased colour bit depth (allowing a greater number of displayable
grey levels and hence luminance levels), improved screen luminance uniformity and less viewing
angle luminance degradation. All these factors would improve on many of the limitations of
the LCD screen used in the current SVOP system.
The software algorithm developed to determine if “test stimuli” have been “seen” based on
three characteristics of a subject’s gaze response (the direction, amplitude and latency), was
developed by measuring gaze response characteristics recorded from 38 subjects viewing over
100 “test stimuli” under conditions comparable to that of SVOP testing and the feasibility of
the developed SVOP technique was assessed with 29 subjects comprising 4 groups: (i) healthy
adults, (ii) healthy children, (iii) adults with visual field defects, and (iv) children with visual
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field defects. Subjects performed SVOP tests which were designed to replicate the Humphrey
Field Analyser (HFA) C-40 screening test with a stimulus size of Goldmann III and intensity of
14 decibels (dB), and subjects able to do so also performed the equivalent HFA C-40 tests for
comparison. In this initial feasibility study SVOP was found to have good agreement with an
equivalent HFA test, so a larger clinical trial involving over 120 subjects was devised to more
fully assess the SVOP technique. In this larger trial, the sensitivity and specificity of SVOP
tests were computed using a direct comparison with reliable HFA tests (as determined using the
manufacturers test reliability guidelines). Repeatability of both the SVOP tests and HFA tests
were also assessed by means of Cohen’s kappa coefficient. In child patients unable to provide
a reliable HFA test, their clinical history, other clinical findings and the repeatability of their
SVOP tests were used to assess the SVOP results.
Children had a reduced ability to perform the HFA test reliably with a significant increase
in reliability indices as compared to the adult subjects, in particular due to “fixation losses”.
Including all subjects the sensitivity and specificity of the SVOP testing was 72.7% and 96.8%
respectively. The sensitivity had a greater variation than the specificity amongst the different
subject groups, decreasing to 69.0% and 66.7% for the adult patient and healthy child groups
respectively, but increasing to 96.4% and 73.2% for the healthy adult and child patient groups
respectively. The repeatability of SVOP tests were slightly reduced as compared to the HFA
tests across all groups with an overall kappa statistic for SVOP and HFA tests of 0.65 and 0.74
respectively. In child patients without reliable HFA equivalent tests the SVOP defects picked
up could commonly be associated with their clinical history and repeatable testing added to
the confidence in the reliability of these tests.
The validation trial study has produced results similar to that of the smaller scale feasibility
study, but has provided more detail regarding the variability of comparative results and the
reasons why this variability occurs, particularly with the sensitivity values within different
subject groups. The reason behind variability in the comparative results is due to several
sources of variability present in both HFA tests and SVOP tests. The reason for SVOP being
slightly less repeatable than HFA is most likely due to some additional factors which do not
affect the HFA. These sources of test-retest variability are described in the following paragraphs.
As discussed, SVOP has a reliance on (i) accuracy of distance data, and (ii) accuracy of the
display screen to reproduce specific luminance levels. The errors in these factors were minimised
in the developed SVOP system. However, the HFA uses a fixed head position and so does not
suffer as much from a variability in eye location data (the value is assumed constant). The
HFA has the ability to display specific luminance levels more accurately than a standard LCD
display as it uses a uniformly lit bowl. However, despite these differences between SVOP and
HFA in relation to eye distance data and display luminance. There are other factors which will
more largely contribute to a reduction in perfect comparison and reproducibility. Clearly the
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HFA test was not 100% repeatable itself. This fact alone means that it is not an ideal “gold
standard” comparison for SVOP. Despite this, SVOP tests shows a slightly lower reproducibility
than did the HFA tests. The lower repeatability in the SVOP tests will have also contributed
to the reducing sensitivity values. One main contributor to this is due to some failings in the
SVOP software decision algorithm which have become apparent during this validation trial.
Throughout all subject groups there can be points labelled as “unseen” in SVOP testing when
in fact, on post test review of gaze data, there has been a clear gaze movement in the direction
of the presented stimuli. The main reason that points are occasionally being falsely labelled
as “unseen” is due to the fixation change “end point” not being correctly identified. At present
the algorithm looks for the very first change in fixation following the presentation of a “test
stimulus”. If, for any reason the patient moves their fixation in a different initial direction before
readjusting to look towards the correct area, or if they happen to momentarily fixate while on
the way to the correct area, this is the end point of the gaze change vector which is measured,
and which could easily be incorrect or outside the defined “decision algorithm” limits.
Repeatability in SVOP may also be larger because of potential head tilt. Although errors in
visual field “test stimuli” position were calculated as being small based on the eye tracker camera-
to-eye distance data accuracy, there could be an additional “test stimuli” location error due to
head tilt. Ocular counter-role was expected to counteract this problem to an extent. However,
to completely eliminate this problem, a 1:1 ratio (100% gain) between head tilt angle and ocular
counter-roll angle would be required. There is debate over the gain of ocular counter-roll, but it
is usually reported as a low gain effect of between 10-25% and is dependent on whether vision is
binocular or monocular, whether there are visual clues to spatial orientation, and the amount
of eye convergence.44,128,129. As a result, head tilt has the potential to add variability to SVOP
test results. It may be possible to automatically measure head tilt during a test so as to advise
an examiner if there are any test points which are likely to have been affected. Additionally, the
eye tracker stops tracking at head tilt angles larger than approximately 22◦ from the horizontal,
which prevents more extreme head tilt angles being introduced during a test.
Despite the above described current limitations of SVOP, there are suggested improvements
which can reduce or even eliminate many of them. Although discussing all these limitations is
important, it should not be forgotten that the results obtained with this “Version 1.0” of SVOP
are still highly encouraging. Consistent defects were found in young children where other formal
visual field assessment was difficult, or the only other available visual field assessment was the
confrontation method which, in some cases proved inaccurate as compared to SVOP. SVOP
clearly has the potential to detect more subtle characteristics of visual field defects in these
patients than does confrontation and therefore can allow better monitoring of any potential
changes to visual field defects. This highlights the lack of detail possible with the confrontation
technique which uses a stimulus moving in from the edge of the visual field, and which cannot
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analyse specific areas in the central visual field. This is a major advantage of SVOP. The very
fact that child SVOP test results obtained during this research have already proved beneficial
to the ophthalmologists who have been involved with this study, adds weight to the usefulness
of the developed technique. The youngest age child was a surprising 8 months old. Without
any alteration the the general SVOP testing procedure or test parameters this infant was able
to complete the test easily, and it will be interesting to identify the lower age limit of infants
able to perform SVOP testing in future studies.
The way in which SVOP uses the natural saccadic eye movement response to assess the visual
field also poses a question about exactly what is being measured. Clearly visual field function
is being measured in the vast majority of cases (as the test results have proved). However,
it is also possible that SVOP could be making a measurement of a subject’s perception of
movement. In humans, the lateral geniculate nucleus in the brain receives information from
retinal ganglion cells which are not only attributed to dealing with the perception of “seeing”
stimuli (the parvocellular system), but also instinctively “reacting” to stimuli (the magnocellular
system). The term “blindsight” has been given to a phenomenon where a person who is blind
or has visual field defects as a result of damage to the visual cortex, can still “perceive” stimuli
presented in their blind field.130 This has suggested that neural projections from the lateral
geniculate body not only travel to the visual cortex, but also to higher cortical areas which
are thought to deal with the very quick perception of movement in the visual field. While
this presents another potential limitation of SVOP in assessing the visual field of patients with
defects as a result of visual cortex damage, it may also mean that SVOP could inadvertently
be making an assessment of the retinal ganglion cells which deal with “reacting to” rather than
“seeing” stimuli. In glaucoma patients, who potentially have damage to the retinal ganglion
cells which deal with “reacting” to stimuli, it may be possible that their initial saccadic reaction
to a “test stimulus” is different (perhaps less accurate) to those who are healthy, even though
the glaucoma patient still sees the “test stimulus”. If this is the case then the current SVOP
system which analyses only the first saccadic eye movement could be labelling such a visual
stimulus as “unseen” while on the HFA the stimulus would be registered by the patient as “seen”.
If this is the case it could be a reason for some of the disparities in comparative SVOP and HFA
test results for some of the adult glaucoma patients. At this stage, these are simply possible
ideas for future work. However, a form of SVOP which assesses the initial saccadic reaction
(and compares with normative data) could potentially be a screening test for glaucoma. This
of course would require further clinical experimental work. However, it would be reasonably
simple to implement using the existing SVOP system.
The young age of many of the child participants in the studies presented here also poses an
interesting question for any commercial application of the SVOP screening test. Perimetry
guidelines state that suprathreshold screening test stimuli should be presented at a known
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brightness level above the “expected” threshold values (unlike the current developed SVOP test
which uses a constant luminance level at all locations). These “expected” threshold values will
vary with age and the eccentricity of visual field angle being tested. Ordinarily the HFA does
do this for its default suprathreshold tests and in order to produce a comparative HFA test to
compare with the developed “single intensity” SVOP test in this research, the HFA test had
to be forced to present stimuli at a known constant brightness value. This was done because
otherwise it was not known at what brightness the HFA would be using during any test (it
would be dependent upon the HFA normative database values for different ages) and would be
a useless comparison. For the current SVOP technique to satisfy official perimetry guidelines
would it need to present stimuli above an expected threshold level, and if so, what would that
level be? The question of threshold values in young children (below approximately 7 years) is
still largely unanswered.
The developed SVOP technique performs well with accurate eye tracking data and an interested
child. The developed system has proved clinically useful in identifying and monitoring visual
field defects in several child patients who required regular visual field assessment such as those
with visual pathway tumours, and yet there are still improvements which can further enhance
the SVOP system described in this thesis.
Future work
Immediate future work includes implementing the improvements which can be made to the
current SVOP system. These improvements can be divided into two groups: (i) improvements
to hardware, and (ii) improvements to software. Hardware improvements include using a newer
model of eye tracker which has demonstrated improved eye location data. Additionally, im-
proved display screen technology has the possibility of reducing the previously described screen
luminance uniformity problems and providing the potential for displaying brighter stimuli and
an improved ability to display dimmer stimuli approaching normal threshold values. Software
improvements are several. The most important of which is improving the “decision algorithm”
so that it identifies gaze movements using more than just the first initial fixation change follow-
ing stimulus presentation. Other software improvements involve introducing a more interactive
“game-like” scenario for older children who may quickly become bored of the current strategy,
and methods to reduce the test duration.
Future clinical studies will involve visual field testing on a greater number of child patients
within specific patient groups. Additionally, more SVOP visual field testing in normal children,
in particular in the very young children and infants should be undertaken.
Further development work will include investigating the possibility of extending the current
SVOP suprathreshold test so that it can be used to perform threshold testing. This will be
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a particular challenge and will require a change in how the “test stimuli” are displayed as the
standard LCD screen used is not capable of faithfully reproducing the subtle changes approach-
ing normal threshold brightness values, and may well require different testing strategies.
208
References
[1] GN Dutton and LK Jacobson. Cerebral visual impairment in children. Semin Neonatol,
6(6):477–485, 2001.
[2] E Fazzi, SG Signorini, SM Bova, R La Piana, P Ondei, C Bertone, W Misefari, and
PE Bianchi. Spectrum of visual disorders in children with cerebral visual impairment. J
Child Neurol, 22(3):294–301, 2007.
[3] RS Lowery, D Atkinson, and SR Lambert. Cryptic cerebral visual impairment in children.
Br J Ophthalmol, 90(8):960–963, 2006.
[4] J Duin, G Cioni, B Bertuccelli, B Fazzi, C Romano, and A Boldrini. Visual outcome at
5 years of newborn infants at risk of cerebral visual impairment. Dev Med Child Neurol,
40(5):302–309, 1998.
[5] WC Huang and LS Lee. Visual field defects in patients with pituitary adenomas. Zhonghua
Yi Xue Za Zhi, 60(5):245–251, 1997.
[6] WV Good, JE Jan, L Desa, AJ Barkovich, M Groenveld, and CS Hoyt. Cortical visual
impairment in children. Surv Ophthalmol, 38(4):351–364, 1994.
[7] CE Gilbert, L Anderton, L Dandona, and A Foster. Prevalence of visual impairment in
children: a review of available data. Ophthalmic Epidemiol, 6:73–82, 1999.
[8] T Eke, JF Talbot, and MC Lawden. Severe persistent visual field constriction associated
with vigabatrin. Br Med J, 314(7075):180–181, 1997.
[9] IM Russell-Eggitt, DA Mackey, DS Taylor, C Timms, and JW Walker. Vigabatrin-
associated visual field defects in children. Eye, 14:334–339, 2000.
[10] EL Spencer and GFA Harding. Examining visual field defects in the paediatric population
exposed to vigabatrin. Doc Ophthalmol, 107(3):281–287, 2003.
[11] M Papadopoulos and PT Khaw. Advances in the management of paediatric glaucoma.
Eye, 21(10):1319–1325, 2007.
209
[12] EC de Souza, A Berezovsky, PH Morales, PA de Arruda Mello, PP de Oliveira Bonomo,
and SR Salomao. Visual field defects in children with congenital glaucoma. J Pediatr
Ophthalmol Strabismus, 37:266–272, 2000.
[13] RG Ross, AD Radant, DA Young, and DW Hommer. Saccadic eye movements in normal
children from 8 to 15 years of age: a developmental study of visuospatial attention. J
Autism Dev Disord, 24:413–431, 1994.
[14] DP Munoz, JR Broughton, JE Goldring, and IT Armstrong. Age related performance of
human subjects on saccadic eye movement tasks. Exp Brain Res, 121:391–400, 1998.
[15] E Mutlukan and BE Damato. Computerized perimetry with moving and steady fixation
in children. Eye, 7(4):554–561, 1993.
[16] SC Johnston, BE Damato, AL Evans, and D Allan. Computerised visual-field test for
children using multiple moving fixation targets. Med Biol Eng Comput, 27(6):612–616,
1989.
[17] R Lakowski and PA Aspinall. Static perimetry in young children. Vision Res, 9(2):305–
312, 1969.
[18] C Tschopp, AB Safran, P Viviani, A Bullinger, M Reicherts M, and C Mermoud. Auto-
mated visual field examination in children aged 5-8 years. part i: Experimental validation
of a testing procedure. Vision Res, 38(14):2203–2210, 1998.
[19] EZ Blumenthal, A Haddad, A Horani, and I Anteby. The reliability of frequency doubling
perimetry in young children. Ophthalmology, 111:435–439, 2004.
[20] J Morales and SM Brown. The feasibility of short automated static perimetry in children.
Ophthalmology, 108:157–162, 2001.
[21] GE Quinn, AM Fea, and N Minguini. Visual-fields in 4-year-old to 10-year-old children
using goldmann and double-arc perimeters. J Pediatr Ophthalmol Strabismus, 28(6):314–
319, 1991.
[22] M Wilson, G Quinn, V Dobson, and M Breton. Normative values for visual-fields in 4-
year-old to 12-year-old children using kinetic perimetry. J Pediatr Ophthalmol Strabismus,
28(3):151–153, 1991.
[23] JD Trobe, PC Acosta, JJ Shuster, and JP Krischer. An evaluation of the accuracy of
community-based perimetry. Am J Ophthalmol, 90:654–660, 1980.
[24] TE Inder, SK Warfield, H Wang, PS Huppi, and JJ Volpe. Abnormal cerebral structure
is present at term in premature infants. Pediatrics, 115:286–294, 2005.
210
[25] B Bengtsson and A Heijl. Sita fast, a new rapid perimetric threshold test: Description of
methods and evaluation in patients with manifest and suspect glaucoma. Acta Ophthalmol
Scand, 76:431–437, 1998.
[26] B Bengtsson, A Heijl, and J Olsson. Evaluation of a new threshold visual field strategy,
sita, in normal subjects. Acta Ophthalmol Scand, 76:165–169, 1998.
[27] J Morales, ML Weitzman, and M Gonsalez de la Rosa. Comparison between tendency-
oriented perimetry (top) and octopus threshold perimetry. Ophthalmology, 107:134–142,
2000.
[28] SP Donahue and A Porter. Sita visual field testing in children. J AAPOS, 5:114–117,
2001.
[29] SM Brown, JC Bradley, MJ Monhart, and DK Baker. Normal values for octopus tendency-
oriented perimetry in children 7 through 13 years old. Graefes Arch Clin Exp Ophthalmol,
243:886–893, 2005.
[30] AB Safran, GL Laffi, and A Bullinger. Feasibility of automated visual field examination
in children between 5 and 8 years of age. B J Ophthalmol, 80:515–518, 1996.
[31] IC Murray, BW Fleck, HM Brash, ME MacRae, LL Tan, and RA Minns. Feasibility
of saccadic vector optokinetic perimetry - a method of automated static perimetry for
children using eye tracking. Ophthalmology, 116:2017–2026, 2009.
[32] DB Elliott, I North, and J Flanagan. Confrontation visual field tests. Opthal Physiol Opt,
17:S17–S24, 1997.
[33] JP Ranjeet, K Gales, and PG Griffiths. Effectiveness of testing visual fields by confront-
ation. Lancet, 358:1339–1340, 2001.
[34] MD Sheridan. The stycar graded-balls vision test. Dev Med Child Neurol, 15:423–432,
1973.
[35] A Heijl and CET Krakau. An automatic perimeter, design and pilot study. Acta Oph-
thalmol, 53:293–310, 1975.
[36] A Heijl and CET Krakau. A note on fixation during perimetry. Acta Ophthalmol, 55:854–
861, 1977.
[37] RHS Carpenter. Movements of the eyes. Pion, London, 2nd edition, 1988.
[38] JE Hyde. Some characteristics of voluntary human ocular movements in the horizontal
plane. Am J Ophthalmol, 48(1):85–94, 1959.
211
[39] DA Robinson. The mechanics of human saccadic eye movements. J Physiol, 174:245–264,
1964.
[40] LL Wheeless, GH Cohen, and RM Boynton. Luminance as a parameter of the eye-
movement control system. J Opt Soc Am, (57):394–400, 1967.
[41] S de Brouwer, D Yuksel, G Blohm, M Missal, and P Lefèvre. What triggers catch-up
saccades during visual tracking? J Neurophysiol, 87(3):1646–1650, 2002.
[42] L R Young. Measuring eye movements. Am J Med Electron, 2:300–307, 1963.
[43] SJ Belcher. Ocular torsion. Br J Physiol Opt, 21:1–20, 1964.
[44] AP Petrov and GM Zenkin. Torsional eye movements and consistency of the visual field.
Vision Res, 13:2465–2477, 1973.
[45] EB Delabarre. A method of recording eye movements. Am J Psychol, 9:572, 1898.
[46] CH Judd, CN McAllister, and WM Steele. General introduction to a series of eye move-
ments by means of kinetoscope photographs. Psychol Monogr, 7:1, 1905.
[47] R Dodge. An experimental study of visual fixation. Psychol Monogr, 8(4):1, 1907.
[48] E Totten. Eye-spots for photographic records of eye-movments. J Comp Psychol, 6(3):287,
1926.
[49] GH Byford. A sensitive contact lens photoelectric eye movement recorder. Trans Bio-Med
Electron, 9:236–243, 1962.
[50] DA Robinson. A method of measuring eye movement using a scleral search coil in a
magnetic field. Trans Bio-Med Electron, 10:137–145, 1963.
[51] L Martin. Measurement of eye movements by contact lens techniques: Analysis of meas-
uring systems and some new methodology. J Opt Soc Am, 54(8):1008–1018, 1964.
[52] J Fukushima, T Hatta, and K Fukushima. Development of voluntary control of saccadic
eye movements - age related changes in normal children. Brain Dev, 22:173–180, 2000.
[53] U Schiefer, J Pätzold, and B Wabbels F Dannheim. Conventional techniques of visual
field examination: part 4 static perimetry: interpretation–perimetric indices–follow-up–
perimetry in childhood. Ophthalmologe, 103(3):235–254, 2006.
[54] U Schiefer, J Pätzold, and F Dannheim. Conventional techniques of visual field exam-
ination part 2: confrontation visual field testing – kinetic perimetry. Ophthalmologe,
102(8):821–827, 2005.
212
[55] C Tschopp, AB Safran, JL Laffi, C Mermoud, A Bullinger, and P Viviani. Automated
static perimetry in children - methodological and practical issues. Klin Monatsbl Augen-
heilkd, 206(5):416–419, 1995.
[56] C Tschopp, AB Safran, P Viviani, M Reicherts, A Bullinger, and C Mermoud. Automated
visual field examination in children aged 5-8 years. part ii: Normative values. Vision Res,
38(14):2211–2218, 1998.
[57] B Bengtsson and A Heijl. Evaluation of a new perimetric threshold strategy, sita, in
patients with manifest and suspect glaucoma. Acta Ophthalmol Scand, 76(3):268–272,
1998.
[58] H Stiebel-Kalish, M Lusky, Y Yassur, Y Kalish, A Shuper, R Erlich, S Lubman, and
M Snir. Swedish interactive thresholding algorithm fast for following visual fields in
prepubertal idiopathic intracranial hypertension. Ophthalmology, 111(9):1673–1675, 2004.
[59] BK Wabbels and S Wilscher. Feasibility and outcome of automated static perimetry in
children using continuous light increment perimetry (clip) and fast threshold strategy.
Acta Ophthalmol Scand, 83:664–669, 2005.
[60] Y Akar, A Yilmaz A, and I Yucel. Assessment of an effective visual field testing strategy
for a normal pediatric population. Ophthalmologica, 222(5):329–333, 2008.
[61] GE Quinn, DL Miller, JA Evans, WE Tasman, JA McNamara, and DB Schaffer. Meas-
urement of goldmann visual fields in older children who received cryotherapy as infants
for threshold retinopathy of prematurity. Arch Ophthalmol, 114(4):425–428, 1996.
[62] L Jacobson, A Rydberg, AC Eliasson, A Kits, and C Flodmark. Visual field function in
school-aged children with spastic unilateral cerebral palsy related to different patterns of
brain damage. Dev Med Child Neurol, 52(8):184–187, 2010.
[63] S Agrawal, DL Mayer, RM Hansen, and AB Fulton. Visual fields in young children treated
with vigabatrin. Optom Vis Sci, 86(6):767–773, 2009.
[64] E Gaily, H Jonsson, and M Lappi. Visual fields at school-age in children treated with
vigabatrin in infancy. Epilepsia, 50(2):206–16, 2009.
[65] TL Schwartz, V Dobson, DJ Sandstrom, and J van Hof-van Duin. Kinetic perimetry as-
sessment of binocular visual field shape and size in young infants. Vision Res, 27(12):2163–
2175, 1987.
[66] MF Cummings, J van Hof-van Duin, DL Mayer, RM Hansen, and AB Fulton. Visual
fields of young children. Behav Brain Res, 29(1-2):7–16, 1988.
213
[67] J van Hof-van Duin, DJ Heersema, F Groenendaal, W Baerts, and WP Fetter. Visual
field and grating acuity development in low-risk preterm infants during the first 2 1/2
years after term. Behav Brain Res, 49(1):115–122, 1992.
[68] GE Quinn, V Dobson, RJ Hardy, B Tung, DL Phelps, and EA Palmer. Visual fields meas-
ured with double-arc perimetry in eyes with threshold retinopathy of prematurity from
the cryotherapy for retinopathy of prematurity trial. the cryo-retinopathy of prematurity
cooperative group. Ophthalmology, 103(9):1432–1437, 1996.
[69] V Dobson, AM Brown, EM Harvey, and DB Narter. Visual field extent in children 3.5-30
months of age tested with a double-arc led perimeter. Vision Res, 38(18):2743–2760,
1998.
[70] A Guzzetta, B Fazzi, E Mercuri, B Bertuccelli, R Canapicchi, J van Hof-van Duin, and
G Cioni. Visual function in children with hemiplegia in the first years of life. Dev Med
Child Neurol, 43(5):321–329, 2001.
[71] S Wilscher, B Wabbels, and B Lorenz. Feasibility and outcome of automated kinetic
perimetry in children. Graefes Arch Clin Exp Ophthalmol, 248(10):1493–1500, 2010.
[72] RS Harwerth, L Carter-Dawson, EL Smith 3rd, G Barnes, WF Holt, and ML Crawford.
Neural losses correlated with visual field losses in clinical perimetry. Invest Ophthalmol
Vis Sci, 45:3152–3160, 2004.
[73] RS Harwerth, L Carter-Dawson, F Shen, Smith 3rd, and ML Crawford. Ganglion cell
losses underlying visual field defects from experimental gloucoma. Invest Ophthalmol Vis
Sci, 40:2242–2250, 1999.
[74] L Frisen. New, sensitive window on abnormal spatial vision: rarebit probing. Vision Res,
42:1931–1939, 2002.
[75] LM Martin. Rarebit and frequency-doubling technology perimetry in children and young
adults. Acta Ophthalmol Scand, 83:670–677, 2005.
[76] LM Martin and AL Nilsson. Rarebit perimetry and optic disc in pediatric glaucoma. J
Pediatr Ophthalmol Strabismus, 44(4):223–231, 2007.
[77] T Maddess and GH Henry. Performance of nonlinear visual units in ocular hypertension
and glaucoma. Clin Vision Sci, 7:371–383, 1992.
[78] KE Cello, JM Nelson-Quigg, and CA Johnson. Frequency doubling technology perimetry
for detection of glaucomatous visual field loss. Am J Ophthalmol, 129:314–322, 2000.
[79] AJ Anderson and CA Johnson. Frequency-doubling technology perimetry. Ophthalmol
Clin North Am, 16:213–225, 2003.
214
[80] DH Kelly. Frequency doubling in visual responses. J Opt Soc Am, 56:1628–1633, 1966.
[81] DH Kelly. Nonlinear visual responses to flickering sinusoidal gratings. J Opt Soc Am,
a71:1051–1055, 1981.
[82] CA Johnson and SJ Samuels. Screening for glaucomatous visual field loss with frequency-
doubling perimetry. Invest Ophthalmol Vis Sci, 38:413–425, 1997.
[83] K Becker and L Semes. The reliability of frequency doubling technology (fdt) perimetry
in a pediatric population. Optometry, 74(3):173–179, 2003.
[84] R Nesher, G Norman, Y Stern, L Gorck, E Epstein, Y Raz, and E Assia. Frequency
doubling technology threshold testing in the pediatric age group. J Glaucoma, 13(4):278–
282, 2004.
[85] LM Quinn, SK Gardiner, DT Wheeler, M Newkirk, and CA Johnson. Frequency doubling
technology perimetry in normal children. Am J Ophthalmol, 142(6):983–989, 2006.
[86] L Frisen. A computer graphics visual field screener using high-pass spatial frequency
resolution targets and multiple feedback devices. Doc Ophthalmol Proc Ser, 49:441–446,
1987.
[87] L Frisen. High-pass resolution targets in peripheral vision. Ophthalmology, 94:1104–1108,
1987.
[88] BC Chauhan. The value of high-pass resolution perimetry in glaucoma. Curr Opin
Ophthalmol, 11:85–89, 2000.
[89] M Marraffa, V Pucci, G Marchini, S Morselli, R Bellucci, and L Bonomi. Hpr perimetry
and humphrey perimetry in glaucomatous children. Doc Ophthalmol, 89:383–386, 1995.
[90] HA Baseler, EE Sutter, and SA Klein. The topography of visual evoked response prop-
erties across the visual field. Electroenceph Clin Neurophysiol, 90:65–81, 1994.
[91] AI Klistorner, SL Graham, JR Grigg, and FA Billson. Multifocal topographic visual
evoked potential: improving objective detection of local visual field defects. Invest Oph-
thalmol Vis Sci, 39:937–950, 1998.
[92] GFA Harding, EL Spencer, JMWild, and RL Bohn. Field-specific visual-evoked potentials
- identifying field defects in vigabatrin-treated children. Neurology, 58(8):1261–1265, 2002.
[93] E Yukawa, YJ Kim, K Kawasaki, F Taketani, and Y Hara. A child with epilepsy in
whom multifocal veps facilitated the objective measurement of the visual field. Epilepsia,
46(4):577–579, 2005.
215
[94] C Balachandran, AI Klistorner, and F Billson F. Multifocal vep in children: its maturation
and clinical application. Br J Ophthalmol, 88(2):226–232, 2004.
[95] JP Kelly and AH Weiss. Comparison of pattern visual-evoked potentials to perimetry in
the detection of visual loss in children with optic pathway gliomas. J AAPOS, 10(4):298–
306, 2006.
[96] YJ Kim, E Yukawa, K Kawasaki, H Nakase, and T Sakaki. Use of multifocal visual evoked
potential tests in the objective evaluation of the visual field in pediatric epilepsy surgery.
J Neurosurg, 104(3):160–165, 2006.
[97] BE Damato. Oculokinetic perimetry: a simple visual field test for use in the community.
Br J Ophthalmol, 69:927–931, 1985.
[98] A Hermann, J Paetzold, R Vonthein, E Krapp, S Rauscher, and U Schiefer. Age-dependent
normative values for differential luminance sensitivity in automated static perimetry using
the octopus 101. Acta Ophthalmol, 86(4):446–455, 2008.
[99] BJ Katz and HD Pomeranz. Visual field defects and retinal nerve fiber layer defects in
eyes with buried optic nerve drusen. Am J Ophthalmol, 141(2):248–253, 2006.
[100] N Calixto, RM Santos, and S Cronemberger. Visual field (octopus 1-2-3) in normal
subjects divided into homogeneous age-groups. Arq Bras Oftalmol, 69(5):637–643, 2006.
[101] E Larsson, L Martin, and G Holmström. Peripheral and central visual fields in 11-year-old
children who had been born prematurely and at term. J Pediatr Ophthalmol Strabismus,
41(1):39–45, 2004.
[102] L Lobefalo, A Verrotti, L Mastropasqua, G Della Loggia, V Cherubini, G Morgese,
PE Gallenga, and F Chiarelli. Blue-on-yellow and acromatic perimetry in diabetic chil-
dren without retinopathy. Diabetes Care, 21(11):2003–2006, 1998.
[103] L Lobefalo, A Verrotti, L Mastropasqua, F Chiarelli, G Morgese, and PE Gallenga. Flicker
perimetry in diabetic children without retinopathy. Can J Ophthalmol, 32(5):324–328,
1997.
[104] AI Klistorner and SL Graham. Multifocal pattern vep perimetry: analysis of sectoral
waveforms. Doc Ophthalmol, 98(2):183–196, 1999.
[105] DC Hood, x Zhang, and BJ Winn. Detecting glaucomatous damage with multifocal visual
evoked potentials: how can a monocular test work? J Glaucoma, 12(1):3–15, 2003.
[106] E Alvarez, BE Damato, JL Jay, and E McClure. Comparative evaluation of oculokinetic
perimetry and conventional perimetry in glaucoma. Br J Ophthalmol, 72(4):258–262,
1988.
216
[107] N Ideguchi, Y Nakano, and K Nunokawa. Development of an objective automatic peri-
metry using saccadic eye movement. Proceedings of Vision, 2005.
[108] K Nunokawa, N Ideguchi N, and Y Nakano. The influence of fixation on new visual field
measurement using saccadic eye movement. Proceedings of Vision, 2005.
[109] LJ Alexander, DA Corliss, C Vinson, L Casser J Williams, M Fingeret, V Malinovsky, and
JC Townsend. Clinical implications of intra- and inter-reader agreement in four different
automated visual fields. J Am Optom Assoc, 66(11):681–692, 1995.
[110] A Hard-Boberg and JD Wirtschafter. Evaluating the usefulness in neuro-ophthalmology
of visual field examination peripheral to 30 degrees. Doc Ophthal Proceedings Series,
42:197–206, 1985.
[111] JL Keltner, CA Johnson, JO Spurr, and RW Beck. Comparison of central and peri-
pheral visual field properties in the optic neuritis treatment of trial. Am J Ophthalmol,
128(5):543–553, 1999.
[112] FH Raab, EB Blood, TO Steiner, and HR Jones. Magnetic position and orientation
tracking system. IEEE Transactions on Aerospace and Electronic Systems, 15(5):709–
717, 1979.
[113] MA Nixon, BC McCallum, and NB Price. The effects of metals and interfering fields on
electromagnetic trackers. Presence: Teleoperators and Virtual Environments, 7(2):204–
218, 1998.
[114] J Elvesjo, M Skogo, and G Elvers. Tobii technology. method and intallation for detecting
and following an eye and the gaze direction thereof. Patent WO 2004/045399 A1, 3 June
2004.
[115] A Heijl, A Lindgren, and G Lindgren G. Test-retest variability in glaucomatous visual
fields. Am J Ophthalmol, 108:130–135, 1989.
[116] YH Kwon, HJ Park, A Jap, S Ugurlu, and J Caprioli J. Test-retest variability of blue-
on-yellow perimetry is greater than white-on-white perimetry in normal subjects. Am J
Ophthalmol, 126:29–36, 1998.
[117] DB Henson, S Chaudry, PH Artes, EB Faragher, and A Ansons. Response variability in
the visual field: comparison of optic neuritis, glaucoma, ocular hypertension, and normal
eyes. Invest Ophthalmol Vis Sci, 41:417–421, 2000.
[118] M Wall, KR Woodward, CK Doyle, and PH Artes. Repeatability of automated perimetry:
a comparison between standard automated perimetry with stimulus size iii and v, matrix,
and motion perimetry. Invest Ophthalmol Vis Sci, 50:974–979, 2009.
217
[119] AT Duchowski. Eye tracking methodology: theory and practice. Springer-Verlag, London,
2nd edition, 2007.
[120] DB Granet and S Khayali. Amblyopia and strabismus. Pediatr Ann, 40(2):89–94, 2011.
[121] Humphrey Field Analyzer II-i series User Manual. 2005.
[122] TW Loong. Understanding sensitivity and specificity with the right side of the brain.
BMJ, 327:716–719, 2003.
[123] J Cohen. A coefficient of agreement for nominal scales. Educ Psychol Meas, 20:37–46,
1960.
[124] DG Altman. Practical Statistics for Medical Research. Chapman and Hall, London, 1991.
[125] A Heijl and VM Patella. Essential Perimetry. Carl Zeiss Meditec AG, Gena, Germany,
3rd edition edition, 2002.
[126] AJ Viera and JM Garrett. Understanding interobserver agreement: the kappa statistic.
Fam Med, 37(5):360–363, 2005.
[127] M Fingeret, E Smith, L Reminick, and C Johnson. Frequency doubling technology peri-
metry as a screening tool in the general ophthalmic elderly population. in perimetry
update 2000/2001. Ed. M Wall and RP Mills, pages 271–275, 2001.
[128] D Ooi, ED Cornell, IS Curthoys, AM Burgess, and HG MacDougall. Convergence reduces
ocular counterroll (ocr) during static roll-tilt. Vision Res, 44:2825–2833, 2004.
[129] HD Schworm, J Ygge, T Pansell, and G Lennerstrand. Assessment of ocular counterroll
during head tilt using binocular video oculography. Invest Ophthalmol Vis Sci, 43(3):662–
667, 2002.




The table below details the ethical applications relevant to this research. Both of these applic-
ations were approved by the Lothian research ethics committee, and were also granted NHS
research and development approval.
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Tobii x50 eye tracker data fields
All data fields supplied by the Tobii x50 eye tracker (at a frequency of 50Hz).
Data Field Description (units)
Time stamp (Second) Time stamp when data was sampled
Time stamp (Microsecond) Microsecond fraction of time stamp when data was
sampled
Left eye horizontal gaze point X screen location of left eye gaze point (0-1, where 0 is left
edge of screen)
Left eye vertical gaze point Y screen location of left eye gaze point (0-1, where 0 is
top edge of screen)
Left eye horizontal position as
seen by eye tracker
X position of left eye in eye tracker camera field of view
(0-1, where 0 is left)
Left eye vertical position as seen
by eye tracker
Y position of left eye in eye tracker camera field of view
(0-1, where 0 is top)
Left eye distance (mm) Distance of the left eye from the eye tracker (mm)
Left eye validity code An estimate of how valid data for this sample is (0-4, see
“Validity Codes” below)
Left eye pupil size (mm) The length of the longest chord of the left pupil ellipse
Right eye horizontal gaze point X screen location of right eye gaze point (0-1, where 0 is
left edge of screen)
Right eye vertical gaze point Y screen location of right eye gaze point (0-1, where 0 is
top edge of screen)
Right eye horizontal position as
seen by eye tracker
X position of right eye in eye tracker camera field of view
(0-1, where 0 is left)
Right eye vertical position as
seen by eye tracker
Y position of right eye in eye tracker camera field of view
(0-1, where 0 is top)
Right eye distance (mm) Distance of the right eye from the eye tracker (mm)
Right eye validity code An estimate of how valid data for this sample is (0-4, see
“Validity Codes” below)
Right eye pupil size (mm) The length of the longest chord of the right pupil ellipse
220
Validity Codes
The validity codes are an estimate of how certain the eye tracker is that the data given for
an eye really belongs to that eye. The validity code takes one of five values for each each eye
ranging from 0 to 4, with the following interpretations:
0 - The eye tracker is certain that the data for this eye is correct. There is no risk of confusing
data from the other eye.
1 - The eye tracker has only detected one eye, and has made some assumptions and estimations
regarding which is the left and which is the right eye (primarily based on the location of the
eye within the camera field of view). The validity code for the other eye in this case is always
set to 3.
2 - The eye tracker has only detected one eye, and has no way of determining which one is the
left and which one is the right eye. The validity code for both eyes is set to 2.
3 - The eye tracker is fairly confident that the actual gaze data belongs to the other eye. The
other eye will always have a validity code of 1.
4 - The data is missing or definitely belongs to the other eye.
Hence there are a limited number of possible combinations of validity codes for the two eyes
which are described in the table below:
Validity codes (left eye - right eye) Description
0 - 0 Both eyes found. Data is valid for both eyes.
0 - 4 or 4 - 0 One eye found. Gaze data is the same for both eyes.
1 - 3 or 3 - 1 One eye found. Gaze data is the same for both eyes.
2 - 2 One eye found. Gaze data is the same for both eyes.
4 - 4 No eyes found. Gaze data for both eyes is invalid.
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